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Abstract 
The Drosophila innate immune system is one of the most widely characterised of all 
metozoan defense systems, and shares many similar characteristics to the innate 
immune systems of higher organisms. As such, Drosophila has become the model 
organism of choice for many researchers with regards to the study of the general 
mechanisms and regulatory elements of innate immunity. There are a number of 
mechanisms that Drosophila employ in order to combat infection, and these include 
both humoral and cellular responses. However, perhaps the most widely characterised 
of these mechanisms is the systemic production of anti-micorobial peptides (AMPs) via 
the activation of two specific immune signalling pathways – Toll and Imd (Lemaitre et 
al. 1995a; Belvin and Anderson 1996). 
 
In Drosophila, a number of recent studies have identified a role for the diffusible 
second messenger nitric oxide (NO) in the positive regulation of the Imd pathway, a 
pathway that is fundamental to host defence against Gram-negative bacteria (Lemaitre 
et al. 1995a; Nappi et al. 2000; Foley and O'Farrell 2003; McGettigan et al. 2005). To 
date, the exact mechanism by which NO is mediating its effects on the Imd pathway has 
not yet been determined. However, it can be suggested that this effect is mediated 
through activation of the cGMP signalling pathway, via interaction with one of its 
upstream components, soluble guanylate cyclase (sGC), the main intracellular target for 
NO (Marletta and Spiering 2003).   
 
Therefore, the aim of this study was to determine the potential role of the cGMP 
signalling pathway on regulation of the Drosophila Imd immune pathway. To do this, 
the Drosophila Malpighian (renal) tubule was used as a model system. The Malpighian 
tubule is a very well characterised, extensively studied epithelial tissue and for a 
number of years has comprised the model system of choice with regards to the study of 
the epithelial roles of signalling and transport genes (Dow and Davies 2001). The 
suitability of this tissue as a model system for this study is two-fold: Firstly, for many 
years, the NO/cGMP signalling pathway has been deemed as critical to tubule function 
(Dow et al. 1994a). Secondly, a recent study has identified the tubule as an important 
autonomous immune-sensing tissue where, upon immune challenge with Gram-negative 
bacteria, Imd pathway-associated AMPs are systemically produced in the tubule 
principle cells. Importantly, it has been demonstrated that activation of the Imd pathway 
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in the principle cells is regulated via the autocrine production of NO (McGettigan et al. 
2005).   
 
Data obtained from this study has demonstrated a completely novel role for cGMP 
signalling in the tubule. Expression analysis has revealed that cGMP acts to modulate 
the expression of Imd pathway-associated AMPs in a dose-dependent manner; whereby 
low nanomolar concentrations are shown to stimulate diptericin expression and higher 
micromolar concentrations of cGMP are shown to inhibit it. This effect does not appear 
to extend to the fat body, the canonical tissue involved in the systemic induction of 
AMPs, thus suggesting a completely tissue-specific mechanism. 
 
Importantly, it is shown here that the cognate cGMP-dependent protein kinases (cGKs), 
DG1 and DG2 (MacPherson et al. 2004a; 2004b), mediate differential effects on AMP 
production in the tubule. Targeted modulation of the expression of these kinases to the 
principle cells of the tubule using the GAL4/UAS system demonstrates that activation 
of DG1 mediates positive modulation of diptericin expression in the tubule. By contrast, 
negative modulation of diptericin expression is shown to occur following the activation 
of the two main isoforms of DG2, DG2P1 and DG2P2. These data therefore describe a 
completely novel role for each of these kinases. Significantly, the effects of these 
kinases on diptericin expression in the tubule are sufficient to impact on survival of the 
whole fly in response to septic infection with Gram-negative bacteria, as well as 
contribute significantly to bacterial clearance in the gut following natural infection with 
E.coli. This study has therefore revealed a critical novel role for both the tubule and 
cGKs in the regulation of defence mechanisms in response to both septic and natural 
infection in the adult fly.  
 
Interestingly, Q-PCR has revealed that DG1 mediates its effects downstream of Imd. 
Additionally, studies have revealed that both DG1 and DG2 act to regulate the Imd 
pathway via modulation of Relish activation, the NFκB transcription factor responsible 
for the induction of AMPs following activation of the Imd pathway (Hedengren et al. 
1999). Translocation assays have demonstrated that targeted over-expression of dg1 to 
the principal cells of the tubule results in enhanced translocation of activated Relish into 
the nucleus, whereas targeted knock-down of this kinase by RNAi results inhibition of 
Relish activation. In contrast to DG1, overexpression of either dg2P1 or dg2P2 to the 
principal cells of the tubule results in inhibition of Relish activation, even in the 
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presence of immune challenge. However, this study has not revealed the exact 
mechanism by which these kinases mediate their effects on Relish activation, and 
therefore it is not clear whether DG1 and/or DG2 are acting directly on Relish, or 
indirectly via phosphorylation of an, as of yet, unidentified substrate(s). Despite this, a 
completely novel function for each of these kinases is described here for the first time. 
 
Importantly, data described in this study also identifies that, with regards to Imd 
pathway regulation, DG1 and DG2 may be activated via different sources of cGMP 
within the cell. Data shows that stimulation of the Imd pathway in the tubule is 
facilitated by the activation of sGC via interaction with NO. Alternatively, inhibition of 
the Imd pathway in the tubule is shown to be facilitated by the activation of a receptor 
guanylate cyclase (rGC). Additionally, it is demonstrated by this study that cGMP-
mediated inhibition of the Imd pathway in the tubule is regulated by the dual-specificity, 
tubule-enriched phosphodiesterase (PDE), PDE11 (Day et al. 2005), thus describing a 
functional role for this regulatory enzyme for the first time in Drosophila.  
 
In conclusion, this study further validates the role of the tubule as a critical immune-
sensing tissue in Drosophila melanogaster. In addition, a completely novel role for the 
cGMP signalling pathway, as a differential regulator of Imd pathway activation in the 
tubule, is described here for the first time. In particular, an important novel functional 
role for each of the Drosophila cGKs, DG1 and DG2, is revealed. The data shown in 
this study therefore contributes to fuller understanding of not only Imd pathway 
regulation in Drosophila, but also provides a significant advance in the understanding 
of the complexities of cGMP signalling and its regulation of tubule function. 
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1.1 Innate immune response 
1.1.1 Introduction 
There are two systems that eukaryotes utilise to combat microbial invasion – the acquired 
immune system and the innate immune system. The acquired immune system operates by 
producing receptors through somatic gene rearrangement that recognise specific antigens, 
therefore allowing organisms to develop immunological memory. Alternatively, the 
innate immune system relies on germline-encoded receptors for detection of microbes 
(Janeway 1989). Vertebrates are capable of activating both of these systems, where the 
innate immune system acts as the first line of defence against microbial attack. However 
in invertebrates, innate immunity is the sole mechanism employed to combat infection 
(Brennan and Anderson 2004). Understanding the mechanisms which regulate innate 
immune responses is therefore of major importance. 
 
1.1.2 Drosophila melanogaster as a model organism for innate immunity 
Over the years, insects have emerged as ideal model organisms for the study of innate 
immune function. Many important discoveries were made initially in Lepidopteron 
insects such as the silkworm Bombyx mori and later in moths such as Hyalophora 
cecropia, Trichoplusia ni and Manduca Sexta, where their large size made them suitable 
for biochemical work (Steiner et al. 1981; Yoshida et al. 1996). However, in recent years, 
studies using the fruit fly Drosophila melanogaster have emerged as fundamental to the 
contribution of knowledge within the field. This was first illustrated by Lemaitre et al 
(1995b) who identified a key regulatory signalling pathway involved in innate immune 
response in Drosophila. These findings subsequently led to the discovery that 
components of this pathway are highly conserved amongst all metazoans, thus 
establishing insects as the ideal models to study general innate immune mechanisms in 
higher animals. 
 
Since this discovery, Drosophila has by far become the preferred and most potent model 
organism for studies into innate immunity and with good reason. Firstly, Drosophila has 
been studied as a model organism for over 100 years and as a result more is known about 
the genetics of this insect than any other multi-cellular animal. The wealth of information 
that has been gathered about Drosophila over the past century has subsequently led to the 
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development of an array of both molecular and genetic techniques that make Drosophila 
the most easily manipulated of any model organism. Additionally, the completion of the 
Drosophila genome project has only further enhanced the benefits of using Drosophila as 
the model of choice. Drosophila has therefore proved invaluable in the last 10 years with 
regards to studies in innate immunity and has been instrumental in the rapid progress of 
the field.    
 
 
  
Figure 1.1 - Immune response mechanisms of Drosophila melanogaster. To combat infection, 
Drosophila employs a plethora of defence mechanisms that can be divided into both humoral and cellular 
responses. Humoral responses include the systemic production of anti-microbial peptides, which are 
secreted into the hemolymph to directly kill invading pathogens; melanization and coagulation around the 
wound site via specific signalling cascades; and production of reactive oxygen species in response to 
natural infection. Cellular responses mainly involve the haemocytes, which play a part in both 
encapsulation and phagocytosis of invading pathogens. Anti-microbial peptides are also produced locally in 
epithelial tissues as a result of natural infection 
 
 
1.1.3 Innate Immune Response in Drosophila melanogaster 
The innate immune response in Drosophila is known to manifest itself in a number of 
ways, many of which are shared with higher organisms, and can be divided into both 
humoral and cellular responses (Figure 1.1). Humoral responses include the systemic 
production of anti-microbial peptides (AMPs) via specific signalling pathways (Lemaitre 
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et al. 1995a), melanization and coagulation at the site of injury (Nappi and Vass 1993; 
Muta and Iwanaga 1996) and production of reactive intermediates of oxygen or nitrogen 
in response to natural infection (Nappi et al. 2000; Ha et al. 2005b). Cellular responses in 
Drosophila are mainly mediated by blood cells where invading microbes are 
encapsulated and destroyed by specific haemocytes (Meister 2004). In addition, barrier 
epithelia such as the gut and trachea, which are in constant contact with large numbers of 
microorganisms through natural infection, are known to produce AMPs locally 
(Ferrandon et al. 1998; Tzou et al. 2000). Together, the above responses encompass a 
sophisticated defence mechanism to combat infection. The immune response mechanisms 
that form the focus of this thesis, namely the systemic immune response, the mechanisms 
involved in natural infection and the involvement of nitric oxide in immunity, are 
described in detail below.  
 
1.1.3.1 Systemic Immune Response 
1.1.3.1.1 Overview 
The systemic immune response is by far the most extensively characterised of innate 
immune mechanisms in Drosophila and consists of three distinct steps: detection of 
pathogen, activation of the appropriate NFκB signalling pathway (known as the Toll and 
Imd pathways) and production of anti- microbial peptides (Silverman and Maniatis 2001). 
Over the years, considerable progress has been made in identifying and characterising the 
various components of the signalling cascades involved in the systemic immune response, 
resulting in an enhanced understanding of both its activation and regulation. 
 
1.1.3.1.2 Detection of invading pathogens  
Drosophila detects the presence of invading microorganisms through molecules known 
as pathogen-associated molecular patterns (PAMPs), which are absent on host cells and 
therefore serve as discriminators between self and non-self (Janeway 1989). Examples of 
PAMPs include such molecules as β-1,3-glucan of fungi, phosphoglycan of parasites and 
peptidoglycan (PGN) and lipopolysaccharide (LPS) of bacteria, although the effect of 
LPS has been questioned (Leulier et al. 2003). Each of these molecules contains 
repetitive patterns in their structure, e.g. alternating chains of N-acetylmuramic acid and 
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N-acetylglucosamine residues in PGN, that are recognised by specific host pattern 
recognition receptors (PRRs) (Medzhitov and Janeway 1997).  
 
To date, most pathogen recognition studies have focused on PGN recognition in bacteria 
as opposed to the recognition of other PAMPs. PGN is an essential glucopeptidic 
polymer consisting of long glycan chains, cross-linked to each other by short peptide 
bridges.  There are marked differences in the PGN between different bacteria, i.e. gram-
positive and gram-negative bacteria, and it is these differences that ultimately determine 
how the bacteria are recognised (Mengin-Lecreulx and Lemaitre 2005). In recent years a 
significant breakthrough has been achieved with the identification of PGN recognition 
proteins or PGRPs (Steiner 2004). PGRPs were first discovered in 1996 by Yoshida et al 
where a 19kDa protein was purified from the hemolymph of Bombyx mori and found to 
bind strongly to PGN, as well as play a role in activation of the prophenoloxidase (ProPO) 
cascade involved in melanisation (Ashida 1990; Yoshida et al. 1996). Since this initial 
discovery a whole family of PGRPs has emerged and have found to be highly conserved 
from insects to mammals.  
 
In Drosophila, there are 13 PGRP genes that are spliced into 19 different transcripts. 
These transcripts are spilt into two different classes of either short (S) or long (L) 
transcripts and can exhibit either enzymatic or recognition properties (Werner et al. 2000). 
Those that exhibit, or are predicted to exhibit, enzymatic properties (PGRP-SC1, LB, 
SB1, SC2, SC2) are referred to as catalytic PGRPs. These PGRPs are known to 
demonstrate zinc-dependant amidase activity that reduces the biological activity of PGN 
by removing peptides from the glycan chains, thus converting the PGN into non-
immunostimulatory fragments (Mellroth et al. 2003; Zaidman-Remy et al. 2006). Studies 
have indicated that catalytic PGRPs act as scavengers to control levels of PGN (Mellroth 
et al. 2003). The result of this is a negative feedback loop that controls Imd and Toll 
pathway activity levels and ensures the appropriate degree of immune activation.  
 
Alternatively, other PGRPs (PGRP-SA, SD, LA, LC, LE, LF) lack amidase activity but 
still bind strongly to PGN and act solely as recognition proteins (Werner et al. 2000). Of 
these PGRPs, epistatic and phenotypic analysis has indicated membrane-bound PGRP-
LC as the major recognition protein for the activation of the Imd pathway, through the 
recognition of DAP-type PGN from Gram-negative bacteria (Gottar et al. 2002). Three 
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different splice variants of PGRP-LC exist (LCa, LCx and LCy) where each share the 
same intracellular signalling domain but have different extracellular sensing domains 
(Kaneko et al. 2004). Additionally, another PGN recognition protein, PGRP-LE, is 
thought to be involved in activation of the Imd pathway. PGRP-LE also has an affinity to 
DAP-type PGN and is expressed both extracellularly, where it enhances PGRP-LC PGN 
recognition, and intracellularly, where it interacts with any monomeric PGN in the 
cytoplasm that has passed through the cell membrane due to its small size (Takehana et al. 
2002; 2004).  
 
Alternatively, activation of the Toll pathway in response to bacteria is thought to be 
mediated by PGRP-SA. PGRP-SA is a secreted PGRP that is present in the hemolymph 
and recognises the Lys-type PGN of Gram-positive bacteria (Michel et al. 2001). Recent 
studies have indicated that PGRP-SA may form a complex with another type of pattern 
recognition receptor known as GNBP1 (Gram-negative binding protein), which was 
originally thought to bind to the LPS of Gram-negative bacteria (Gobert et al. 2003). 
GNBP1 shares sequence homology with bacterial β-glucanases and current hypothesis 
suggests that it plays a role in degrading Gram-positive PGN. The degraded PGN is then 
thought to be recognised by PGRP-SA (Wang et al. 2006). Additionally, another secreted 
PGRP, PGRP-SD, is thought to play a roll in Toll pathway activation where it is thought 
to cooperate with PGRP-SA and GNBP1 to allow the detection of some Gram-positive 
bacteria such as Staphylococcus aureus (Bischoff et al. 2004).  
 
In addition to recognition of bacteria, specific PRRs are utilised to recognise other forms 
of potential pathogen such as fungi. In Drosophila, some types of fungi are recognised by 
the presence of β-1,3-glucan and recent studies have suggested that the GNBP family are 
involved in this recognition (Bangham et al. 2006). As mentioned earlier, the GNBP 
family share a high sequence homology to bacterial glucanases and in Drosophila there 
are 3 members of this family (Kim et al. 2006). Of these, GNBP3 has been shown to 
contain a highly similar sequence to that of the Lepidopteran β-glucan recognition 
proteins, which are known to bind to fungal β-1,3-glucans (Ochiai and Ashida 1988). It is 
therefore suggested that GNBP3 acts as a fungal PRR, further supported by the reported 
sensitivity of GNBP3 mutants to fungal infection. These mutants are also unable to 
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activate the Toll pathway, known to be the signalling pathway activated as a response to 
fungal infection (Gottar et al. 2006). 
 
1.1.3.1.3 NFκB immune signalling: The Toll pathway 
Throughout the 1980’s and into the early 1990’s, significant progress was made in the 
insect immunity field, with the discovery of a battery of anti-microbial peptides and the 
genes that encode them (Steiner et al. 1981; Hultmark et al. 1983; Wicker et al. 1990).  
The mechanisms that regulate the production of these peptides remained elusive, however 
subsequent sequencing of these genes resulted in the discovery of sequence motifs similar 
to those recognised by the mammalian nuclear factor-κB (NFκB)/REL family of 
transcription factors (Lemaitre 2004). Since that time, NFκB transcription factors and the 
signalling pathways that control them have been established as fundamental to the 
regulation of Drosophila systemic immune response, and represent the crucial link 
between microbial recognition and the anti-microbial response that follows.  
 
The first of these pathways to be identified in Drosophila is known as the Toll pathway, 
so called after one of its main components – the Toll receptor (Lemaitre et al. 1996). The 
gene encoding Toll was discovered in the early 1980’s, however it was originally 
classified as an essential component in the establishment of the dorso-ventral axis of the 
Drosophila embryo, as well as several other developmental processes (Belvin and 
Anderson 1996). The connection between the Toll pathway and immune response was 
not made until the mid-1990s when several research groups identified a number of 
similarities between the Drosophila Toll pathway and the interleukin-1 receptor (IL-1R) 
signalling cascade in mammals (Lemaitre et al. 1996). The Toll and IL-1R receptors are 
highly similar and share an intra-cytoplasmic homology domain, known as a Toll/IL 
receptor (TIR) domain. Activation of these receptors results in a signalling cascade 
leading to the eventual nuclear translocation of NFκB transcription factors (Gay and 
Keith 1991). The IL-1R pathway was already known to induce the expression of several 
immune effector genes in mammals, suggesting that the Toll pathway might play a role in 
immune response in Drosophila (Gay and Keith 1991). This hypothesis was supported by 
the fact that NFκB transcription sites had already been identified in Drosophila AMP 
gene sequences (Engstrom et al. 1993).  
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Since that time, the Toll pathway has emerged as the key pathway involved in both anti-
fungal and, to a degree, anti-bacterial (Gram-positive only) responses (Rutschmann et al. 
2000b; 2002). Over the years, most of the main components of the pathway have been 
identified and its activation and regulation has been widely characterised (Figure 1.2) 
(Lemaitre 2004). The pathway is dependent on an extracellular cysteine-knot polypeptide 
dimer known as Spaetzle, which is activated after cleavage via specific serine protease 
(SP) cascades (Weber et al. 2003; Hu et al. 2004). With regards to immunity, the serine 
proteases involved in the cleavage of Spaetzle differ depending on the nature of the 
invading microbe, and are initiated by recognition molecules such as PGRP-SA/GNBP-1, 
PGRP-SD (Gram-positive bacteria) and GNBP-3 (fungi) (Michel et al. 2001; Gobert et al. 
2003; Gottar et al. 2006; Wang et al. 2006). In addition, certain types of 
entomopathogenic fungi are thought to be able to activate an SP cascade directly, via the 
serine protease Persephone (Ligoxygakis et al. 2002). Once activated, Spaetzle binds to 
the Toll receptor and induces dimer formation (Weber et al. 2003). This leads to a 
cytoplasmic cascade that begins with recruitment of three Death-domain containing 
proteins - the adaptor proteins MyD88 and Tube, and the kinase Pelle (Lemaitre et al. 
1996; Tauszig-Delamasure et al. 2002). Cactus, an NFκB- inhibitor protein recognised by 
its ankyrin repeats and similar to mammalian IκB, is then phosphorylated and 
subsequently targeted by the proteasome for degradation (Nicolas et al. 1998). It should 
be noted that the mechanism of this step is not well characterised, however it is known 
that Cactus is not directly phosphorylated by Pelle, but is thought to be phosphorylated 
by an as of yet unidentified kinase (Nicolas et al. 1998). Removal of Cactus results in 
subsequent activation of the NFκB/Rel transcription factors Dorsal and/or Dorsal-like 
immune factor (Dif), which are analogous to the Rel family of proteins in mammals and 
contain an N-terminal Rel-homology domain (RHD (Lemaitre et al. 1995b; Manfruelli et 
al. 1999). Activation of these transcription factors results in their translocation into the 
nucleus as dimers, where the production of specific AMPs such as drosomycin, 
metchnikowin (fungi) and defensin (Gram-positive bacteria) is induced (Ip et al. 1993; 
Reichhart et al. 1993; Rutschmann et al. 2000a; 2002). 
 
Since the initial discovery that the Toll pathway was involved in the systemic immune 
response, eight other Toll receptors have been identified in Drosophila, although none of 
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these have yet been clearly implicated as playing a role in immunity (Tauszig et al. 2000). 
In fact, most of these receptors are expressed strongly during normal embryonic and 
pupal development, and are therefore presumed to have important developmental 
functions. Additionally, the discovery of Toll as an immune receptor in Drosophila has 
led to a breakthrough in mammalian immunity studies, with the identification of a whole 
family of Toll-like receptors (TLRs) and their ligands. Remarkably, it has been 
demonstrated that mammalian TLRs are important in the control of both innate and 
adaptive immune responses. In addition, unlike the Drosophila Toll receptor, TLRs have 
been identified to function as recognition receptors in their own right, and interact 
directly with invading microbes (Hoebe et al. 2006). 
 
1.1.3.1.4 NFκB immune signalling: The Imd pathway 
The Imd pathway was initially defined via the serendipitous discovery of a mutation, 
subsequently named immune deficiency (imd), which impaired the expression of several 
characterised AMP genes (Lemaitre et al. 1995a; Georgel et al. 2001). Since its 
identification, Imd has been characterised as a 30kDa adaptor protein, containing a C-
terminal death domain and shown to share similarities to a mammalian protein, Receptor 
Interacting Protein (RIP). RIP is involved in the tumour necrosis factor receptor (TNF-R) 
signalling pathway and is known to be essential for both NFκB and mitogen activated 
protein kinase (MAPK) activation (Georgel et al. 2001). Therefore, rather unsurprisingly, 
Imd has since been recognized as a key component of an NFκB signalling cascade, now 
known as the Imd pathway. In recent years, the Imd pathway has emerged as fundamental 
to the production of AMPs in response to Gram-negative bacteria, therefore providing a 
complimentary role to that of the Toll pathway. So far, due to a combination of both 
genetic screens and reverse genetic approaches, eight additional canonical components of 
the Imd pathway have been identified (Figure 1.2) (Lemaitre et al. 1995a; Dushay et al. 
1996; Lu et al. 2001; Leulier et al. 2002; Silverman et al. 2003; Kleino et al. 2005).  
 
Unlike Toll, Imd is an intracellular protein and is therefore not dependent on an 
extracellular ligand for its activation. Instead, Imd interacts directly through both its N-
terminal and C-terminal domains with the cytoplasmic domain of the membrane-bound 
PGRP-LC, which, as mentioned previously, acts as a recognition receptor for DAP-type  
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Figure 1.2 – The Drosophila Toll/Imd Immune Pathways. The Toll pathway (left) is activated in 
response to gram-positive bacteria and fungi and the Imd pathway (right) is activated by gram-negative 
bacteria.  Activation of these pathways leads to signalling cascades that results in the activation of 
NFκB/REL transcription factors known as Dif, Dorsal (Toll pathway) and Relish (Imd pathway). These 
transcription factors are known to translocate into the nucleus as dimers where they initiate the expression 
of anti-microbial transcription factors. SP = serine protease;              = mechanism not confirmed. 
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PGN (Gottar et al. 2002). Once activated, Imd interacts with another death-domain 
adaptor protein known as Drosophila Fas-associated death domain protein (dFADD) 
(Naitza et al. 2002). dFADD is the Drosophila homologue of the mammalian protein 
FADD, which is known to play a critical role in apoptosis and has two conserved 
domains that can act in homotypic protein-protein interactions. Of these domains, the C-
terminal death-domain interacts with homologous domains in other death proteins, 
whereas the N-terminal death effector domain (DED) is needed to recruit apical caspases, 
such as caspase-8, to receptor adaptor complexes (Hu and Yang 2000). Once activated by 
Imd, dFADD therefore initiates caspase interaction and recruits the Drosophila caspase-8 
homologue DREDD to the complex (Hu and Yang 2000; Leulier et al. 2000). Formation 
of this complex is then thought to lead to the activation of Drosophila transforming 
growth factor-activated kinase 1 (dTAK1) via its adaptor protein TAK1-binding protein 2 
(TAB2), the apoptosis inhibitor protein DIAP2 (Drosophila inhibitor of apoptosis 2) and 
the E2 proteins Bendless and dUEVA1 (Vidal et al. 2001; Silverman et al. 2003; Kleino 
et al. 2005; Zhuang et al. 2006). The mechanism by which this occurs has not yet been 
characterised, however it is hypothesised that dTAK1 is activated via an ubiquitination 
step (Zhou et al. 2005). In mammals, homologues of Bendless and dUEVA1, Ubc13 and 
UEVA1 respectively, are known to interact to form an E2-ubiquitin (Ub) conjugating 
enzyme. These enzymes are responsible for the ubiquitination of substrate proteins and 
are known to carry out this process via interaction with the RING (really interesting new 
gene)-finger domain of E3 Ub ligases (Zhou et al. 2005). DIAP2, which has been 
identified as an essential component of the Imd pathway, is known to contain a RING-
finger domain and is therefore a likely candidate as an E3 ligase (Leulier et al. 2006). The 
substrate for this ubiquitination step has not yet been identified, however it is likely to be 
a component of the Imd/dFADD/DREDD complex as the mammalian homologues of 
DIAP2, c-IAP1 and c-IAP2, are known to promote ubiquitination of RIP, the mammalian 
homologue of Imd, and are also known to interact with caspases such as DREDD 
(Leulier et al. 2006). Following this ubiquitination, it’s hypothesised that TAB2, the 
dTAK1 adaptor protein, is recruited to the complex via an N-terminal CUE domain that 
is able to bind specifically to K63-polyUb chains. Consequently, dTAK1 is recruited to 
the complex where it is activated, although this step has yet to be confirmed (Kleino et al. 
2005).  
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In mammals, the dTAK1 homologue, TAK1, is implicated in a number of signalling 
processes, including the activation of the mammalian IKK signalling complex (Wang et 
al. 2001). The mammalian IKK complex is made up of a number of IκB kinases (IKKs), 
which together are capable of phosphorylating and de-activating IκBs, thus leading to the 
activation of NFκB transcription factors (Mercurio et al. 1997). A Drosophila homologue 
of the mammalian IKK complex, the Drosophila melanogaster IKK (DmIKK) complex, 
has been identified in the Imd pathway and is made up of four subunits containing dimers 
of two identified IKKs, Kenny (Key) and ird5 (Rutschmann et al. 2000b; Lu et al. 2001). 
Kenny, a homologue of human IKKγ, is thought to provide a purely structural role in the 
complex, whereas ird5, homologous to human IKKβ, is known to contain the catalytic 
component (Silverman et al. 2000). Epistatic analysis has identified that the DmIKK 
complex is located downstream of dTAK1 and therefore suggests that dTAK1 mediates 
its activation, although direct interaction of the two has yet to be demonstrated 
(Silverman et al. 2003). Once activated, the DmIKK complex is known to interact 
directly with the NFκB/Rel transcription factor Relish (Silverman et al, 2000).  
 
Relish, a 110kDa protein similar to mammalian p105 and p100, was first demonstrated to 
play a role in immunity by Dushay et al (1996) and since then has been identified as the 
downstream NFκB component of the Imd pathway (Dushay et al. 1996; Hedengren et al. 
1999). Relish is a compound protein consisting not only of an N-terminal Rel-homology 
domain (RHD) but also a C-terminal IκB inhibitory domain. Consequently, Relish is not 
regulated by interaction with an IκB protein, such as Cactus in the Toll pathway, but 
instead is regulated by the presence of its own inhibitory domain (Dushay et al. 1996; 
Cornwell and Kirkpatrick 2001). Activation of Relish is initiated by the phosphorylation 
of the IκB domain via the ird5/Kenny IKK complex, which subsequently leads to its 
endoproteolytic cleavage from the Rel-homology domain (Silverman et al. 2000). Rather 
surprisingly, studies have shown that this cleavage step is carried out by the caspase-8 
homologue DREDD, already implicated further up the pathway (Stoven et al. 2000; 
Stoven et al. 2003). It is suggested that DREDD therefore plays two roles in the Imd 
pathway, one downstream in cleaving Relish and the other upstream in the activation of 
dTAK1. Once cleaved, activated Relish translocates into the nucleus in dimeric form, 
where it initiates the production of AMPs such as diptericin, cecropin, attacin and 
drosocin (Cornwell and Kirkpatrick 2001). 
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1.1.3.1.5 Interaction between the Toll and Imd pathways 
To date, it has generally been accepted that the Toll and Imd pathways serve independent 
functions and therefore mediate the specificity of Drosophila immune responses towards 
different microorganisms. The components of each of the pathways are clearly distinct 
and it has been demonstrated that some AMPs, such as defensin in the Toll pathway and 
diptericin in the Imd pathway, exclusively respond to only one of the two pathways 
(Dimarcq et al. 1994; Hedengren et al. 2000). However, some AMP genes have been 
shown, to different extents, to be regulated by both pathways. It has also been 
demonstrated that knocking out both pathways can often have a greater phenotypic effect 
than knocking out Toll or Imd alone (De Gregorio et al. 2002; Hedengren-Olcott et al. 
2004). 
 
As mentioned earlier, AMP expression is induced by dimeric NFκB transcription factors, 
where Relish is induced by the Imd pathway and Dif or dorsal are induced by the Toll 
pathway. It was originally accepted that each of these transcription factors remained 
distinct from one another and operated as homodimers (Dushay et al. 1996; Meng et al. 
1999). However, it has been demonstrated that these transcription factors are able to form 
both homodimers and heterodimers, and that the production of many AMPs can be 
induced by various dimer combinations (Han and Ip 1999). The reason for this appears to 
be the presence of a combination of different κB binding sites within the promoters of the 
AMPs. AMP promoters are known to contain clusters of κB binding sites rather than one 
distinct binding site and, in a recent bioinformatic study, κB binding sites were identified 
that were specific for certain dimer combinations (Senger et al. 2004; Tanji et al. 2007). 
For example, studies in Drosophila S2 cells, using deletion mutants of the promoter 
region of the AMP drosomycin, have shown that there are three κB binding sites in the 
drosomycin promoter, and that each of these sites respond differently to immune 
stimulation. Results show that site 1 responds to Toll pathway stimulation and can be 
bound by Dif or Dorsal homodimers. Alternatively, site 2 responds mainly to Imd 
pathway stimulation, with a very low partial response to Toll pathway induction. Results 
demonstrated that, at this site, relish was able to bind in both homodimeric and 
heterodimeric (DIF/Relish, Dorsal/Relish) forms. Finally, site 3 appeared to play an 
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auxiliary role by demonstrating a very minor response to both pathways. Additionally, 
expression of drosomycin could be induced by sole activation of either site 1 or site 2 
(although to a much lesser extent by site 2 alone), however the highest levels of 
drosomycin activity was seen when both sites were activated together. Therefore, it 
appears that although the Toll pathway primarily induces drosomycin expression, 
simultaneous activation of the Imd pathway acts to enhance expression levels. These 
results therefore suggest a synergistic effect of the two pathways (Tanji et al. 2007).  
 
Although the subject of Toll and Imd pathway synergy is still under investigation, and a 
synergistic effect has not been demonstrated for all Drosophila AMPs, it appears likely 
that the NF-κB transcription factors of the two pathways may cooperate to enhance the 
production of some immune-response genes. The level at which each AMP is induced by 
either pathway is likely to be determined by the ratio of different κB binding sites within 
each of their promoter regions. 
 
1.1.3.1.6 Anti-microbial peptides  
Anti-microbial peptides were first discovered by Hultmark et al (1980) using dormant 
pupae of the moth Hyalophora cecropia. Since this discovery, it has been found that 
AMPs exist as immune effectors across all organisms and, to date, approximately 800 
AMPs have been identified in a diverse range of organisms such as bacteria, plants, 
insects and higher animals, including mammals (Reddy et al. 2004).  
 
Currently, at least 20 AMPs have been characterised in Drosophila (Table 1.1). These 
AMPs can be arranged into seven different groups known as cecropin, diptericin, attacin, 
drosocin, defensin, drosomycin and metchnikowin (Imler and Bulet 2005). Following 
infection, they are rapidly produced (within 0.5-1 hr) by immune tissues such as the fat 
body, some blood cells and the Malpighian tubules, and are secreted into the hemolymph 
where they can reach concentrations between 1 and 100 µM (Uttenweiler-Joseph et al. 
1998). In general, all of these AMPs can be described as small (<10 kDa), with exception 
of the 22 kDa attacins, and cationic (Imler and Bulet 2005). Additionally, as the 
expression of each of these peptides is induced via NF-κB transcription factors, they can 
also be characterised by the existence of NF-κB regulatory domains within their promoter 
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regions, although the number of these domains differs depending on the peptide 
(Engstrom et al. 1993). Despite sharing many common characteristics, these peptides 
differ in both their mode of action and their activity against different types of invaders 
such as gram-positive and gram-negative bacteria and fungi. For example, it’s considered 
that AMPs, due to their highly basic nature, recognise invading microbes via the anionic 
phospholipids on microbial outer surfaces. It’s thought that variations in the net-positive 
charge of AMPs may, to a degree, account for their specificity towards different types of 
microbes (Reddy et al. 2004). Additionally, some other biophysical properties of the 
peptides, such as structural arrangement and hydrophobicity, are known to influence the 
specificity and mechanism of each AMP and they are grouped accordingly (Meister et al. 
1997).  
 
 
Table 1.1 – Summary of Drosophila anti-microbial peptides. Presented in the table is the name, number 
of genes, estimated concentration in the hemolymph after infection and common structural motifs (nd – not 
determined) (adapted from Lemaitre and Hoffmann 2007) 
AMP Number of 
genes 
Main activity Concentration Structural Motif 
Cecropin 4 Gram-negative 
bacteria 
20µM α-helices 
Diptericin 2 Gram-negative 
bacteria 
0.5µM Glycine-rich 
Attacin 4 Gram-negative 
bacteria 
nd Glycine-rich 
Drosocin 1 Gram-negative 
bacteria 
40µM Proline-rich 
Defensin 1 Gram-positive 
bacteria 
1µM CSαβ 
Drosomycin 7 Fungi 100µM CSαβ 
Metchnikowin 1 Gram-positive 
bacteria, fungi 
10µM Proline-rich 
 
The most studied Drosophila AMPs are the cecropins and in Drosophila there are four 
known transcripts (CecA1, A2, B and C). Cecropins are 31-39 residue peptides that 
consist of an amphipathic N-terminal helix and a hydrophobic C-terminal helix, separated 
by a short flexible hinge (Kylsten et al. 1990; Quesada et al. 2005). They are 
predominately induced after activation of the Imd pathway and are mainly active against 
gram-negative bacteria, however some studies have shown that cecropins are also active 
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against some types of fungi and can be induced, to a degree, by the Toll pathway 
(Ekengren and Hultmark 1999). The exact mechanism by which these AMPs function 
remains somewhat elusive, however its considered that these types of AMPs operate by 
destroying the membrane integrity of potential pathogens. This is thought to occur via the 
α-helix structures of cecropin, which are capable of interacting with membrane 
lipopolysaccharides, thus embedding within the membranes to create aqueous pores 
(Christensen et al. 1988).  
 
Diptericin is also induced by the Imd pathway and is active against gram-negative 
bacteria (Lemaitre et al. 1995a). It does not share the same structural motifs as cecropin 
but instead is identified for its higher than average proportion of glycine and proline 
residues. There are two isoforms of diptericin in Drosophila (DiptA and B), each 
approximately 9kDa in size, consisting of a long C-terminal glycine–rich G domain and a 
short N-terminal proline-rich domain (Wicker et al. 1990). In addition, Drosophila 
diptericin contains an O-glycosylation site within its proline domain, resulting in the 
presence of a disaccharide side-chain. This side-chain does not appear to contribute to the 
antibacterial activity of diptericin (Cudic et al. 1999; Winans et al. 1999). The exact 
mechanism of diptericin is not clear, however experiments on E.coli, using a 
synthetically generated peptide, have shown that diptericin may function by disrupting 
both the inner and outer membrane of the bacteria. Since diptericin lacks the required 
secondary structure to create pores in the cell membrane, it’s hypothesised that it may 
instead interact with a target protein to interrupt protein synthesis (Winans et al. 1999).  
 
The attacins are the largest of the AMPs, approximately 19-22kDa, with four known 
isoforms (AttA-D) in Drosophila. As with diptericin, they can be recognised for their 
high proportion of glycine residues and consist of two long C-terminal glycine-rich G 
domains (G1 and G2) (Dushay et al. 2000; Hedengren et al. 2000). Attacins are induced 
predominately by the Imd pathway and are active against gram-negative bacteria. The 
large size of this peptide renders activity studies difficult, however work carried out on 
H.cecropia, the moth where attacin was originally isolated (Hultmark et al. 1983), has 
shown that attacin inhibits the growth of gram-negative bacteria and increases the 
permeability of the outer membrane (Engstrom et al. 1984). This appears to occur via the 
indirect inhibition by attacin of several outer membrane proteins (Omps) (Carlsson et al. 
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1991). Amazingly, it does not appear to be a requirement that attacin actually enters the 
bacterial cells to carry out this mechanism. Instead, attacin is thought to partially embed 
into the outer membrane where it’s thought to interact with LPS receptor sites. This 
interaction then somehow initiates a signal cascade within the cell that results in the 
shutdown of Omp synthesis (Carlsson et al. 1991; 1998).    
 
Drosocin is a short-chain proline-rich peptide (approx. 3kDa) and can be characterised by 
repeated Pro-Arg-Pro tri-peptide fragments that are symmetrically distributed along its 
length (Bulet et al. 1993). Additionally, due to an O-glycosylation site on Thre-11, a 
disaccharide side-chain is present in the middle of the peptide. Unlike diptericin, it 
appears that this side-chain is necessary for anti-bacterial activity, as studies have shown 
that drosocin activity is significantly decreased in the absence of the disaccharide (Bulet 
et al. 1993). The exact mechanism of drosocin remains elusive however it has been found 
that all D-isoforms of this peptide are inactive, thus leading to suggestions that native 
drosocin is bactericidal through a mechanism that involves stereoselective elements 
(Bulet et al. 1996). As with the AMPs described above, drosocin is induced by the Imd 
pathway and is primarily active against gram-negative bacteria (Bulet et al. 1993). 
However, unlike the other acute-phase AMPs induced by the Imd pathway, which are 
active within around 1hr of infection and can kill invading bacteria very rapidly, drosocin 
does not exhibit AMP activity until between 6 and 12hr after infection and can take up to 
24hr to kill bacteria (Bulet et al. 1996). On the other hand, drosocin can be detected in the 
hemolymph up to two weeks after infection (Uttenweiler-Joseph et al. 1998). This 
suggests that drosocin is responsible for ensuring a sustained resistance to gram-negative 
bacteria as opposed to being involved in the acute response of the other Imd pathway-
induced AMPs.  
 
Defensin was first reported from cell cultures of the flesh fly Sarcophaga peregrina and 
has since been found in every insect species investigated to date (Ando et al. 1987). In 
Drosophila, there is one defensin gene encoding a 40-residue (4kDa) peptide. This 
peptide can be characterised by the presence of an α-helical domain linked to anti-
parallel β-strands by two disulphide bridges, known as a cysteine-stabilised α-helix/β-
sheet motif (CSαβ) (Dimarcq et al. 1994). As with cecropin, the mechanism of defensin 
is thought to involve a direct interaction and disruption of the bacterial cell membrane 
 38
through the creation of aqueous pores. Studies carried out using another Dipteran fly 
species, Phormia teranovae, have shown that this disruption results in a loss of 
cytoplasmic potassium, a partial depolarisation of the inner membrane, a decrease in 
cytoplasmic ATP and an inhibition of respiration (Cociancich et al. 1993). Defensin is 
induced by the Toll pathway and is a highly potent anti-bacterial peptide. It is active 
against a broad spectrum of gram-positive strains of bacteria and has been shown to have 
the ability to kill bacteria within less than a minute, even at very low (0.1 - 1µM) 
concentrations (Hoffmann and Hetru 1992). 
 
Drosomycin was first discovered in Drosophila melanogaster by Fehlbaum et al (1994) 
and, since its discovery, six other drosomycin-like genes have been identified in 
Drosophila alone (Jiggins and Kim 2005). It is expressed as a 44-residue (4kDa) peptide 
and shares a high sequence homology with the antifungal plant defensins first isolated 
from seeds of Brassicaceae (Terras et al. 1992). As with insect defensin, drosomycin 
demonstrates a CSαβ structural motif consisting of a central α-helix linked to an anti-
parallel β-sheet by two disulphide bridges. However, it also has an additional short β-
strand at its N-terminal and contains four disulphide bridges in total, similar to plant 
defensins (Landon et al. 1997). Drosomycin expression is induced mainly by the Toll 
pathway and, even at high concentrations, possesses no antibacterial activity whatsoever. 
Instead, this peptide is active against a broad spectrum of filamentous fungi (Fehlbaum et 
al. 1994). Studies have shown that it inhibits spore germination at high concentrations 
and can delay the growth of hyphae at lower concentrations, resulting in abnormal 
morphology (Fehlbaum et al. 1994). The exact mechanism of drosomycin is unknown, 
however, studies using plant defensins Rs-AFP2 and Dm-AMP1 from the seeds of 
Raphanus sativus and Dahlia merckil respectively, have shown that anti-fungal defensins 
appear to induce rapid ion fluxes and membrane potential changes in invading fungi 
(Thevissen et al. 1996). However, despite the CSαβ structure of these defensins, it 
doesn’t appear that they operate by creating aqueous pores in fungal membranes, but 
rather may work via interaction with specific membrane binding sites (Thevissen et al. 
1999).  Drosomycin is induced rapidly following infection (1hr) and can be potent 
towards fungi at concentrations as low as 0.6µM, despite the fact that it can be detected 
in the hemolymph at concentrations up to 100µM (Fehlbaum et al. 1994). As with 
drosocin, drosomycin can also be detected in the hemolymph for 2-3 weeks after 
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infection suggesting a role in a sustained anti-fungal response (Uttenweiler-Joseph et al. 
1998).   
 
The last of the characterised Drosophila AMPs, metchnikowin, was first isolated in 
Drosophila melanogaster by Levashina et al (1995). Metchnikowin is expressed as a 26-
residue proline-rich (>25%) peptide and shares high sequence homology to abaecin, a 
long-chain proline-rich AMP isolated from the honey-bee (Casteels et al. 1990; 
Levashina et al. 1995). Unlike short-chain proline-rich AMPs, which exhibit potent 
activity against gram-negative bacteria, metchnikowin can be characterised by its 
antimicrobial activity against both gram-positive bacteria and fungi (Lemaitre et al. 1997). 
The exact mechanism of this peptide is unknown, however studies on lebocin, a long 
proline-rich peptide isolated from B.mori and also homologous to abaecin, have shown 
that these peptides may function by increasing the permeability of the microbial plasma 
membrane (Hara and Yamakawa 1995). As with many other Drosophila AMPs, 
metchnikowin is expressed within 1-2hrs of infection and is bactericidal and fungicidal at 
concentrations as low as 0.5µM (Levashina et al. 1995). However, as with drosocin and 
drosomycin, metchnikowin can be detected in the hemolymph for 2-3 weeks after 
infection, suggesting a role in maintaining a sustained resistance to infection 
(Uttenweiler-Joseph. 1998). Studies have demonstrated that metchnikowin expression 
can be induced by either the Toll or the Imd pathway (Levashina et al. 1998).  
 
Although each of the AMPs described above are highly potent against certain types of 
microorganism, only defensin and drosomycin are able to combat infection when 
expressed alone in vivo (Tzou et al. 2002b). Studies using imd;spaetzle flies, which are 
deficient for both the Toll and the Imd pathways but are able to constitutively express 
individual AMPs under the control of a non-inducible promoter, have shown that 
defensin and drosomycin are able to confer wild-type resistance to gram-positive bacteria 
and fungi respectively when expressed individually (Tzou et al. 2002). However, there 
aren’t any Drosophila AMPs that are able to confer wild-type resistance in response to 
infection with gram-negative bacteria when expressed alone. This suggests that gram-
negative bacteria may require the differential activity of multiple AMPs for elimination 
(Tzou et al. 2002). Rather unsurprisingly therefore, Drosophila AMPs are expressed as a 
battery of peptides in response to infection and are present in different combinations 
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according to the identity of the invading microorganism. This response ensures the 
efficient elimination of invading pathogens and comprises a sophisticated mechanism of 
deterring the development of pathogen resistance to attack. 
 
1.1.3.1.7 Other pathways involved in systemic immune response 
There are two other important pathways that have been associated with Drosophila 
immune response – the Janus kinase/signal transducers and activators of transcription 
(JAK/STAT) pathway, and the c-Jun N-terminal kinase (JNK) pathway.  
 
The first of these, the JAK/STAT pathway, was first identified in mammals and shown to 
transduce a variety of cytokines and growth factor signals (Darnell 1997). In insects, the 
JAK/STAT pathway was originally identified through its role in embryonic segmentation 
and consists of four main components - the ligand Unpaired (Upd), the receptor 
Domeless (Dome), the JAK Hopscotch (Hop), and the transcription factor 
STAT92E/Marelle (Agaisse and Perrimon 2004). The first evidence for an involvement 
of this pathway in insect immunity was obtained from studies using the mosquito 
Anopheles gambiae, where it was demonstrated that the STAT transcription factor 
accumulates in the nucleus following infection (Barillas-Mury et al. 1999). Since that 
time, gene expression profiles have identified the JAK/STAT pathway as the pathway 
responsible for the regulation of a number of immune-responsive genes, including those 
encoding the complement-like protein Tep2, which is strongly activated in the fat body 
upon immune challenge (Lagueux et al. 2000), and the turandot (tot) stress genes, which 
accumulate in the hemolymph in response to various stress conditions, including septic 
injury (Ekengren and Hultmark 2001). The precise role of this pathway remains to be 
established however it has been proposed that the JAK/STAT pathway could respond to 
tissue damage encountered during infection (Agaisse and Perrimon 2004). 
 
The JNK pathway in Drosophila is a highly conserved MAPK signal transduction 
module and is known to play a role in a variety of different processes such as 
proliferation, differentiation, morphogenesis, apoptosis and immune response (Sluss et al. 
1996; Leppa and Bohmann 1999; Stronach and Perrimon 1999; Boutros et al. 2002; Dong 
et al. 2002). In this pathway, the main components are the Jun N-terminal kinase kinase 
(JNKK) Hemipterous (Hep), the JNK Basket (Bsk) and the transcription factor Jun (Glise 
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et al. 1995; Holland et al. 1997). Once activated, Hep phosphorylates and activates the 
downstream substrate, Bsk. Bsk then goes on to stimulate the activity of Jun, which, 
together with a separate protein Fos, constitutes the transcription factor AP-1 (Kockel et 
al. 2001). Activation of the pathway upstream of Hep is thought to involve a number of 
different JNKK kinases (JNKKKs) and in the Drosophila genome there are six known 
genes encoding for putative JNKKKs (Stronach 2005). It’s hypothesised that the variety 
of kinases acting at this level may account for the vast array of different processes 
regulated by the JNK pathway by linking specific upstream signals with the downstream 
signalling module (Stronach 2005). The involvement of the JNK pathway in immune 
function was first demonstrated by its induction in response to LPS stimulation (Sluss et 
al. 1996). Since that time, using a combination of gene expression studies and epistatic 
analysis, studies have demonstrated that the JNK pathway (i.e. Hep) is actually activated 
in response to infection via the Imd pathway kinase dTAK1 (Boutros et al. 2002; 
Silverman et al. 2003). Despite sharing a common component, studies have shown that 
the JNK pathway and the Imd pathway remain distinct from one another downstream of 
dTAK1 and regulate the transcription of separate sets of genes. However, in a study by 
Park et al (2004) it was demonstrated that JNK signalling exhibited a sustained activation 
in response to infection when the Imd pathway was blocked downstream of dTAK1. This 
data suggests that the JNK pathway may be negatively regulated by the Relish branch of 
the Imd pathway (Park et al. 2004). The exact role of the JNK pathway in immune 
response hasn’t yet been confirmed however it is suggested that the JNK pathway may 
play and important role in stress response and wound repair following infection 
(Silverman et al. 2003). 
 
1.1.3.2 Drosophila immunity in response to natural infection 
The systemic immune response has been proven critical to host survival. However, most 
of the studies carried out regarding this response have been carried out using septic injury 
as a means of infection, i.e. direct injection of microbes into the hemocoel (Silverman 
and Maniatis 2001; Boutros et al. 2002; Tzou et al. 2002a; Hoffmann 2003; Hultmark 
2003; Brennan and Anderson 2004). In nature, it is far more common for an insect to 
become infected via the ingestion of microbe-contaminated food, known as natural 
infection. During this type of infection, the barrier epithelia, and not the fat body, are 
believed to be the first line of defence and are critical to host survival (Ferrandon et al. 
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1998; Tzou et al. 2000). There are two main defence mechanisms that the epithelial 
tissues are known to employ in response to natural infection - firstly, the production of 
reactive oxygen species (ROS) and, secondly, local production of AMPs. 
 
Reactive oxygen species can be defined as oxygen-derived small molecules. These 
include oxygen radicals such as superoxide (O2-.), hydroxyl (.OH), peroxyl (RO2.) and 
alkoxyl (RO.), as well as non-radicals that can easily be converted such as hypochlorous 
acid (HOCl), ozone (O3) and hydrogen peroxide (H2O2) (Brown and Borutaite 2006). 
Once created, ROS can interact with a number of different molecules, such as proteins, 
lipids, carbohydrates and nucleic acids, and act to irreversibly destroy or alter the 
function of these molecules (Bedard and Krause 2007).  In Drosophila, ROS synthesis is 
induced rapidly in the gut following natural infection and acts to eliminate invading 
pathogens by causing oxidative damage in the form of both lipid peroxidation and protein 
carbonylation (Ha et al. 2005a; 2005b). The generation and elimination of ROS is a finely 
regulated process, allowing for enough ROS production to combat the pathogen whilst at 
the same time eliminating any residual ROS in order to protect the host (Geiszt et al. 
2003). This fine redox balance is mediated by Drosophila dual oxidase enzyme (dDuox) 
and immune-regulated catalase (IRC) (Figure 1.3). Studies have shown that flies deficient 
in dDuox are unable to generate ROS and succumb rapidly to oral infection by the gram-
negative bacteria Erwinia carotovora (Ha et al. 2005a). Conversely, flies deficient in IRC 
produce higher levels of ROS, resulting in fly death due to irreversible oxidative damage 
(Ha et al. 2005b). Studies have shown that ROS-dependent immunity is critical to host 
survival and is the primary mechanism by which Drosophila combats natural infection. 
 
 
Figure 1.3 – Production and elimination of reactive oxygen species. The production of superoxide from 
O2 is catalysed by dual oxidase in the presence of NADPH. Superoxide is then able to spontaneously form 
hydrogen peroxide. Hydrogen peroxide is then broken down into oxygen and water by immune-related 
catalase (Ha et al. 2005a; 2005b). 
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In addition to ROS-dependent immunity, several barrier epithelia, including the 
epidermis, digestive tract, Malpighian tubules, trachea and reproductive tissues, are 
known to produce AMPs locally in response to natural infection (Ferrandon et al. 1998; 
Tzou et al. 2000). Studies using β-galactosidase (β-Gal) and Green Fluorescent Protein 
(GFP) reporter transgenes have shown that at least two AMPs with complementary 
activity spectra are expressed in each of these tissues (Basset et al. 2000; Tzou et al. 
2000). For example, in the respiratory tract, antibacterial drosocin is expressed alongside 
the antifungal drosomycin. Similarly, in the Malpighian tubules, antibacterial AMPs 
diptericin and cecropin are expressed alongside antifungal metchnikowin (Tzou et al. 
2000).  To date, a response to natural infection in Drosophila has only been demonstrated 
using gram-negative bacteria such as E.carotovora and the entomopathogenic 
Pseudomonas emtomophila (Basset et al. 2000; Vodovar et al. 2005; Liehl et al. 2006). 
There is no evidence at present that suggests AMPs are induced in epithelia in response 
to gram-positive bacteria or fungi, despite the fact that antifungal AMPs are expressed in 
epithelial tissues (Ferrandon et al. 1998; Tzou et al. 2000). Interestingly, it appears that 
the Imd pathway acts as the sole mediator of AMP regulation in epithelia, with no 
evidence to date to suggest that the Toll pathway has any involvement in local AMP 
production (Ferrandon et al. 1998; Tzou et al. 2000; Onfelt Tingvall et al. 2001; Ryu et al. 
2006). This is particularly interesting in the case of the antifungal peptides drosomycin 
and metchnikowin, which, in imd mutants, are not upregulated in the epithelial tissues 
following natural infection but remain fully inducible by the Toll pathway in the fat body 
following systemic infection (Tzou et al. 2000). Finally, studies have shown that although 
the systemic immune response can be activated after natural infection, via an as of yet 
unknown signalling mechanism between the gut and the systemic immune tissues, it does 
not appear to contribute whatsoever to host survival (Liehl et al. 2006; Zaidman-Remy et 
al. 2006). Instead, bacterial clearance after natural infection is achieved solely through 
local AMP expression and ROS production (Liehl et al. 2006; Ryu et al. 2006). Together, 
both ROS-dependent immunity and local AMP production encompass two 
complimentary inducible defence mechanisms that are critical to host survival and act as 
the first line of defence following natural infection. 
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1.1.3.3 Nitric oxide and immunity 
Nitric oxide (NO) is a soluble gas that has been demonstrated to play role in a variety of 
biological processes in both vertebrates and invertebrates. These include vascular smooth 
muscle relaxation, neurotransmission, apoptosis, cell motility and immunity  
(Davies 2000; Bogdan 2001b). NO is produced by a group of enzymes known as nitric 
oxide synthases (NOS), which act to convert L-arginine into citrulline (in the presence of 
NADPH and O2), producing NO in the process (Figure 1.4). In vertebrates, there are three 
NOS enzymes, neuronal NOS (nNOS/NOS1), endothelial NOS (eNOS/NOS2) and 
inducible NOS (iNOS/NOS3) where NOS1 and NOS2 are constitutively expressed, 
calcium-dependent enzymes and NOS3 is an inducible enzyme with activity independent 
of cellular calcium levels (Stuehr 1999). Over the years, several NOS homologues have 
been identified in insects such as A.stephensi, A.gambiae, M.sexta and B.mori (Luckhart 
et al. 1998; Nighorn et al. 1998; Imamura et al. 2002; Dimopoulos 2003). In Drosophila 
there is one gene encoding NOS (dNOS), which is most closely related to vertebrate 
NOS1 (Regulski and Tully 1995).  
 
 
Figure 1.4 – Generation of NO by the NOS enzyme. NOS-catalysed generation of NO occurs using the 
substrates L-arginine, NADPH and molecular oxygen. NO is produced alongside citrulline and NADP+.  
 
Once generated, NO is able to diffuse rapidly across cell membranes and can interact as a 
signalling molecule with a number of biological targets such as heme groups, cysteine 
residues and iron and zinc clusters (Bogdan 2001b). Many of these targets are regulatory 
molecules, such as transcription factors and components of various signalling cascades, 
and therefore NO is able to exert heterogeneous and diverse phenotypic effects (Bogdan 
2001b). Additionally, NO is able to act as a reactive nitrogen species (RNS) and is able to 
 45
form a number of RNS derivatives including peroxynitrate (ONOO-), nitrogen dioxide 
(NO2), S-nitrosothiols and dinitrogen trioxide (N2O3) (Brown and Borutaite 2006). 
 
In mammals, NO has been implicated in a number of immune response processes and is 
considered a critical component of mammalian immunity. These responses include 
antimicrobial activity, pathogen tissue damage, anti-inflammatory activity, T helper cell 
deviation and anti-tumour activity (Bogdan 2001a). Similarly, in recent years a role for 
NO in Drosophila immunity has emerged (Nappi et al. 2000; Foley and O'Farrell 2003; 
Silverman 2003; McGettigan et al. 2005).  Studies have shown that NO contributes to 
Drosophila immunity in two ways. Firstly, NO (and its derivatives) are known to act as 
RNS at the site of infection and are able to directly destroy invading microbes via a 
combination of nitrosylation, nitration and oxidation of essential microbial components 
(Nappi et al. 2000). Secondly, various studies have shown that NO acts as an important 
signalling molecule in response to infection. This effect was first indicated by Nappi et al 
(2000), where it was demonstrated that there was a significant increase in diptericin 
expression in NO-treated larvae. Similarly, NO levels in infected larvae were 
significantly higher than controls. Since that time, studies have shown that NO is critical 
to survival in response to both septic and natural infection with the gram-negative 
bacteria E.caratovora caratovora and is a crucial component in upstream activation of 
the Imd pathway (Foley and O'Farrell 2003).  
 
The mechanism of action of NO as a signalling molecule in immunity is still not clear, 
however it has been suggested that NO mediates signalling between immune tissues upon 
infection. In this model it is proposed that NOS is up-regulated in any particular immune 
tissue that has come into contact with an invading pathogen. The resulting NO produced 
is then thought to mediate a signal, possibly via hemocytes, to other immune tissues in 
order to alert them to activate their own defence systems (Basset et al. 2000; Foley and 
O'Farrell 2003; Silverman 2003). This model is supported in a recent study by 
McGettigan et al (2005), which has shown that dNOS activity is significantly increased in 
the Malpighian tubules upon immune challenge. Similarly, targeted over-expression of 
dNOS to the principal cells of the Malpighian tubules was seen to confer increased 
survival to adult flies upon infection, suggesting an enhancement of AMP expression 
within the fly (McGettigan et al. 2005). To date, the identity of the downstream effector 
of NO with regards to immune function has not yet been confirmed. However, it is 
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possible that this effect is mediated via the cGMP pathway (Figure 1.5). The main 
intracellular receptor for NO is the heme moiety of soluble guanylate cyclase, one of the 
enzymes responsible for the generation of cGMP and subsequent activation of cGMP-
dependent protein kinases (cGKs), ion channels and cGMP-dependent 
phosphodiesterases (PDEs) (Schulz et al. 1989; Davies 2000). It is clear, therefore, that 
the role of cGMP signalling in Drosophila immunity requires further investigation.   
 
1.2 cGMP signalling 
1.2.1 Introduction 
The intracellular second messenger guanosine 3’5’ cyclic monophosphate (cGMP) was 
first discovered by in rat urine in 1963 (Ashman et al.). In the years since this discovery 
cGMP has been recognised as a key signalling molecule responsible for mediating a wide 
variety of physiological responses in both vertebrates and invertebrates. These responses 
include the regulation of smooth muscle relaxation, phototransduction, renal function, 
neuronal plasticity and development of the nervous system (Beavo and Brunton 2002; 
Pilz and Casteel 2003).  
 
cGMP is produced as part of a specific signalling pathway (Figure 1.5), where 
intracellular levels of cGMP are elevated after the activation of a family of enzymes 
known as guanylate cyclases (GCs). These enzymes exist as either soluble or membrane 
bound proteins that are stimulated by specific ligands (Drewett and Garbers 1994; Lucas 
et al. 2000). Once activated, guanylate cyclases work by catalysing the conversion of 
GTP into cGMP. The cGMP produced goes on to interact with intracellular receptor 
proteins such as cGMP-dependent protein kinases (cGK), cGMP-regulated ion channels 
or cGMP-regulated phosphodiesterases (PDE) - with PDE acting to regulate cGMP levels 
by catalysing the conversion of cGMP to 5’GMP (Lincoln and Cornwell 1993; 
Vaandrager and de Jonge 1996; Omori and Kotera 2007). Interaction of cGMP with these 
effectors ultimately determines the physiological response of the cell. 
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Figure 1.5 – The cyclic GMP signalling pathway. cyclic GMP is generated through the activation of 
guanylate cyclases. Raised levels of cGMP have then been shown to interact with either ion channels, or 
cGMP-dependent kinases (cGK) to mediate physiological responses. cGMP production is regulated by c-
GMP-dependant phosphodiesterases which convert cGMP into 5’ GMP. 
 
 
1.2.2 Guanylate cyclases 
The guanylate cyclase family of enzymes was discovered in 1969 and were found to exist 
in both soluble and particulate fractions, suggesting the occurrence of two different forms 
of the protein (Hardman and Sutherland 1969). Since this discovery, two classes of GC 
have emerged.  
 
The first of these, soluble guanylate cyclase (sGC), exists as a heterodimer made up of 
both alpha and beta subunits (Kamisaki et al. 1986). Although very similar, studies have 
shown that co-expression of both subunits is required to produce an enzymatically active 
protein (Stone and Marletta 1994). Soluble guanylate cyclases are typically activated by 
nitric oxide, which binds to a heme moiety within the N-terminal regulatory domain of 
the enzyme. Upon NO binding, a ferrous-nitrosyl-heme complex is formed, leading to a 
conformational change within the catalytic domain of the sGC (Craven et al. 1979). 
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Studies have shown that activation of sGC results in an increase in guanylate cyclase 
activity of up to 200-fold (Friebe and Koesling 2003). In Drosophila, there are two sGC 
genes, Gycα99B and Gycβ100B, encoding for the alpha subunit and the beta subunit 
respectively. So far, a number of different transcripts of these genes have been identified 
(Yoshikawa et al. 1993; Liu et al. 1995; Shah and Hyde 1995). Interestingly, a variety of 
atypical soluble guanylate cyclases have also been identified in recent years. The first of 
these, discovered by Nighorn et al (1999) in Manduca sexta (MsGC-β3) is reported to act 
as a homodimer that can function in the absence of nitric oxide (Morton and Anderson 
2003). Since this discovery, three genes encoding atypical NO-insensitive sGCs have 
been identified in Drosophila, and it has been demonstrated that they play an oxygen-
sensing role (Morton 2004; Vermehren et al. 2006).  
 
The second class of guanylate cyclases, known as receptor guanylate cyclases (rGC), are 
made up of single transmembrane proteins acting as receptors for a variety of ligands 
(Lucas et al. 2000). Receptor guanylate cyclases act primarily as homodimers, exhibiting 
highly conserved domain structures. The C-terminal catalytic domain of rGCs is highly 
conserved, however rGC isoforms are found to differ remarkably in their extracellular 
binding domains depending upon the ligand to which they bind. Unfortunately, the 
extracellular ligands of many rGCs still remain unknown, thus making it difficult to 
define specific function. Receptor GCs were first discovered in the sea urchin Arbacia 
punctulata in 1981 (Suzuki et al.), and since that time a number of rGCs have been 
identified in both vertebrates and invertebrates.  In mammals, seven receptor guanylate 
cyclases have been identified (GC-A – GC-G), three of which are well characterised and 
possess identified ligands (Chang et al. 1989; Chinkers et al. 1989; Lowe et al. 1989; 
Schulz et al. 1989; Yuen et al. 1990). For example, GC-A is known to be activated by the 
extracellular ligands atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) 
and has been implicated in such processes as natriuresis, diuresis and hypertension 
(Kishimoto et al. 1996; 2001). Alternatively, GC-B is activated by C-type natriuretic 
peptide (CNP), and is thought to play a role in bone development and the inhibition of 
smooth muscle and fibroblast proliferation (Garbers et al. 2006). Lastly, GC-C has a 
number of identified ligands such as heat-stable enterotoxin (STa), guanylin, uroguanylin 
and lymphoguanylin (Schulz et al. 1990; Hamra et al. 1993; Forte et al. 1999), and has 
been implicated to play a role in intestinal function (Steinbrecher et al. 2001). 
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Unfortunately, GC-D – GC-G remain orphan receptors with no identified ligands and 
therefore unknown function (Schulz et al. 1998). In Drosophila, there are at least nine 
genes encoding receptor guanylate cyclases (Flybase – http://flybase.bio.indiana.edu). 
Three of these genes, gyc32E, gyc76C and gyc89A, have been cloned in previous studies 
using rat GC-A cDNA as a probe (Gigliotti et al. 1993; Liu et al. 1995; McNeil et al. 
1995). However, as of yet there are no identified ligands of receptor GCs in insects and 
therefore these genes still remain to be characterised.   
 
1.2.3 Phosphodiesterases 
Cyclic nucleotide phosphodiesterases (PDEs) were first discovered by Butcher and 
Sutherland (1962). They comprise a superfamily of metallophosphohydrolases that act as 
negative regulators of cyclic nucleotide signalling and are therefore pivotal in 
maintaining the role of cyclic nucleotides in cellular function (Omori and Kotera 2007).  
PDE families can be specific to either cGMP or cAMP, or can exhibit a dual specificity 
for both, and function by cleaving the phosphodiester bonds of either cyclic nucleotide in 
order to produce a 5'-nucleotide. To date, a number of PDE genes and their numerous 
splice variants have been identified in both vertebrates and invertebrates, each with 
unique kinetic and regulatory properties. Over the years, it has become clear that any 
single cell type can express multiple different PDEs and that the nature and localisation 
of these PDEs is likely to be a major regulator of local cGMP or cAMP concentrations in 
each cell (Francis et al. 2001). Cyclic nucleotides are generated in a limited space within 
the cell, in close proximity to both their activating enzymes and their downstream 
effectors. It is suggested therefore that the localisation of each PDE acts to control the 
specific ‘pools’ of cyclic nucleotides within each cell, i.e. to prevent cyclic nucleotides 
from spreading to inappropriate areas of the cell, or to regulate the levels of cyclic 
nucleotides able to activate the downstream effectors in close proximity (Bender and 
Beavo 2006; Omori and Kotera 2007). PDEs themselves are regulated by diverse 
biochemical reactions including phosphorylation/dephosphorylation, allosteric binding of 
cGMP or cAMP, binding of Ca2+/calmoldulin and various protein-protein interactions 
(Bender and Beavo 2006; Omori and Kotera 2007). 
 
There are six PDEs expressed in Drosophila, Drosophila melanogaster (Dm) PDE1, 
DmPDE4 (Dunce), DmPDE6, DmPDE8, DmPDE9 and DmPDE11 (Day et al. 2005; 
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Davies and Day 2006). Of these, Dunce is the most widely characterised and acts as a 
cAMP-specific PDE with a role in learning and memory functions (Davis and Dauwalder 
1991). Biochemical characterisation of the remaining Drosophila PDEs has demonstrated 
that DmPDE1 and DmPDE11 are dual-specificity PDEs, whereas DmPDE6 is specific to 
cGMP (Day et al. 2005). Interestingly, despite its dual-specificity, DmPDE11 has been 
demonstrated to exhibit the highest specificity for cGMP of all other Drosophila PDEs 
(Km: 6 + 2µM). Unfortunately, due to the lack of appropriate antibodies, DmPDE8 and 
DmPDE9 have yet to be fully characterised (Day et al. 2005).  Expression studies have 
shown that all DmPDEs are expressed in the adult head and body and, interestingly, 
DmPDE6, DmPDE8 and DmPDE11 are all significantly enriched in the Malpighian 
tubules, an important cGMP signalling tissue (Day et al. 2005). 
 
1.2.4 Cyclic nucleotide-gated channels 
Cyclic nucleotide gated (CNG) channels were first discovered in the plasma membrane of 
retinal photoreceptors (Fesenko et al. 1985). CNG channels are activated by cyclic 
nucleotides that bind to probably four intracellular sites showing differing ligand 
selectivity towards cyclic AMP and cyclic GMP (Kaupp and Seifert 2002). Activation of 
CNG channels results in the fluctuation of different ions, such as sodium, potassium and 
calcium, within the cell. CNG channels are highly sensitive to changes in cytosolic cyclic 
nucleotide concentration and therefore provide a powerful route by which cyclic 
nucleotide signalling pathways regulate cellular processes (Zagotta and Siegelbaum 
1996).  
 
In vertebrates, the activation of CNG channels has mainly been associated with olfactory 
and visual processing, where their role has been widely characterised (Yau and Baylor 
1989; Zufall et al. 1994). Additionally, CNG channels have been associated with the 
regulation of synaptic plasticity and neuronal pathfinding, however their role in these 
processes is not as well understood (Zagotta and Siegelbaum 1996; Kaupp and Seifert 
2002). Unfortunately, very little is known about the in vivo function of CNG channels in 
invertebrates, suggesting a wider spectrum of action. In Drosophila, there are at least four 
genes encoding CNG channels, including cng, originally shown to be expressed in the 
eye and the antennae; cngl, expressed in the neuronal cells and mushroom bodies in the 
brain; CG3536 and CG17922 (Miyazu et al. 2000).   
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1.2.5 cGMP-dependent protein kinases 
cGMP-dependent kinases (cGKs) belong to a large superfamily of protein kinases. They 
function by catalysing the transfer of γ-phosphoryl group of ATP to the hydroxyl group 
of serine, threonine or tyrosine residues of acceptor substrate proteins and, as a result, are 
able to regulate the activity of numerous proteins (Vaandrager and de Jonge 1996). In 
general, cGKs can be described as homodimers, with each subunit containing an N-
terminal domain that mediates dimerisation and protein-protein interactions; a regulatory 
domain that contains two identical cGMP binding sites; and a kinase domain responsible 
for substrate phosphorylation (Takio et al. 1984). 
 
In Drosophila, there are two genes encoding confirmed cGKs, dg1 and dg2 (foraging, for) 
and another putative cGK gene – CG4389 (Kalderon and Rubin 1989; Davies 2000). At 
present, there is no functional information available for the CG4289-encoded product, 
however the kinases encoded by dg1 and dg2 are quite widely characterised. DG1 and 
DG2 were first discovered serendipitously as part of a screen to identify cAMP-
dependent protein kinases (Kalderton and Rubin 1989). In this study, expression data 
indicated that DG1 was a head-specific kinase, whereas DG2 was seen in both the head 
and body of adult flies. Subsequent studies have revealed that dg1 encodes an 84kDa 
protein, with bona fide cGK activity, which is expressed in the optic lobes and proximal 
cortex (Foster et al. 1996). It has also been demonstrated in recent years that DG1 is 
expressed in the Malpighian tubules and appears to be cytosolic in nature, with some 
association at the basolateral membrane (Dow et al. 1994a; MacPherson et al. 2004b). 
Interestingly, overexpression studies have implicated a role for DG1 in cGMP-mediated 
fluid transport (MacPherson et al. 2004b). 
 
DG2 has been widely characterised and has traditionally been implicated as having a role 
to play in Drosophila feeding behaviour (Osborne et al. 1997). dg2 is a complex gene, 
comprising several exons encoding a number of major transcripts, which encode proteins 
of differing sizes (Kalderton and Rubin 1989; http://flybase.bio.indiana.edu/cgi-
bin/uniq.html?FBgn0000721%3Efbtr). A role for the dg2 gene was first assigned after 
studies into larval food-search behaviour identified it as the source of the naturally 
occurring rover/sitter foraging polymorphism, where rovers (forR) are seen to be much 
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more active than sitters (forS) when searching for food (de Belle et al. 1989; 1993). 
Subsequent phosphorylation studies in for mutants revealed that a ~10% reduction in 
cGK activity may account for the forS phenotype in larvae (Osborne et al 1997). 
Interestingly, the forS allele has been shown to confer an epithelial phenotype in the 
Malpighian tubules, where forS flies were shown to demonstrate a hypersensitivity to 
capa-1, a nitridergic neuropeptide known to stimulate the cGMP signalling pathway 
(MacPherson et al. 2004a).  Although all of the studies mentioned above have identified 
an important role for the dg2 gene, the proteins encoded by the gene have only recently 
been investigated. In a recent study, the in vivo roles of the transcripts of dg2 were 
examined. Results demonstrated that the two major transcripts of dg2, DG2P1 and 
DG2P2, encode bona fide cGKs. Additionally, cGK activity in adult flies appears to be 
enriched in the heads and Malpighian tubules, further suggesting an important renal 
function for cGKs. Targeted expression of DG2P1 and DG2P2 to the Malpighian tubules 
showed that DG2P1 appears to localise to the apical membrane of tubule principal cells. 
Conversely, DG2P2 was shown to be expressed both apically and basolaterally, again 
only in the tubule principal cells (MacPherson et al. 2004b).  
 
To date, there are no documented phosphorylation targets of cGKs in Drosophila, 
however it appears that both DG1 and DG2 kinases may have important roles to play in 
the Malpighian tubule. Interestingly, the differential localisation of each cGK or cGK 
isoform suggests that each has a distinct role from one another, and are probably 
controlled by different sources of cGMP.   
 
1.3 The Drosophila Malpighian tubule 
1.3.1 Introduction 
Insect Malpighian tubules have been extensively studied in terms of both morphology 
and function over the years and as a result more is known about this tissue than any other 
animal epithelia (Dow and Davies 2001). The Malpighian tubule can be defined as a  
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Figure 1.6 – The Drosophila melanogaster Malpighian tubule. Left panel: morphology of the 
Malpighian tubule, showing each of the distinct segments of the tubule as reported by Wessing and 
Eichelberg (1978). Right panel (top): tubules of enhancer trap fly lines, showing each of the different 
regions of the tubule. Right panel (bottom): tubules of enhancer trap fly lines, showing various pictures of 
different cell types within the tubules. Top two pictures show the principal and stellate cell types of the 
main segment of the tubule (Sozen et al. 1997).    
 
fluid-transporting osmoregulatory epithelium that is critical for detoxification and ion 
homeostasis in the fly. It has emerged over the years as a potent model system for the 
study of the signalling and transport genes involved in epithelial fluid transport (Dow et 
al. 1994b).   
 
1.3.2 Morphology 
Insect Malpighian tubules are simple, free-floating, tubular epithelia, joined in pairs 
through short common ureters to the alimentary canal (Wessing and Eichelberg 1978). 
Drosophila tubules are amongst the smallest ever studied, measuring ~2 mM long by ~35 
µM in diameter, and comprising of ~150 cells. Each fly possesses two pairs of tubules, an 
anterior and a posterior pair, both contributing equally to tubule function. The tubule can 
be divided into three segments; an enlarged initial segment, a narrower transitional 
segment and a main segment that leads to the ureter.  The main segment is responsible for 
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fluid secretion and is composed of two cell-types, the columnar epithelial principal cell 
(type I) and the star-shaped stellate cell (type II). Other cell types, such as bar-shaped 
cells, are present on the initial and transitional segments (Figure 1.6; Sozen et al. 1997). 
 
1.3.3 The Malpighian tubule and the cGMP signalling pathway 
Studies have shown that the Malpighian tubule is responsible for many processes within 
the fly, including fluid transport, osmoregulation, detoxification and ion homeostasis. All 
of these processes are known to be regulated by the cGMP signalling pathway in the 
tubule (Davies 2006). Microarray studies have demonstrated that many genes associated 
with cGMP signalling are expressed in the tubule and are typically enriched in this tissue 
compared to the whole fly (Wang et al. 2004). For example, the tubule has been shown to 
express NOS and sGC, and also shows a high enrichment of the receptor guanylate 
cyclase Gyc76c. Additionally, three as of yet uncharacterised rGCs, CG4224, CG9873 
and CG5719 are expressed in the tubule, and a putative atypical guanylate cyclase 
CG14885 (Wang et al. 2004). The presence of multiple activators of the cGMP pathway 
therefore suggests its role in regulation of a variety of physiological processes.  
 
Similarly, as mentioned earlier in the text, the tubule has been demonstrated to express 
multiple cGMP effector molecules (MacPherson et al. 2004b; Wang et al. 2004; Day et al. 
2005). All known Drosophila CNG channels, PDEs and cGKs are expressed in the tubule 
with particular enrichment of DmPDE11 and the cGK DG1 (Wang et al. 2004). 
Therefore, it would seem that the Malpighian tubule is the ideal tissue to study their 
effects. Fortunately, following the development of the fluid secretion assay by Dow and 
colleagues (1994), the tubule has proved to be a robust, quantitative phenotype with 
regards to the study of not only cGMP signalling, but a whole host of signalling and 
transport mechanisms (Dow and Davies 2006).    
 
1.3.4 The Malpighian tubule and immunity 
One of the most recent developments with regard to tubule function is the identification 
of the tubule as an important immune sensing tissue. Studies have shown that the tubule 
constitutes an autonomous immune system that is capable of sensing bacterial challenge 
and mounting an immune response, entirely independently of the fat body (McGettigan et 
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al. 2005). Previously, a role for the tubule in local epithelial AMP production has been 
indicated, where it was shown that diptericin, cecropin and metchnikowin levels are 
upregulated in the tubule in response to natural infection (Tzou et al. 2000). However, 
since that time it has been demonstrated the tubule is capable of activating immune 
mechanisms in response to septic injury, suggesting a role in systemic immunity 
(McGettigan et al. 2005). In this study, it was demonstrated that tubules, excised and 
incubated in vitro with E.coli, show an up-regulation of diptericin expression, confirming 
that the tubule is capable of sensing and responding to bacterial infection autonomously. 
Additionally, targeted over-expression of dNOS to the tubules (the enzyme responsible 
for generation of NO, a known activator of immune responses) was seen to confer 
increased survival to adult flies upon septic infection, thus confirming the involvement of 
the tubule in systemic immunity and also demonstrating its importance in immune 
function (McGettigan et al. 2005). In support of these data, microarray studies have also 
indicated the importance of the tubule in immune response (Chintapalli et al. 2007 - 
www.flyatlas.org). When comparing expression levels of major components of immune 
signalling pathways in different tissues of the adult fly, it can be seen that many 
components of the Imd signalling pathway are highly enriched in the tubule. For example, 
Relish shows an mRNA signal of 783+91 in the adult tubule, compared to an mRNA 
signal of 426+31 in the adult carcass (consisting of the adult fat body cells, as well as 
cuticle). Additionally, Relish is also highly enriched in the larval tubule (mRNA signal = 
398+12) although not to the same level as the larval fat body (mRNA signal = 685+55) 
(www.flyatlas.org - search string Relish). These data therefore suggest that the tubule is 
very important to Imd pathway activation in the adult fly.  
 
The involvement of the tubule in immune function is not surprising. The morphology of 
the tubules means that they are spread throughout the body cavity, both anteriorly and 
posteriorly, which suggests that they are likely to be one of the first tissues exposed to 
bacteria upon infection. It makes sense therefore, that the tubule may act alongside the fat 
body in the activation of immune response. Secondly, the tubules open into the gut lumen 
and are therefore in contact with a large number of microorganisms on a constant basis 
(Dow and Davies 2006). It is possible therefore that the tubule may act as the signalling 
tissue between natural infection defence mechanisms and the systemic immune system. 
To date, investigation into the involvement of the Malpighian tubule in immune function 
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is still in the early stages, however, from the evidence seen so far it appears that the 
tubule is a critical immune sensing tissue in Drosophila.   
 
1.4 Drosophila as a model organism – useful genetic tools  
Although traditionally associated with developmental studies, over the years Drosophila 
has become a valuable model organism for studying many physiological processes (Dow 
and Davies 2003). There are a number of reasons why Drosophila is of particular 
biological significance as a model organism. Firstly, Drosophila has a short generation 
time and is cheap and easy to breed in large numbers, without compromising genetic 
power. Secondly, Drosophila has been studied as a model organism for over 100 years 
and as a result there is a wealth of genetic markers available. Thirdly, those wishing to 
use Drosophila as their model of choice have access to a sequenced, and very well 
annotated, genome. Finally, a wealth of available transgenic tools has made Drosophila a 
very powerful model system for integrative organismal studies (Dow and Davies 2003).  
 
An example of this is the adaptation of the Drosophila P-element by enhancer trapping, a 
technique that has allowed rapid identification of genetic domains and genes with 
expression patterns of interest (Rubin and Spradling 1983; Bellen et al. 1989). P-elements 
are known to form a classic transposable system whereby transposons are able to ‘jump’ 
around the genome, an effect mediated by the transposase enzyme (Robertson et al. 1988). 
In the enhancer trapping technique, the transposase gene in the P-element is replaced with 
a reporter gene, consisting of various genetic markers, downstream of a weak promoter. 
Flies carrying the P-element are then crossed to another fly line carrying ∆2,3 P-element, 
a defective transposon that can only express transposase in the germ line, and which itself 
is unable to move. Therefore, as the ∆2, 3 P-element flies provide a source of transposase, 
the reporter P-element can effectively jump around the genome in the progeny of this 
cross. Thus, the progeny are allowed to breed and then the subsequent progeny that have 
lost the ∆2, 3 P-element are selected. These flies are now carrying the reporter gene 
trapped in a new position (Bellen et al. 1989). This technique is extremely useful as, in a 
significant fraction of these enhancer trap lines, the reporter P-element may become 
trapped near a potentially interesting gene and may become activated to produce a similar 
expression pattern. 
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Figure 1.7 – The GAL4/UAS crossing system. In this system an enhancer-trap line expressing GAL4 in a 
tissue of interest is crossed to flies carrying a UAS-transgene. Expression of the transgene is subsequently 
driven in the GAL4 tissue in the resulting progeny (Brand and Perrimon 1993)  
 
 
The genetic toolbox of Drosophila has evolved even further with the development of the 
GAL4/UAS (upstream activating sequence) system (Brand and Perrimon 1993). In this 
system, the reporter gene is the yeast transcription factor GAL4. This transcription factor 
is completely inert in the Drosophila genome under normal circumstances, however it is 
capable of driving transgenes under the control of the yeast UAS promoter (Fischer et al. 
1988).  Therefore, by cloning a gene of interest downstream of the UAS promoter, its 
expression can be activated in cells where GAL4 is present (Figure 1.7). Targeted 
expression of genes of interest using this system became possible after the development 
of an enhancer-trap GAL4 construct (pGAWB) (Brand and Perrimon 1993). Using this 
construct, it has been possible to develop GAL4 ‘driver’ fly lines for any tissue or cells of 
interest and, as a result, an astounding array of GAL4 lines are now available for use. The 
advantages of this system are extensive. For example, once an appropriate GAL4 driver 
line has been developed, it can be maintained as a parental stock. Targeted expression of 
any gene can then be achieved in a tissue of interest simply by crossing this GAL4 line to 
the UAS-transgene fly line of choice, without the need for further enhancer trapping 
studies. Similarly, a UAS-transgene fly line can be kept as a parental stock without any 
serious loss of fitness, as there is no source of GAL4 to promote expression. This is 
particularly useful in fly lines where a gene is silenced using UAS-RNAi, resulting in an 
easily maintained and viable stock. Overall, the development of the GAL4/UAS system 
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has been paramount in improving the genetic tractability of Drosophila even further, 
confirming the status of Drosophila as a very powerful model organism. 
 
1.5 Project Aims 
In recent years, nitric oxide signalling has emerged as a key component of the immune 
response in Drosophila, using both in vivo and in vitro systems (Weiske and Wiesner 
1999; Nappi et al. 2000; Foley and O'Farrell 2003). It has been suggested that NO plays 
some functional role in activating the Imd pathway upstream of the Imd protein and that 
NO may act to mediate signalling between immune tissues (Basset et al. 2000; Foley and 
O'Farrell 2003; Silverman 2003). The mechanism by which this occurs has not been 
elucidated, however, considering that the main intracellular receptor for NO is soluble 
guanylate cyclase, it is highly possible that cGMP signalling may play a role.  
 
Recently, the Malpighian tubule has been demonstrated as an important immune sensing 
tissue (Tzou et al. 2000; McGettigan et al. 2005). Similarly, NO/cGMP signalling has 
long been reported as critical to normal tubule function (Davies 2006). Consequently, the 
tubule appears to be the ideal tissue for studying the role of cGMP in immune response. 
Therefore, using a combination of microarray, Q-PCR and transgenic approaches, the aim 
of this study was to investigate the role of cGMP signalling in immune response. This 
was achieved using the Drosophila Malpighian tubule as a model system, with particular 
emphasis being placed on its role in Imd pathway regulation.  
  
 
 
 
2 Chapter 2 
 
Materials and Methods 
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2.1 Drosophila melanogaster 
2.1.1 Drosophila stocks  
Table 2.1 – Drosophila melanogaster lines used in this study 
σ 
– Kind gift from Professor J. L Imler, University of Strasbourg, France; δ – Bloomington Stock Centre; * - Kind gift from 
Professor S Kurata, Tohoku University, Sendai, Japan; § - Kind gift from Professor D Hultmark, University of Umea, Sweden. 
Strain  Genotype Description and application Reference (if 
applicable) 
Oregon R Wild type Q-PCR, survival assays. - 
Diptericin-GFPσ w-; +/+; diptGFP Fluorescence studies, natural infection experiments Tzou et al. 2000 
Cecropin-GFPσ w-; +/+; cecA1GFP Flouresence studies As above 
c42  w-; +/+; c42 Tubule principal cell-specific GAL4 driver Sozen et al. 1997; 
McGettigan et al. 
2005 
c42 (balanced) w-;bl/Cyo;c42 As above - 
GAL80δ w;P{tub-GAL80ts}; 
TM2/TM6b 
GAL4 repressor line, inactivated after heat shock at 
30 °C 
(Lee and Luo 
1999) 
GAL80;c42 w-;P{tub-GAL80ts}; 
c42 
Inducible tubule principal cell-specific GAL4 driver 
– used for Q-PCR and survival assays 
- 
UO UO; +/+; +/+ Tubule principal cell-specific GAL4 driver Terhzaz et al, in 
preparation 
c564* w-; c564; +/+ Fat body specific driver  
UAS-dg1 w-;+/+;UAS-dg1 Overexpressor of dg1, crossed to either c42 or c564 
GAL4 drivers – used for Q-PCR, survival assays and 
natural infection experiments   
MacPherson et 
al. 2004a ; 2004b 
UAS-dg1RNAi w-; UAS-dg1RNAi; 
+/+ 
Knocks down dg1 expression by RNAi – crossed to 
either c42 or c564 and used as above 
- 
UAS-dg2P1 UAS-dg2P1; +/+; 
+/+ 
Overexpressor of dg2P1, crossed to either c42 or 
c564 and used as above 
MacPherson et al. 
2004a; 2004b 
UAS-dg2P2 w-; UAS-dg2P1; +/+ Overexpressor of dg2P2, crossed to either c42 or 
c564 and used as above 
As above 
UAS-dg2RNAi w-; UAS-dg2RNAi; 
+/+ 
Knocks down dg2 expression by RNAi - crossed to 
the GAL80;c42 driver, used as above 
- 
UAS-
PDE11RNAi 
w-; +/+; UAS-
PDE11RNAi  
Knocks down PDE11 expression by RNAi - crossed 
to the c42 GAL4 driver and used for Q-PCR and 
survival assays  
- 
UAS-GC-A w-; UAS-GC-A; +/+ Overexpressor of the rat ANP receptor – crossed to 
c42 and used for Q-PCR 
(Kerr et al. 2004) 
dN1-8 w-; UAS-dNOS; +/+ dNOS overexpressor – crossed to UrO and used for 
Q-PCR  
McGettigan et al. 
2005 
Relish E20 * w-; +/+; relishE20, e- Homozygous Relish null mutant carrying the ebony 
marker – used for Q-PCR 
Hedengren et al. 
1999 
Imd1 * w-; pr,imd1/CyO; 
TM3sb/GFPser 
Balanced Imd mutant carrying the purple marker – 
used for Q-PCR and to generate lines for epistatic 
analysis 
Lemaitre et al. 
1995, Georgel et 
al. 2001 
Key1 * w-; cn-bw, Key1/ 
CyO; TM2tb/TM6e 
Balanced Kenny mutant carrying the cinnabar-
brown marker – used to generate lines for epistatic 
analysis 
Rutschmann et al. 
2000 
UAS-imd * w-; UAS-imd/CyO; 
TM3sb/TM6e 
Balanced Imd overexpressor – used to generate lines 
for epistatic analysis 
Georgel et al. 
2001 
UAS-relish § w-; UAS-relish-
HIS/CyO; 
TM3sb/TM6e  
Balanced Relish overexpressor tagged with 6xHIS – 
used to generate lines for epistatic analysis 
Hedengren et al. 
1999; Stoven et 
al. 2000; 2003 
Imd1;c42 w-; pr,imd1/CyO; 
c42/TM3sb 
Tubule principle cell-specific GAL4 driver in an imd 
mutant background – crossed to UAS-dg1 and used 
for epistatic analysis (Q-PCR) 
- 
Key1;c42 w-; cn-bw, Key1/ 
CyO; c42/TM2tb 
Tubule principle cell-specific GAL4 driver in an 
Kenny mutant background 
- 
UAS-imd;c42 w-; UAS-imd/CyO; 
c42/TM3sb 
Tubule principle cell-specific GAL4 driver 
overexpressing Imd 
- 
UAS-relish;c42 w-; UAS-relish-
HIS/CyO; 
c42/TM3sb 
Tubule principle cell-specific GAL4 driver 
overexpressing Relish – crossed to cGK transgenic 
lines and used for epistatic analysis (ICC) 
- 
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The various Drosophila lines used in this study and their genotypes and application are 
listed in Table 2.1. Unless otherwise stated, fly lines are lab stocks. Relavent 
references for these lines are also listed where applicable. 
 
2.1.2 Drosophila rearing 
Flies were reared in vials on standard Drosophila medium (appendix 1) at 22-25°C in 
a 12 h: 12 h light: dark cycle.  If large quantities were required (>100), flies were 
reared in large bottles on standard medium.  
 
2.1.3 Dissection of Drosophila tissues 
For dissection of tubule and midgut samples, 7-day old adult flies were anesthetized on 
ice before acute dissection in sterile Schneider’s media (Invitrogen). For dissection of 
fat body, late third-instar larvae were dissected live in sterile Schneider’s medium. For 
RNA samples, approximately 50 tubule pairs (25 flies) or fat body from approximately 
10 larvae were dissected for each sample. Where appropriate, samples were then 
incubated in 3 ml of sterile Schnieder’s medium containing the appropriate 
concentration of either cGMP, dibutyryl-cGMP, cAMP, SNAP, ODQ (all Sigma), or 
PGN(-) (Invivogen) as stated throughout the text.  
 
2.2 RNA extraction 
RNA extraction was carried out using the QIAGEN® RNeasy® Mini kit and a 
QIAGEN® RNase-free DNase set as according to the manufacturers’ instructions. 
RNA was typically eluted in 25µl RNase-free water and quantified as described in 
Section 2.5.  
 
2.3 First strand cDNA synthesis 
First strand cDNA synthesis was carried out using Superscript TM II Reverse 
Transcriptase (Invitrogen). For each 20 µl reaction, 1 µl of Oligo(dT)12-18 (500 µg/ml), 
1 – 10 µl total RNA (up to 1 µg) and 1 µl of dNTP mix (final concentration 200 µM 
each) were added to a nuclease-free PCR tube. Each reaction was then made up to a 
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volume of 12 µl with RNase-free water and incubated at 65 °C for 5 min followed by a 
quick chill on ice. The contents of each tube were then collected by brief 
centrifugation, followed by the addition of 4 µl of 5x First strand buffer (250 mM Tris-
HCl [pH 8.3], 375 mM KCl, 15 mM MgCl2), 2 µl of 0.1 M DTT and 1 µl of 
RNaseOUT TM (40 units/µl). Each reaction was then mixed briefly and incubated at 42 
°C for 2 min. 1 µl of Superscript TM II Reverse Transcriptase was then added to each 
tube and the contents mixed by gentle pipetting. Each reaction was then incubated at 
42 °C for 50 min, followed by heat inactivation of the enzyme at 70 °C for 15 min. 
cDNA concentration was then quantified as described in Section 2.4. Unless otherwise 
stated, all components used in this reaction were purchased from Invitrogen.     
 
2.4 Preparation of genomic DNA 
For PCR procedures that required moderate amounts of genomic DNA, the Berkeley 
Drosophila Genome Project Quick Fly Genomic DNA prep, by E. Jay Rehm, was used 
(see http://www.fruifly.org/about/methods/inverse.pcr.html). Briefly, 30 anaesthetised 
flies were collected in a 1.5 ml eppendorf tube and briefly frozen at -70°C. Flies were 
then ground in 200 µl of Buffer A (100 mM Tris-HCl [pH 7.5], 100 mM EDTA, 100 
mM NaCl, 0.5 % [w/v] SDS) using a disposable tissue grinder (Kontes). An additional 
200 µl of Buffer A was then added and grinding continued until only cuticles remained. 
The suspension was then incubated at 65°C for 30 min. 800 µl of LiCl/KAc solution (1 
part 5 M KAc: 2.5 parts 6 M LiCl) was then added and the resulting solution incubated 
on ice for at least 10 min. Samples were then centrifuged at 13,000 g at for 15 min at 
room temperature. 1 ml of the supernatant was then transferred into a new tube, 
avoiding floating material. 600 µl of isopropanol was then added, the solution mixed, 
and centrifuged at 13,000 g for 15 min at room temperature. The supernatant was then 
carefully aspirated, and the DNA pellet washed with 70 % ethanol (v/v) in H2O. The 
washed pellet was air-dried and then resuspended in 150 µl of TE buffer (10 mM Tris-
HCl [pH 8.0], 1 mM EDTA). Genomic DNA samples were then stored at –20°C.  
 
2.5 Quantification of nucleic acids 
Nucleic acid concentrations were measured at 260 nm (A260) using a NanoDrop 
1000TM (Thermo Scientific) according to manufacturers’ instructions. Readings were 
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zeroed with the solution in which the samples had been diluted and nucleic acid 
concentrations were displayed as ng/µl. A ratio of A260/A280 provided an estimate of 
nucleic acid purity. Values of 1.8 for DNA and 2.0 for RNA indicated pure 
preparations.  
 
2.6 Oligonucleotide synthesis 
Oligonucleotides were synthesised by the MWG Biotech custom primer service on a 
0.01 µmol scale, purified by High Purity Salt Free (HPSF®) technology, and their 
quality assessed by Matrix Assisted Laser Desorption Ionisation - Time of Flight 
(MALDI-TOF) analysis. Oligonucleotides were received as a lyophilised pellet, 
resuspended in H2O to a stock concentration of 100 µM, and further diluted with H2O 
to a working concentration of 6.6 µM. All primers were stored at -20°C. A list of all 
the primers used in this study is provided in appendix 2. 
 
2.7 Polymerase chain reaction (PCR) 
2.7.1 Standard PCR using Taq DNA polymerase 
Standard PCR protocols were used in the everyday amplification of DNAs. For a small 
number of PCRs, reactions were set up according to manufacturers’ instructions using 
a pre-aliquoted PCR master mix containing Thermoprime Plus DNA polymerase and 
2.5 mM MgCl2 (Abgene). For each reaction, 2 µl each of forward and reverse primers 
(final concentration 260 nM each) and 1 µl of template DNA (up to 1 ng of plasmid 
DNA, 100 ng of genomic DNA or 500 ng of cDNA) or dH2O (no template control) 
were added to the master mix to make up a final volume of 50 µl.  
 
For large numbers of PCRs, reactions were set up in 0.2 ml thin walled PCR tubes to 
contain 5 µl of 10x PCR reaction buffer containing 2.5 mM MgCl2, 1 µl of dNTP mix 
(final concentration of 200 µM each), 2 µl each of forward and reverse primers (final 
concentration 260 nM), 0.5 µl of Taq DNA polymerase (1.25 Units) and 1 µl of 
template DNA (concentrations as before) or dH2O (control). Each reaction was then 
made up to a final volume of 50 µl with dH2O. All components were purchased from 
Invitrogen. Cycling was then performed using either a Hybaid OmnE, Hybaid PCR 
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Sprint or Hybaid PCR Express-Gradient thermocycler.  A typical cycling procedure is 
described in Table 2.2.  
 
Table 2.2 – Typical cycling procedure for DNA amplification using Taq DNA polymerase. 
Step Temperature Time Comments 
Initial 
Denaturation 
94 °C 3 min To ensure template denaturation 
Denaturation 94 °C 30 sec - 
Annealing 50 – 60 °C 30 sec Temperature is set depending on the 
melting temperature of the primers 
used; typically ~5 °C lower than Tm 
Extension 72 °C 30 sec 
– 5 min 
 
25 – 30 
cycles 
30 sec extension for each 500 bp of 
DNA to be amplified 
Final 
Extension 
72 °C 5 min - 
 
 
2.7.2 PCR using pfu DNA polymerase 
Pfu DNA polymerase (Promega) is a thermostable enzyme from Pyrococcus furiosus 
which catalyses DNA dependent polymerisation of nucleotides into duplex DNA in 
the 5’→3’ direction, exhibits 3’→5’ exonuclease (proofreading) activity and is used 
for PCR reactions requiring high fidelity synthesis such as expression constructs. The 
reaction mix was set up as follows; 5 µl of 10x Pfu DNA polymerase buffer (Promega), 
1 µl dNTPs (final concentration 200 µM each - Invitrogen), 2 µl each of forward and 
reverse primers (final concentration 260 nM each), 1 µl of DNA template 
(concentrations as before) or dH2O (control), 0.5 µl Pfu DNA polymerase (1.25 Units -
Promega), made up to a final volume of 50 µl with dH2O. Temperature cycling for a 
typical pfu DNA polymerase PCR was carried out as described in Table 2.2, however 
as pfu exhibits a lower extension rate compared to Taq DNA polymerase, extension 
times were increased to 1 min for every 500 bp of DNA to be amplified.  
 
For all PCR protocols, DNAs were separated following amplification by agarose gel 
electrophoresis (Section 2.7.5).  
 
2.7.3 Reverse-transcription (RT)-PCR 
RT-PCR was carried out in two steps in order to facilitate the amplification of a 
number of different sequences from the same cDNA sample. For this approach, total 
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RNA was extracted from tissues of interest as described in Section 2.2. cDNA was 
then synthesised from each sample using SuperscriptTM II Reverse Transcriptase 
(Section 2.3). Sequences of interest were then amplified from the resultant cDNA 
using a standard PCR protocol (Section 2.7.1). Prior to use, the concentration of cDNA 
was quantified as described in Section 2.5 and equal amounts of cDNA added to each 
PCR reaction. Additionally, in order to control for possible genomic contamination, 
primer pairs were designed to span intron/exon boundaries of each gene of interest. 
Following amplification, DNAs were separated by electrophoresis on a 0.1 % agarose-
TBE gel (Section 2.7.5).  
 
2.7.4 Quantatitive (Q)-PCR 
To quantify levels of expression of genes of interest, Q-PCR was carried out using the 
fluorescent double-stranded DNA dye DyNAmoTM SYBR® Green (Finnzymes). As 
with RT-PCR, total RNA was extracted from tissues of interest as described in Section 
2.2. cDNA was then synthesised from each sample using SuperscriptTM II Reverse 
Transcriptase (Section 2.3). Prior to setting up each reaction, gene-specific primers 
were designed to generate an optimal PCR product of <500 bp (Appendix 2). In 
addition, primers were designed, where possible, to span intron/exon boundaries of 
each gene of interest in order to control for possible genomic contamination. For each 
cDNA sample, reactions were set up in triplicate to contain 25 µl 2x SYBR Green 
Master Mix (Tbr DNA polymerase, SYBR Green I, optimised PCR buffer, 5mM 
MgCl2, dNTP mix), 2 µl each of primers (0.3 µM final concentration) and 1 µl of 
template cDNA (up to 500 ng), made up to a final volume of 50 µl with dH2O. 
Additionally, in order to facilitate quantification of each gene of interest relative to a 
standard reference gene, reactions were also set up in triplicate for each cDNA sample 
containing primers specific for the rp49 gene, known to encode a ribosomal protein of 
standard expression.  
 
Reactions were set up on ice using optical grade PCR strips (MJ Research) alongside 
two blanks (1 x SYBR Green Master Mix), primer-only controls (set up in duplicate 
for each set of primers used) and a range of external standards (in duplicate) for each 
gene containing 10-1 – 10-7 ng of template amplicon DNA (obtained from PCR 
amplification). Cycling was then performed using an OpticonTM 3 thermal cycler 
according to the protocol described in Table 2.3. 
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Table 2.3 – Typical cycling conditions for Q-PCR 
Step Temperature Time Comments 
Initial 
Denaturation 
95 °C 10 min To ensure template denaturation 
Denaturation 95 °C 20 s - 
Annealing 55 °C 20 s Temperature is set depending on the 
melting temperature of the primers used; 
typically ~5 °C lower than Tm 
Extension 72 °C 5 – 20 s 5 s per 100 bp of product 
Data 
Acquisition 
- - 
 
 
35 – 45 
cycles 
Fluorescence data collection is performed 
after each cycle 
Final Extension 72 °C 5 min - 
Melting Curve 60 – 90 °C 1 s hold per 0.3 °C Used to check the specificity of the 
amplified product 
        
Following amplification, each Q-PCR reaction was analysed using OpticonTM 3 
software as according to the manufacturers’ instructions. Absolute quantification of 
gene expression was calculated using a standard curve whereby threshold cycle C(t) 
values of each unknown sample were compared to the C(t) values of gene standards of 
known DNA concencentrations. Specificity of each amplified product was also 
analysed using melting curve data.  
 
Following absolute quantification of DNA in each reaction, relative quantification of 
each sample was determined by calculating a ratio of target gene DNA concentration 
to rp49 DNA concentration. Results were then plotted as means + SEM (where control 
= 1) using GraphPad Prism 4.0 software. Statistical significance of data was 
determined by 2-way ANOVA and/or Student’s t tests where appropriate.     
 
2.7.5 Agarose gel electrophoresis 
DNAs were separated in 1 % agarose in 0.5x TBE [90 mM Tris, 90 mM boric acid 
(pH 8.3), 2 mM EDTA] containing 0.1 µg/ml EtBr as described in Sambrook and 
Russell, 2001), using 0.5x TBE as the electrophoresis buffer. Sizes were compared to a 
1kb ladder (Invitrogen). Prior to loading, 6x loading dye [0.25 % (w/v) bromophenol 
blue, 0.25 % (w/v) xylene cyanol, 30 % (v/v) glycerol in water] was added to the 
samples to a final 1x concentration of loading dye in the sample. 
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2.7.6 PCR purification  
DNA bands were excised from agarose gels using a clean scalpel blade and the DNA 
extracted using the QIAGEN® QIAquick Gel Extraction Kit according to the 
manufacturers’ instructions. Alternatively, PCR products were purified directly using 
the QIAGEN® QIAquick PCR purification kit according to instructions. DNA was 
typically eluted in 20 µl of Buffer EB (10 mM Tris-HCl, pH 8.5) and quantified as 
described in Section 2.5. 
 
2.8 DNA Cloning  
2.8.1 E.coli strains and plasmids  
Listed below are the E.coli strains and plasmids used in this study (Table 2.4). 
Table 2.4 – E.coli strains and plasmids 
E.coli 
Strain Genotype 
DH5αTM subcloning efficiency 
competent cells (Invitrogen) 
(F- φ80dlacZ ∆M15, ∆(lacZYA-argF), U169, deoR, recA1, endA1, 
hsdR17 (rK-,mK+), phoA, supE44,λ-, thi-1, gyrA96, relA1). 
Plasmids 
Name Purpose 
pGL3-Basic Vector  
(Promega) 
Used to clone AMP promoter sequences of interest upstream of the 
luc+ luciferase gene. Also contains the AmpR gene to confer 
ampicillin resistance when transformed into E.coli. 
pAc5.1/V5-His/lacZ 
(Invitrogen) 
Plasmid expressing the lacZ β-galactosidase gene. Co-transfected 
alongside AMP promoter/pGL3 constructs in order to determine 
transfection efficiency. Also contains the AmpR gene to confer 
ampicillin resistance when transformed into E.coli. 
 
 
 
2.8.2 DNA constructs generated for this study 
Table 2.5 lists the DNA constructs generated for this study. Constructs were made 
according to the protocols listed in Sections 2.8.3 – 2.8.8. DNA inserts were generated 
by pfu DNA polymerase PCR (Section 2.7.2) using forward and reverse primers 
encoding appropriate restriction sites for ease of cloning. The primer sequences used 
for this study, including restriction sites, are described in Appendix 2. 
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Table 2.5 – DNA constructs generated for this study 
Construct Method of cloning Purpose 
Dipt-pGL3 Promoter sequence of diptericin cloned upstream 
of luc+ in the multiple cloning region of pGL3 
between the KpnI and HindIII restriction sites 
Measurement of diptericin 
expression by luminescence  in 
Drosophila S2 cells  
AttD-pGL3 Promoter sequence of attacin D cloned upstream 
of luc+ in the multiple cloning region of pGL3 
between the KpnI and BglII restriction sites 
Measurement of attacin D 
expression by luminescence  in 
Drosophila S2 cells 
CecA1-pGL3 Promoter sequence of cecropin A1 cloned 
upstream of luc+ in the multiple cloning region 
of pGL3 between the KpnI and HindIII 
restriction sites 
Measurement of cecropin A1 
expression by luminescence  in 
Drosophila S2 cells 
 
 
2.8.3 Restriction digests 
Restriction digests were set up to contain 10 µl of the appropriate 10 x Buffer for the 
restriction enzyme(s) used, bovine serum albumin (BSA; final concentration of 100 
µg/ml, only used if necessary), up to 1 µg of template DNA and the appropriate 
restriction enzyme(s) (10 Units/µl) at a ratio of 1 Unit of enzyme/µg of DNA. Each 
reaction was then made up to 100 µl with dH2O and incubated for 1-2 h at 37°C. 
Where a double digest was required but enzymes were not compatible to use in the 
same buffer, a single digest was first of all performed and the resultant DNA product 
purified using a QIAGEN® QIAquick PCR Purification kit (Section 2.7.6). Purified 
DNA was then eluted in an appropriate volume of dH2O and another digest performed 
with the second enzyme and appropriate buffer as described above. Following each 
digest, samples were purified as described above and quantified as described in 
Section 2.5. For this study, all restriction enzymes and corresponding buffers used 
were purchased from New England Biolabs. 
 
2.8.4 DNA ligation 
For cloning DNA inserts into vectors, the vector and the DNA insert were first 
digested with the appropriate restriction enzymes and purified as described in section 
2.8.3. Ligation reactions were then carried out using the Roche Rapid DNA Ligation 
Kit according to the manufacturers’ instructions. For each reaction, a molecular ratio 
of 3:1 insert: vector was used (typically 50-100 ng of vector). Ligations were 
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incubated for 5 - 30 min at room temperature before transformation into competent 
E.coli.  
 
2.8.5 Transformation into E.coli 
Plasmids were transformed into DH5αTM subcloning efficiency chemically competent 
cells (Invitrogen) by the addition of 50-100 ng of plasmid to 50 µl of cells on ice. 
Samples were then incubated on ice for 15 min followed by a heat-shock at 37 °C for 
30 s. Following heat-shock, samples were transferred back to ice for a further 2 min, 
and 950 µl of L-broth added (appendix 1). Each sample was then incubated at 37 °C 
for 30 min to allow expression of the ampR gene. 100 µl of each transformation was 
then spread onto L-Agar plates (appendix 1) containing 100 µg/ml ampicillin and 
incubated overnight at 37 °C.  
 
2.8.6 Identification of positive clones 
2.8.6.1 Plasmid selection 
Each plasmid used in this study contained the ampicillin resistance gene (ampR) 
encoding β-lactamase. Therefore, transformed E.coli containing the plasmid of interest 
were selected for by their ability to grow in the presence of 100 µg/ml ampicillin when 
cultured in L-Broth media or on L-Agar plates. Ampicillin (Sigma) was made as a 100 
mg/ml stock solution (w/v) in 50% H2O, 50% ethanol) and stored at -20°C. 
 
2.8.6.2 Diagnostic PCR 
To identify the presence and orientation of a DNA insert in a vector, bacterial colonies 
could be tested directly using PCR. Reactions were set up according to the protocol 
described in Section 2.7.1 using one primer that bound to the insert and one primer 
that bound within the vector (facing into the cloning site). For DNA template, selected 
colonies were touched with a sterile pipette tip, which was then used to pipette the 
PCR solution up and down.  
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2.8.6.3 Diagnostic restriction digest 
For diagnostic restriction digests, selected colonies were grown overnight at 37 °C in 5 
ml of L-broth supplemented with 100 µg/ml ampicillin. Plasmid DNA was then 
isolated from each culture as described in Section 2.8.7 and quantified as described in 
section 2.5. Isolated plasmids were then digested in order to determine the successful 
insertion and orientation of the DNA insert into the vector. To do this, digestion sites 
were identified in each construct both within the DNA insert and within the plasmid 
that, once digested, would result in DNA products of known size. Digestions were 
carried out as described in Section 2.8.3, however the total volume of each reaction 
was reduced to 10 µl. The volumes of the components of each digest were also 
adjusted accordingly. Following digestion, DNA was separated in each sample by 
agarose gel electrophoresis (Section 2.7.5).   
 
2.8.7 Isolation of plasmid DNA 
Small scale plasmid DNA preparation was carried out using the QIAGEN® Qiaprep 
Spin Miniprep kit. Large scale preparation for germline transformation and cloning 
was carried out using the QIAGEN® Qiagen Plasmid Maxi, Endofree Maxi or the Hi-
Speed Plasmid Maxi kit according to the manufacturers’ instructions. 
 
2.8.8 Automated DNA sequencing 
Automated sequencing was performed at the Glasgow University Molecular Biology 
Support unit (MBSU). Automated sequencing at the MBSU was performed as a 
single-stranded reaction with template and primer supplied at 1 µg and 3.2 pmol, 
respectively, with a PCR mix containing fluorescently labelled dideoxynucleotides.  
Samples were run on an agarose gel with the nucleotides being detected on an ABI 
automated DNA sequencer. Analysis was performed using an Applied Biosystems 
automated sequence analysis programme and the sequences were down-loaded from 
the server onto Editview (version 1.0, free DNA sequencing software from Perkin 
Elmer) and further analysed.  
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2.9 Drosophila S2 cell culture 
2.9.1 Passaging of S2 cells 
Drosophila S2 cells (Invitrogen) were maintained in Complete Schneider’s Medium 
(Schneider’s medium (Invitrogen) supplemented with 10% heat-inactivated Foetal 
Bovine serum) (CSM) at a temperature of 28 oC.  Cells were typically kept in a total 
volume of 15 ml in 75cm3 flasks.  For general maintenance, cells were passaged at a 
density of 107 cells/ml. To do this, cells were resuspended by gentle pipetting and then 
diluted 1:2.5 by adding 6 ml of cells into 9 ml of fresh CSM.   
 
2.9.2 Transient transfection of S2 cells 
Transient transfection was carried out in tissue culture six-well plates.  24 hours before 
transfection 6 x 106 cells in a volume of 3 ml were seeded into individual wells.  For 
each 600 µl transfection, 19 µg of each plasmid DNA and 36 µl CaCl2 (2 M - 
Invitrogen) were added to a sterile 1.5 ml eppendorf tube and made up to a total 
volume of 300 µl with dH2O.  This was mixed well and then added drop-wise over 1-2 
min to 300 µl of 2 x Hepes buffered saline (HBS – 50 mM Hepes, 1.5 mM Na2HPO4, 
280 mM NaCl, pH 7.1; Invitrogen) with continuous mixing. Each 600 µl reaction was 
then left to precipitate for 30 min at room temperature before being added drop-wise to 
the seeded S2 cells whilst swirling continually to mix.  Cells were then incubated for 
16 – 24 hr at 28 oC. Following incubation, cells were resuspended by gentle pipetting 
and transferred to a 15 ml falcon tube. Each sample was then pelleted by 
centrifugation at 1500g for 1 min at room temperature and resuspended in 3 ml fresh 
CSM to wash.  This step was repeated twice more before cells were resuspended in 3 
ml of CSM and returned to the same six-well plate.  If a plasmid encoding a metal 
inducible promoter was used, protein expression was induced in each 3 ml culture by 
the addition of 15 µl of 100 mM CuSO4 and expression was allowed to proceed for 40-
42 hours. Cells were then incubated with 100 µM di-butyryl-cGMP (Sigma) and/or 10 
µg/ml lipopolysaccharide (LPS - Calbiochem) for 3 hr before harvest. Cells were then 
harvested by centrifugation at 1500g for 1 min, washed once in phosphate-buffered 
saline (PBS – 135 mM NaCl, 1.3 mM KCl, 3.2 mM Na2HPO4, 0.5 mM KH2PO4 [pH 
7.4]) and pelleted by centrifugation as before. 100 µl of room temperature Reporter 
Lysis Buffer (RLB – Promega) was then added to each pellet and cells lysed using a 
single freeze-thaw cycle. Each cell lysate was then mixed thoroughly and centrifuged 
 72
at 13,000g for 5 min at 4 °C. The supernatant of each sample was then transferred to a 
microcentrifuge tube and mixed thoroughly by pipetting. Cell lysates were then used 
for further analysis as described in Sections 2.10 and 2.11.   
 
2.10 β-galactosidase assays 
In order to account for discrepancy in both cell numbers and transfection efficiency, 
each cell lysate was assayed for levels of β-galactosidase activity as well as 
luminescence. For this assay, β-galactosidase activity was measured using an 
Invitrogen β-gal assay kit as according to manufacturers’ instructions. Briefly, 5 µl of 
cell lysate was added to a sterile microcentrifuge tube and made up to 30 µl using 
dH2O. To this, 70 µl of ortho-nitrophenyl-β-D-galactopyranoside (ONPG – stock of 4 
mg/ml) and 200 µl of 1x Cleavage buffer containing 200 mM β-mercaptoethanol 
(Sigma) were added and each sample mixed thoroughly. Samples were then incubated 
at 37 °C for 30 min. Each reaction was then stopped by the addition of 500 µl of STOP 
buffer. The absorbance of each sample was read at 420 nm using a standard 
spectrophotometer (CECIL CE2021 2000 Series) against a blank containing ONPG 
and 1x Cleavage buffer without cell lysate. β-galactosidase activity was then 
calculated for each sample using the equation below; 
 
nmoles of ONPG hydrolysed = )1)(/4500(
)108)(( 5420
cmcmnmolesnl
nanolitresxOD
−
 
 
where; 
4500 = extinction coefficient 
1cm = path length 
8 x 105 nl = total volume of the reaction 
 
 
2.11 Luciferase assays 
Luciferase assays were carried out using a Promega Luciferase Assay System kit as 
according to the manufacturers’ instructions. For each sample, 20 µl cell lysate was 
added to 100 µl Luciferase Assay Reagent and transferred to a luminometer tube. 
Luminescence was then detected in each sample using
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programmed to perform a 2 second measurement delay followed by a 10 second 
measurement read. Luminescence counts were then normalised for each sample by 
comparison to corresponding β-galactosidase expression levels assayed from same cell 
lysate (Section 2.10) and expressed as counts/nmole of hydrolysed ONPG.     
 
 
2.12 cGMP-dependent protein kinase assays 
The cyclic GMP-dependent protein kinase activity of Malpighian tubules was 
ascertained by using direct measurement of radiolabelled phospho-transfer to a short 
peptide sequence substrate (MacPherson et al. 2004b).  Approximately 400 tubules per 
sample were dissected and homogenised on ice in 20 µl of homogenisation buffer (20 
mM Tris [pH 7.5], 250 mM sucrose, 2 mM EDTA, 100 mM NaCl, 50 mM β-
mercaptoethanol, 1:100 dilution of protease inhibitor cocktail (Sigma)).  Protein 
concentration of each sample was then determined by Bradford assay (Section 2.13). 
Two stock solutions of kinase assay buffer were prepared, with and without 1 µM 
cGMP.  This comprised 20 mM Tris-HCl, pH 7.5, 1 mM EDTA, 2 mM EGTA, 10 mM 
magnesium acetate, 1 nM PKA inhibitor (TYADFIASGRTGRRNAI-NH2), 20 µM 
ATP, 1 mM zaprinast, 1 µM sildenafil, 1 mM DTT, 0.2 µg/ml GLASS-tide 
(RKRSRAE, a heptapeptide cGK-specific substrate, Calbiochem), 0.5-2 µl of [γ-32P] 
ATP (370 MBq/ml, to an approximate specific activity of 4000 cpm/pmol ATP). 
 
For each reaction, 40 µl reaction buffer was added to a 5 µl (approximately 30 µg of 
protein) tubule sample.  This was carried out with both cGMP-containing (+cGMP) 
and cGMP-absent (-cGMP) buffer.  Sample blanks were generated using 40 µl 
reaction buffer and 5 µl of homogenisation buffer.  Reactions were incubated for 30 
min at 30 °C, after which 35 µl of each sample was spotted onto individual squares of 
P81 paper (Whatman).  These squares of paper are referred to as reaction samples.  In 
order to determine the specific activity of the radiolabelled ATP at the end of the 
reaction, several reactions were chosen randomly and 5 µl samples (representative of 
1/9 of total counts) of each spotted onto individual squares of P81 paper (‘total count’), 
allowed to dry and set aside. 
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The reaction samples were washed for 3 x 5 min in 75 mM phosphoric acid, then 
washed once for 15-20 s in ethanol and allowed to dry.  All squares of paper, including 
the total count samples, were then transferred to scintillation vials, with the addition of 
3 ml scintillation fluid and counted in a scintillation counter (Beckman) for 60 s. 
Specific activity of [γ-32P] ATP was calculated (9 x mean c.p.m. of total count 
squares/[ATP] in reaction) and used to calculate protein kinase activity (pmol ATP 
min-1 µg-1 protein). 
 
 
2.13 Bradford protein assay  
The Bradford protein assay was used to estimate the protein concentration of different 
protein samples.  Each assay was carried out on a 96-well plate.  Eight standards of 0-5 
µg of BSA in water were set up in triplicate in a 50 µl total volume.  Between 1 and 3 
µl of each protein sample (usually approximately 2 µg of protein) were also set up in 
triplicate in a final volume of 50 µl.  To these were added 200 µl of a 1 in 5 dilution of 
Bradford reagent concentrate (Biorad).  The absorbance at 590 nm of the samples were 
read on a standard plate reader and standard curve and protein concentrations 
calculated using Quanta Smart software. 
 
 
2.14 Survival assays 
Cultures of E. coli, B. subtilis or P. aeruginosa (Selectrol freeze-dried pellets, TCS 
Biosciences) were grown overnight in 5 ml LB-broth to stationary phase at 37 °C. 
Bacterial challenge was performed by pricking groups of 30 five to seven day old adult 
flies of the appropriate genotype (as stated throughout the text) with a thin needle (BD 
Microlance TM 3, 26 G x 5/8) dipped in the concentrated bacterial cultures. Control 
experiments were carried out by mock-stabbing flies with a sterile needle. Following 
infection, flies were transferred into clean vials and survival monitored over several 
days. The percentage of survivors was then calculated for each experiment and plotted 
using a Kaplan-Meier survival curve (GraphPad Prism), as means ± SEM. 
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2.15 Natural Infection assays 
2.15.1 Natural infection of Drosophila using E.coli 
Prior to infection, 7-day old adult flies of appropriate genotype were incubated for 2 hr 
without food. Flies were then transferred into empty vials containing filter paper 
hydrated with 5 % sucrose solution contaminated with concentrated ampicillin-
resistant E.coli (OD600 = 1; concentrated to contain ~1010 CFU/ml). Control flies were 
transferred to vials containing filter paper hydrated with 5 % sucrose solution alone. 
Each vial was then incubated at 25 °C for 24 hr, following which flies were dissected 
and assessed for either levels of bacterial clearance in the gut (Section 2.15.2) or 
diptericin expression levels in the tubules, either by Q-PCR (Section 2.7.4) or GFP 
fluorescence (Section 2.16.1). 
 
2.15.2 Assessment of bacterial clearance 
For the assessment of E.coli proliferation in the intestine, adult flies of the appropriate 
genotype were infected as described in Section 2.15.1. Following infection, the midgut 
of each fly was carefully dissected (10 per sample), rinsed in dH2O and then dipped in 
70 % (v/v) ethanol for surface sterilisation. Midguts from each sample were then 
transferred into 100 µl of sterilised PBS (pH 7.4) and homogenized using a disposable 
tissue grinder (Kontes). Each sample was then diluted 1:100 with LB-broth and 150 µl 
of each mixture spread onto LB-agar plates in the presence of 100 µg/ml ampicillin. 
Each plate was then incubated overnight at 37 °C and the number of colony forming 
units (CFUs) monitored. Results were then plotted using GraphPad Prism 4.0 software 
as means + SEM and significance of data determined by Student’s t-tests.   
 
2.16 Fluorescence Imaging of Tubules 
2.16.1 Live imaging of GFP fluorescence 
For live imaging of GFP expression in Drosophila, tissues were carefully dissected as 
described in Section 2.1.3 and mounted on pre-treated Poly-L-lysine-coated (100 µl/ml 
– Sigma) BDH microscope slides in 100 µl PBS for immediate viewing using either 
the Zeiss Axiocam HRC System or the Zeiss 510 Meta confocal system as stated 
throughout the text. For samples viewed using the Zeiss Axiocam HRC system, GFP 
fluorescence was excited using a standard UV source (mercury lamp) and images 
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recorded at identical exposure conditions using Axiovision 5.0 acquisition software.  
Confocal analysis of GFP fluorescence is described in Section 2.16.3.  
 
2.16.2 Immunocytochemistry (ICC) of Relish translocation  
Malpighian tubules from 7-day old adult flies (either c42;UAS-relish or UAS-
cGK/c42;UAS-relish as appropriate) were dissected and incubated as described in 
Section 2.1.3 with appropriate concentrations of either cGMP (Sigma) and/or PGN(-) 
(Invivogen) as stated throughout the text. Tubules were then arranged on pre-treated 
Poly-L-lysine-coated BDH microscope slides in 100 µl PBS. PBS was then carefully 
removed and each sample fixed with 4% (w/v) paraformaldehyde in PBS for 15 min. 
Samples were then washed 5 times in PBS and incubated in 0.2 % (v/v) Triton-X-100 
in PBS for 15 min in order to permeabilise the cells. Tubules were then washed in 0.2 
% (v/v) Triton-X-100, 0.5 % (w/v) bovine serum albumin in PBS (PAT) for 3 hr and 
then incubated overnight at 4°C in PAT containing a 1:50 dilution of monoclonal 
mouse anti-tetra-HIS primary antibody (QIAGEN®). After washing in PAT for 2 hr 
(changing solution every 30 min) tubules were incubated in PAT containing 2 % (v/v) 
goat serum for 4 hr and then subsequently incubated overnight at 4°C in PAT 
containing anti-mouse FITC-labelled secondary antibody (1:500 dilution; Jackson). 
Tubules were then washed in PAT for 2 hr and incubated in 4, 6-diamidino-2-
phenylindole (DAPI) solution (1:5000 dilution of a 5 mg/ml stock - Sigma) for 1-2 
min in order to stain the nuclei. After washing three times with PBS for 10 min, 
tubules were mounted in VectaShield (Vector Labs) using 22 mm square BDH 
coverslips, and sealed with glycerol/gelatin (Sigma). Samples were then viewed using 
the Zeiss 510 Meta confocal system. 
 
2.16.3 Confocal microscopy  
Samples were imaged using a Zeiss 510 Meta confocal system coupled to a Zeiss 
microscope. An Argon 488 laser and a 505-530 band pass filter were used for imaging 
the FITC antibody or GFP-fluorescent proteins. For visualisation of DAPI, a pseudo-
DAPI technique was used. The DAPI was excited using the standard UV source 
(mercury lamp) and the image captured using the confocal photomultipliers. The DAPI 
image was then merged with the other channels retrospectively, using LSM 510 Meta 
Browser software. A 63x objective was used in all cases.
  
 
 
 
3 Chapter 3 
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3.1 Summary 
Recently, NO has been determined as a key regulatory molecule in both mammalian and 
Drosophila immunity (Nappi et al. 2000; Bogdan 2001a; Foley and O'Farrell 2003; 
McGettigan et al. 2005). In Drosophila, studies have identified NO as critical to fly 
survival in the adult fly in response to infection by gram-negative bacteria (McGettigan et 
al. 2005), and have implicated NO as playing a crucial role in upstream activation of the 
Imd pathway (Foley and O’Farrell. 2003). The mechanism by which NO exerts its effects 
is likely to be mediated by the cGMP signalling pathway via soluble guanylate cyclase, 
however this has yet to be determined. Therefore, using a combination of microarray, 
quantitative (Q) PCR and transgenic approaches, the role of cGMP signalling in immune 
response was investigated. Given the role of the Malpighian tubule as both an immune-
sensing tissue and one that utilises NO/cGMP, these experiments were carried out using 
the adult tubule as the model system. In this chapter, results show that not only does 
cGMP have a modulatory effect on the expression of Imd pathway AMPs in the tubule, 
but that this effect is both dose and time-dependent. It is also demonstrated that the effect 
of cGMP does not appear to occur in all immune-sensing tissues, with no change in Imd 
pathway AMP expression seen in the larval fat body in response to exogenous cGMP. 
Additionally, it is indicated that there may be a role for cAMP signalling in Drosophila 
tubule immune response, possibly involving the regulation of an anti-fungal response. 
  
3.2 The Malpighian tubule is a viable model for investigating immune 
response in Drosophila 
3.2.1 Introduction 
Over the years, NO/cGMP signalling has been established as essential to the regulation of 
tubule function (Davies 2006). As such, the tubule has emerged as the ideal genetic 
model for investigation into NO/cGMP signalling in vivo. However, the role of the 
Malpighian tubule as an important immune-sensing tissue has only recently been 
established (Tzou et al. 2000; McGettigan et al. 2005). In these studies, it is demonstrated 
that certain AMPs (diptericin, cecropin and metchnikowin) are upregulated in the tubule 
in response to infection (Tzou et al. 2000) and that all the major immune-associated 
genes of the Imd pathway are expressed in Drosophila tubules (McGettigan et al. 2005). 
Additionally, experiments using lacZ reporter flies have indicated that diptericin 
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expression is under the control of the Imd pathway in tubules, although this regulation 
has not yet been demonstrated quantitatively (Tzou et al. 2000). Therefore, using a both a 
bioinformatic and reverse transcriptase (RT)-PCR approach, further validation of the 
results of previous studies was carried out, as well as confirmation by Q-PCR that the 
Imd pathway is responsible for diptericin production in the Malpighian tubule. 
 
3.2.2 Imd pathway-associated genes are strongly expressed in the Drosophila 
Malpighian tubule 
The Imd pathway has been established as the main pathway involved in sensing and 
response to gram-negative bacteria (Georgel et al. 2001). A number of AMPs are also 
known to have specific activity against gram-negative bacteria and it has been 
demonstrated that the expression of these AMPs is directly induced through activation of 
the Imd pathway (Lemaitre et al. 1995a). As mentioned above, in a previous study by 
McGettigan et al, it was demonstrated that all of the main components of the Imd 
signalling pathway are expressed in the tubule (Figure 3.1A; taken from McGettigan et al. 
2005). However, to date, the only Imd pathway-associated AMPs that have been 
identified in the tubule are diptericin and cecropin (Tzou et al. 2000; McGettigan et al. 
2005). Therefore, in order to further validate that the Imd pathway may be operational in 
the tubule, the expression of selected Imd pathway-associated AMPs was investigated. 
This was carried out via an RT-PCR approach whereby gene-specific primers were used 
to amplify cDNA derived from the tubules of 7-day old Oregon R (OrR, wild type) adult 
flies. It should be noted that all primers were designed around intron/exon boundaries of 
the genes so as to control for the possibility of genomic contamination of cDNA 
preparations. Results show that all of the AMP genes tested are expressed in the tubule, 
including two cecropin isoforms and two attacin isoforms (Figure 3.1B). Therefore, these 
data further demonstrate that the tubule has all the relevant components in place to 
activate a sufficient immune response to gram-negative bacteria via the Imd pathway.  
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Figure 3.1 - Expression of Imd pathway-associated genes in the Malpighian tubule. [A] Previous 
studies have demonstrated that all components of the Imd pathway are expressed in the tubule (taken from 
McGettigan et al. 2005). [B] Imd pathway-associated AMPs are also expressed in the tubule. RT-PCR was 
performed on tubule cDNA from 7-day old OrR flies using gene-specific primers. Results show that all of 
the AMPs tested are expressed in the Malpighian tubules. Lane 1 depicts a ‘no template’ control.  
 
 
In order to determine the relevance of these data with regards to expression of the Imd 
pathway in the tubule compared to other tissues, a bioinformatics approach was used. 
Using the Drosophila database www.flyatlas.org, a comprehensive view of gene 
expression in specific tissues can be obtained. Therefore, searches were performed using 
this database to determine expression levels of Imd pathway components in various 
tissues of the fly. Interestingly, results show that many components of the Imd pathway 
are highly enriched in the tubule, especially Dredd and Relish (Table 3.1). In fact, it is 
demonstrated that Relish, the NFκB/Rel transcription factor involved in AMP induction, 
is most abundantly expressed in the adult tubule compared to other tissues. Therefore, it 
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is suggested that not only is the Imd pathway active in the tubule, but that the tubule is a 
significantly important tissue with regards to Imd pathway activation. 
 
Table 3.1 – Expression of Imd pathway components in Drosophila fly tissues.  Table shows mRNA 
abundance of both Dredd and Relish in various fly tissues and indicates their enrichment in comparison to 
the whole fly signal. Major sites of enrichment are shown in red and tubule data is shown in bold. Dredd 
and Relish are tabulated here as an example, for expression of other Imd pathway components see 
www.flyatlas.org  
 Dredd Relish 
Tissue mRNA 
signal 
Enrichment Affy 
Call 
mRNA 
signal 
Enrichment Affy 
Call 
Brain 63 ± 2 0.70 Down 114 ± 6 0.50 Down 
Head 92 ± 3 1.00 None 445 ± 35 1.80 UP 
Thoracicoabdominal 
ganglion 
82 ± 2 0.90 None 147 ± 5 0.60 Down 
Crop 202 ± 5 2.20 UP 724 ± 10 2.90 UP 
Midgut 170 ± 7
 
1.90 UP 517 ± 15
 
2.10 UP 
Tubule 170 ± 4 1.90 UP 783 ± 91 3.10 UP 
Hindgut 217 ± 8 2.40 UP 735 ± 33 2.90 UP 
Ovary 91 ± 2 1.00 None 211 ± 6 0.80 None 
Testis 54 ± 6 0.60 Down 40 ± 3 0.20 Down 
Male Accessory 
Gland 
251 ± 7 2.80 UP 380 ± 22 1.12 UP 
Adult carcass 140 ± 2 1.50 UP 426 ± 34 1.50 UP 
Larval tubule 189 ± 5 2.10 UP 398 ± 12 1.60 UP 
Larval fat body 191 ± 9 2.10 UP 685 ± 55 2.70 UP 
Whole fly 90 ± 8   250 ± 14   
 
 
3.2.3 Diptericin expression in the Malpighian tubule is dependent on the Imd 
pathway 
To date, evidence that the Imd pathway is responsible for the regulation of AMP 
expression in the tubule has been provided using diptericin-lacZ transgenic reporter flies, 
where it was reported that activation of the diptericin promoter is hindered in imd mutant 
flies (Tzou et al. 2000). To further support this data, experiments were carried out in 
order to quantify the levels of diptericin expression in the tubule in both wild type and 
mutant flies. In this experiment, tubules of 7-day old adult flies were excised in Relish 
E20 and imd1 flies, null mutants of the relish and imd genes respectively (Hedengren et al. 
1999; Lemaitre et al. 1995; both kind gifts from Professor S Kurata, University of 
Tohoku, Japan). Additionally, tubules from wild type Oregon R (OrR) flies were excised 
to act as controls. Tubule cDNA was then generated for each line and diptericin 
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expression quantified by Q-PCR using an Opticon 2 thermal cylcer. Results show that 
diptericin expression is completely abolished in the tubules of relish flies and that there is 
only minimal expression of diptericin in the tubules of imd mutant flies (Figure 3.2). 
These data support the results of previous studies and confirm quantitatively that the Imd 
pathway is responsible for diptericin expression in the Malpighian tubule. 
 
 
Figure 3.2– Diptericin expression in tubules is dependent on the Imd pathway. Expression of diptericin 
was assessed by Q-PCR in OrR tubules (Control) and in tubules from both relish and imd1 mutant flies. 
Resulting data were normalised against expression of the standard, rp49, and expressed as a fold change of 
diptericin expression where control =1 (N=4, + SEM). Significance of data was determined by one-way 
ANOVA (See table). Data shows that diptericin expression is significantly lower in the tubules of both 
relish and imd mutant flies.  
 
3.3 cGMP modulates expression of Imd pathway-associated anti-
microbial peptides in the Drosophila Malpighian tubule 
3.3.1 Introduction 
In recent years, NO has been shown to modulate function of the Imd pathway in a 
number of different Drosophila tissues such as the hemocytes, Malpighian tubules and 
the fat body (Bassett et al. 2000; McGettigan et al. 2005; Foley and O’Farrell. 2003). The 
main role of NO is to stimulate cGMP production and activate cGMP-dependent 
signalling processes. As such, it is likely that the mechanism by which NO acts to 
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regulate immune function occurs via cGMP signalling. To date, a definitive role for 
cGMP signalling in immunity has not been established in vertebrates or invertebrates, 
however studies have implicated the involvement of the cGMP pathway in mammalian 
immune processes. For example, cGMP signalling is suggested to be involved in the 
proliferation of lymphocytes (Sadighi Akha et al. 1996; Fischer et al. 2001), chemotaxis 
and adhesion of neutrophils and macrophages (Syrovets et al. 1997; VanUffelen et al. 
1998; Lawrence and Pryzwansky 2001), and the gene expression of iNOS and TNFα in 
macrophages and dendric cells (Harbrecht et al. 1995; Kiemer et al. 2000; Paolucci et al. 
2000). Therefore, given the already established role of NO in Drosophila immunity and 
the implication from mammalian studies that cGMP could also be involved in immune 
regulation, studies were initiated to determine the potential role of cGMP signalling in 
Drosophila innate immunity. This was carried out using the tubule as an in vivo model 
system and achieved using a combination of microarray, Q-PCR and transgenic 
approaches.   
 
3.3.2 Expression of Imd pathway-associated AMPs is down-regulated in the 
Malpighian tubules in response to stimulation by cGMP in vitro  
With the development of microarray analysis it has become possible to generate large 
amounts of information regarding changes in gene expression in response to specific 
signals. Therefore, microarray analysis was carried out in Drosophila Malpighian tubules 
in order to ascertain the effect of cGMP on gene expression (Dow, Davies and Day, 
unpublished). In this study, tubules of 7-day old OrR flies were excised and incubated for 
3 hr in either sterile Schneiders medium (control) or sterile Schneiders medium 
containing 100 µM cGMP. It should be noted that 100 µM cGMP was used in this assay 
as previous studies have determined this to be the concentration which elicits maximum 
physiological response from the tissue (Davies et al. 1995). RNA was then extracted from 
these tubules and applied to Affymetrix Drosophila genome array chips according to a 
standard protocol. Results were then analysed using Affymetrix MAS 5.0 software (Dow, 
Davies and Day, unpublished).  
 
The effect of cGMP on immune-related genes in the tubule is summarised in Table 3.2. 
Interestingly, the genes that appear to be modulated by cGMP are those expressed in 
response to Imd pathway activation. This data further supports the evidence that NO is 
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involved in Imd pathway regulation and suggests that cGMP is also a key modulator of 
immune response in Drosophila. However, in complete contrast to studies carried out 
using NO, cGMP appears to modulate AMP expression in a negative manner. Results 
show that, at this concentration, cGMP is responsible for between approximately a 25-
90% downregulation of Imd pathway-associated AMPs. 
 
Table 3.2 – Tubule expression of AMP genes in response to cGMP stimulation. Summary of 
microarray analysis of gene expression in cGMP-stimulated tubules compared to non-stimulated tubules. 
Data shows that in the presence of cGMP there is between a ~25-90% downregulation of Imd pathway-
associated AMPs compared to controls 
Average mRNA signal (+SEM)  
Gene Control cGMP-
treated 
Fold 
Change  
Diptericin 734 + 90 368 + 65 0.50 
Attacin C 216 + 48 160 + 49  0.74 
Attacin D 9480 + 615 2839 + 499 0.30 
Cecropin A1 4168 + 473 789 + 77 0.19 
Cecropin A2 1770 + 183 363 + 50 0.21 
Cecropin C 2639 + 221 279 + 89 0.11 
 
 
In order to validate this data, both a Q-PCR and transgenic approach was used (Figure 
3.3). In these experiments, tubules of 7-day old OrR flies were excised and incubated 
under exactly the same conditions as the previous microarray experiment. For Q-PCR, 
cDNA was then derived from RNA extracted from each tubule sample and expression of 
specific AMP genes quantified as described previously. As can be seen in Figure 3.3A, 
quantitative analysis of microarray results confirms that Imd pathway-associated AMPs 
are down-regulated in response to 100 µM cGMP in the tubules. Results show that the 
tubule expression levels of all the AMPs tested are significantly lower after cGMP 
stimulation, with the decrease in expression levels compared to controls ranging from 
approximately 30% (AttC) to 80% (CecA1 and CecC).   
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Figure 3.3– Validation of microarray by Q-PCR and transgenic methods. For both approaches, tubules 
were dissected and incubated under the same condition as microarray. [A] Q-PCR shows approximately 
between a 30% and 80% down-regulation of Imd pathway-associated AMPs in response to cGMP. 
Resulting data were normalised against expression of a standard gene, rp49, and expressed as a fold change 
of AMP expression where control =1 (N=4, + SEM). Data significant from control are indicated by * 
(P<0.05) or ** (P<0.01) (as analysed by Students t-test). [B] Fluorescence is reduced in AMP-GFP 
transgenic flies in response to cGMP, suggesting a down-regulation in expression. All pictures were taken 
at the same exposure using a Zeiss Axiocam HRC.    
 86
 
To further support this data, AMP expression in response to cGMP was monitored in the 
tubules of both diptericin-GFP and cecropinA1-GFP reporter flies (Tzou et al. 2000; 
McGettigan et al. 2005; kind gifts from J.L Imler, University of Strasbourg). In these flies, 
GFP expression is under the control of the promoter of the corresponding gene. It should 
be noted that in unchallenged flies, fluorescence levels of both diptericin-GFP and 
cecropin-GFP are relatively low, however this experiment was carried out merely as 
further support to both the microarray and Q-PCR data. 
 
As with the Q-PCR, tubules of 7-day old flies were dissected and incubated under the 
same conditions as those used for the microarray. After incubation, all tubules were 
mounted in Phosphate Buffered Saline (PBS) for immediate viewing under fluorescence 
using a Zeiss Axiocam HRC System. All subsequent pictures were taken under exactly 
the same exposure conditions. As Figure 3.3B shows, expression of both cecropinA1 and 
diptericin is reduced in the tubules when stimulated with 100µM cGMP. Therefore, these 
data further support the evidence provided by microarray and Q-PCR that cGMP is a key 
modulator of Imd pathway activation in the Malpighian tubule.  
 
 
3.3.3 The effect of cGMP on anti-microbial peptide expression occurs in a dose 
and time-dependent manner 
As mentioned earlier, the original time of incubation and concentration of cGMP used in 
these assays was determined by results obtained from previous studies (Davies, 1995). 
However, in an organismal context, due to the presence of a number of different cGMP 
activators within each cell, as well as a number of downstream effectors, transporters and 
regulators of cGMP, the basal concentration of cGMP in vivo is difficult to determine. In 
fact, it is known that cGMP is present as specific ‘pools’ of differing concentrations and 
frequency within each cell, allowing for its role in a number of distinct physiological 
processes (Beavo and Brunton 2002; Piggott et al. 2006). Therefore, Q-PCR was carried 
out in order to determine the effect of different concentrations and incubation times of 
cGMP on the expression of Imd-pathway induced AMPs. For these experiments, focus 
was placed on diptericin, an AMP controlled solely by Imd pathway activation 
(Hedengren et al. 2000).  
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Figure 3.4– Dose-dependent effects of cGMP on diptericin expression. Tubules were dissected and 
incubated under the same conditions as described in the text. Resulting data were then normalised against 
expression of a standard gene, rp49, and expressed as a fold change of AMP expression where control =1 
(N=4, + SEM). Significance of data was determined by One-way ANOVA (See table). Data shows that 
effect of cGMP on diptericin expression is biphasic depending on concentration used. Analysis by One-way 
ANOVA shows that this effect is considered statistically significant.  
 
When assaying the effect of different concentrations of cGMP on diptericin expression, 
tubules were excised under the same conditions as previously described and incubated 
with an array of physiologically relevant cGMP concentrations ranging from 1 nM – 100 
µM. Interestingly, results show that at low concentrations of cGMP (within the 
nanomolar range), diptericin expression is increased within the tubule, suggesting that 
cGMP may be involved in activation of the Imd pathway under certain cellular conditions, 
possibly via NO. In contrast, when tubules are incubated with concentrations of cGMP in 
the micromolar range, a decrease in diptericin expression is seen relative to increasing 
cGMP concentration. Therefore, it is implied from these data that cGMP signalling is 
able to mediate either a stimulatory or an inhibitory effect on Imd pathway signalling and 
that this effect is dependent on cGMP concentrations within the cell. 
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When assaying the effect of time on cGMP modulation of diptericin expression, tubules 
were excised as previously described and incubated in 100 µM cGMP for varying time-
points ranging from 0 min-180 min. Additionally, in order to account for any endogenous 
variation in gene expression over time, control sets of tubules were incubated in the 
absence of cGMP for each time-point. Q-PCR analysis was then carried out on cDNA 
derived from each tubule set and resultant data (after initial normalisation to rp49 
expression) was normalised against expression of controls for each time-point (where 
control equals 1) (Figure 3.5). Results show that, at this concentration, cGMP appears to 
exhibit a biphasic effect on diptericin expression depending on whether the cGMP signal 
within the tubule is acute or sustained. 
 
 
Figure 3.5 – Time-dependent effects of cGMP on diptericin expression. Tubules were dissected and 
incubated under the same conditions as previously described. Resulting data were normalised against 
expression of a standard gene, rp49, and expressed as a fold change of AMP expression where control =1 
(N=4, + SEM). Separate control data was obtained for each time-point to account for natural changes in 
gene expression. Significance of data was analysed by one-way ANOVA (See table). Data shows that 
effect of cGMP on diptericin expression is biphasic depending cGMP incubation time, however statistical 
analysis does not show that this effect is significant. 
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To explain further, it appears that when tubules are incubated with 100 µM cGMP there 
is an initial induction of diptericin expression, followed by a down-regulation of 
expression between 30 and 60 min. Unfortunately, the initial increase in diptericin 
expression seen at 30 min was only consistent for the majority of datasets, resulting in a 
large error. This experiment was therefore repeated multiple times (N = 8), using shorter 
time-points of 15min, 30 min and 45min, in order to try and pin down the precise time at 
which the increase in diptericin expression occurs. Unfortunately, although an increase in 
diptericin expression was seen in every dataset before down-regulation occurred, the 
exact time of this increase was very transient, occurring at varying times in the first 30 
min after incubation (data not shown). Therefore, it can only be indicated by this data that 
cGMP might exhibit a biphasic effect depending on time, however further work is 
required to confirm this.  
 
3.4 cGMP modulation of Imd pathway anti-microbial peptide 
expression in other Drosophila tissues. 
3.4.1 Introduction 
Following validation that cGMP signalling acts to regulate the Imd pathway in the 
Malpighian tubule, studies were initiated in order to determine the effects of cGMP on 
AMP production in both the fat body and Drosophila Schneider line 2 (S2) cells. The fat 
body has been described as the canonical immune sensing tissue and therefore the effect 
of cGMP signalling on the Imd pathway in this tissue is of some interest. Similarly, 
Drosophila S2 cells have emerged as a useful in vitro cell-based system for the analysis 
of the activity of many genes and gene products. Therefore, using a combination of Q-
PCR, molecular cloning and reporter assay techniques, the effect of cGMP on Imd 
pathway activation in fat body and S2 cells were investigated.     
 
3.4.2 cGMP modulation of Imd pathway AMP expression does not occur in the 
Drosophila fat body  
To date, most studies of innate immune signalling pathways in Drosophila have been 
carried out in the fat body (Silverman and Maniatis 2001). The fat body originates from 
the mesoderm during embryogenesis and is critical to a number of processes including  
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Figure 3.6 - Fat body expression of Imd pathway-associated AMPs in response to cGMP.  Fat body 
was dissected from 3rd instar larvae and incubated with 100 µM dibutyryl-cGMP for 3hr. Resulting data 
were normalised against expression of a standard gene, rp49, and expressed as a fold change of AMP 
expression where control =1 (N = 4, + SEM). Data shows no significant change in AMP expression in 
response to 100 µM cGMP. 
  
nutrient sensing, energy metabolism and ‘liver’-related functions (Van Doren 2006). Like 
the Malpighian tubules, the fat body is present throughout the body cavity of the fly and 
therefore represents a powerful tissue for sensing and responding to invading pathogens. 
As such, numerous studies have identified the fat body as an important tissue with 
regards to the activation of immune signalling pathways and the subsequent production of 
AMPs. Additionally, in a study by Foley and O’Farrell (2003), NO was demonstrated to 
play a role in regulation of the Imd pathway in the fat body. This would suggest that 
cGMP signalling might also play a role in fat body immune responses. Therefore 
experiments were carried out in order to determine the effect of cGMP on AMP 
expression in larval fat body. Larval tissue was used for these studies as it is extremely 
difficult to isolate intact fat body from the adult fly. Experiments were carried out under 
the same conditions as with tubules however, as there is no known cGMP transporter 
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present in fat body, a cell-permeable analogue of cGMP was used (dibutyrylguanosine 3’, 
5’-cyclic monophosphate). As Figure 3.6 shows, there is no significant difference in 
expression of diptericin, cecropin or attacin in response to 100 µM cGMP. These data 
therefore suggest that Imd pathway regulation in the fat body may occur by cGMP-
independent means, although further investigation is required. 
 
3.4.3 Heterologous expression of Imd pathway AMPs in Drosophila S2 cells 
Drosophila S2 cells are derived from a primary culture of 20-24 hr old Drosophila 
embryos, and are hemocyte-like in quality (Schneider 1972). They have long been 
established as an effective cell-line for the in vitro analysis of the activity of many genes 
and their products, and their suitability as a system for the study of Drosophila innate 
immune responses has been demonstrated in a number of previous studies (Foley and 
O'Farrell 2004; Kallio et al. 2005; Kaneko and Silverman 2005; Thoetkiattikul et al. 
2005).  
 
 
Figure 3.7 – Cartoon map of the promoter regions of diptericin, attacin D and cecropin A1 following 
downstream cloning of the firefly luciferase gene.  
 
 
For this study, the promoter regions of diptericin, cecropinA1 and attacin D were 
amplified and cloned into the pGL3-Basic Vector upstream of the firefly luciferase gene, 
luc+ (Figure 3.7). The resultant DNA plasmids were then purified and transfected into S2 
cells using a calcium phosphate transfection method. Additionally, in order to control for  
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Figure 3.8 – AMP-luciferase gene expression in S2 cells.  The effect of cGMP on Imd pathway 
regulation was monitored in S2 cells after transfection of AMP-luc reporter plasmids. AMP-reporter 
expression was measured by luminescence and data normalised to corresponding β-gal expression levels. 
Data is expressed as luminometer counts per nmole of ONPG (see Materials and Methods for assay 
details). For each reporter gene, 4 datasets of results are depicted above.  Results show highly variable 
expression levels between samples.  Key in top panel is representative of all three graphs. 
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variations in transfection efficiency or cell number, cells were transfected with the β-
galactosidase expression vector, pAc5.1/V5-His/lacZ (Invitrogen). Transfected cells were 
then stimulated with 100 µM cGMP and/or 10 µg/ml LPS for three hours before harvest. 
It should be noted that again a cell-permeable analog of cGMP, di-butyryl-cGMP, was 
used in these studies, as there are no known transporters of cGMP expressed 
endogenously in S2 cells. Once harvested, cells were lysed using the Promega Luciferase 
Assay system and luminescence detected using a standard luminometer. All data obtained 
was then normalised to corresponding expression levels of β-galactosidase. Unfortunately, 
the data obtained from these assays was highly variable and, as a consequence, no 
significant trends could be demonstrated with regards to role of cGMP in Imd pathway 
regulation (Figure 3.8). In the case of diptericin-luciferase, it can be seen that expression 
levels between each individual dataset are extremely variable, with control data alone 
ranging from 4 – 155 counts/nmole ONPG. This variability is also present for stimulated 
cells. However, when looking at each dataset individually, a basic trend can be identified 
whereby diptericin-luc expression is increased in response to LPS, decreased in response 
to cGMP (though not significantly), and increased after stimulation with both LPS and 
cGMP, although to a lesser extent than when stimulated with LPS alone. Unfortunately, 
these data are too variable for this trend to be considered significant. For attacin-luc, both 
control data and cGMP-stimulated data are fairly comparable between datasets, however 
data obtained from cells stimulated with LPS or LPS/cGMP is highly variable. When 
comparing control expression levels to expression levels after cGMP stimulation, it can 
be seen that there is no significant difference in expression of attacin-luc, suggesting that 
cGMP does not have an effect on Imd pathway regulation in S2 cells. Finally, expression 
data obtained from cells transfected with the cecropinA1-luc plasmid shows no 
significant trends whatsoever and variability between datasets is too vast for 
interpretation. 
 
Overall, these experiments have proved inconclusive and suggest that S2 cells do not 
comprise a suitable system for investigation of the role of cGMP in Imd pathway 
regulation.    
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3.5 cAMP signalling also plays a role in Drosophila immune response 
in the Malpighian tubule 
Another important cyclic nucleotide second messenger is adenosine 3’,5’-cyclic 
monophosphate (cAMP). cAMP was first discovered in the late fifties by two different 
groups (Cook et al. 1957; Sutherland and Rall 1958) and since that time it has been 
established as a critical regulator of a number of processes such as glucose and lipid 
metabolism, cell proliferation, vasodilation, neuronal function and fluid secretion 
(Sutherland 1972; Beavo and Brunton 2002). The cAMP and cGMP signalling pathways 
are very closely related, whereby cross talk is known to occur between the pathways via 
dual-specificity phosphodiesterases. For example, in mammals, cGMP is known to 
stimulate cAMP hydrolysis by PDE2. Similarly, cGMP is known to act as a competitive 
inhibitor of cAMP hydrolysis by PDE3 (Omori and Kotera 2007; Zaccolo and Movsesian 
2007). Therefore, given the role of cGMP signalling in the regulation of immune 
response in Drosophila, it is suggested that cAMP may also be implicated in this 
regulation. To date, as with cGMP signalling, a role for cAMP signalling in Drosophila 
immune response has not been investigated. However in mammals, cAMP signalling has 
been implicated in a number of immune-related processes such as macrophage survival 
and regulation of T-cell activation (Park et al. 2005; Roach et al. 2005).  
 
In order to investigate a possible role of cAMP in Imd pathway regulation, a Q-PCR 
approach was used. Tubules from 7-day old OrR flies were dissected as described 
previously and incubated for 3 hr in sterile Schneiders medium (control) or sterile 
Schneiders medium containing 100 µM cAMP. Expression levels of selected Imd 
pathway-associated AMPs were then quantified by Q-PCR using cDNA derived from 
each tubule sample.  
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Figure 3.9 - Effects of cAMP on AMP expression. Tubules were dissected and incubated with or without 
100µM cAMP for 3hrs. Resulting data were normalised against expression of a standard gene, rp49, and 
expressed as a fold change of AMP expression where control =1 (N=4, + SEM) Data significant from 
control are indicated by * (P<0.05).  Data shows that cAMP does not have an effect on either diptericin or 
attacin expression but effects all isoforms of cecropin, showing between a 50-60% downregulation of 
expression for each. 
 
 
As Figure 3.9 shows, stimulation with cAMP does not significantly effect the expression 
of diptericin or attacins C and D, however a significant decrease in expression can be 
seen for all three cecropin peptides. Interestingly, unlike diptericin and attacin, which are 
solely active against gram-negative bacteria, previous studies have demonstrated that 
cecropin is active against both gram-negative bacteria and fungi (Ekengren and Hultmark 
1999). Data therefore indicates that whilst cGMP regulation may be specific to Imd 
pathway activation in response to gram-negative bacteria in tubules, cAMP may play a 
role in regulation of anti-fungal immune response.     
 
3.6 Discussion 
In this chapter, a novel role for cGMP signalling has been identified in the Drosophila 
Malpighian tubule. Data shows that cGMP modulates expression of Imd pathway-
associated AMPs, and that this effect can be either stimulative or inhibitory depending on 
concentration levels of cGMP. These data would therefore suggest that Imd pathway 
regulation by cGMP occurs via two distinct cGMP signals within the cell. As mentioned 
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earlier, cGMP is known to exist in localised ‘pools’ of differing concentrations, generated 
in close proximity to particular upstream activators i.e. soluble or receptor guanylate 
cyclases. Consequently, the action of each distinct cGMP signal within each cell is 
determined by its proximity and affinity to particular downstream effectors such as cGKs, 
PDEs and CNG channels (Beavo and Brunton 2002; Piggott et al. 2006). With regards to 
Drosophila immunity, previous studies have demonstrated a role for NO in the activation 
of the Imd pathway. Similarly, it is shown here that activation of Imd pathway-associated 
AMP expression is observed in response to low nanomolar concentrations of cGMP in 
the Malpighian tubule. Therefore it is suggested that, in vivo, activation of the Imd 
pathway by cGMP may occur via NO-mediated activation of sGC. Alternatively, it can 
be suggested that the inhibitory effect of cGMP seen at micromolar concentrations is 
probably mediated via NO-independent means, through the activation of a receptor GC. 
The differential effects of cGMP on Imd pathway activation in the tubule, as well as the 
cGMP activator and effector proteins involved in this regulation, form the basis of the 
remaining chapters presented in this thesis.   
 
When investigating the effect of cGMP signalling on AMP expression in other 
Drosophila tissues, it is demonstrated that cGMP stimulation has no significant effect on 
AMP expression in the fat body, and, as such, does not appear to play a regulatory role in 
Imd pathway activation in this tissue. Since the fat body has been determined as a key 
immune tissue in Drosophila, this result would suggest that further investigation is 
required to determine the relevance of cGMP regulation of the Imd pathway in the tubule 
with respect to overall immune response in the whole organism. Therefore, this effect is 
investigated in future chapters, whereby whole animal survival is assayed in response to 
infection using a transgenic approach.  
 
Unfortunately, when investigating the effect of cGMP on AMP expression in S2 cells, 
results proved highly variable. The reason for such variability between samples is 
unknown. Promoter sequences were verified before transfection, and variations in 
transfection efficiency were controlled for by simultaneous transfection of a lacZ 
expression vector. As mentioned earlier, S2 cells have previously been validated as a 
suitable model for investigation into immune signalling pathways. However, it is not 
known whether S2 cells are able to naturally express all of the components involved in 
cGMP signalling, as previous studies have involved the heterologous expression of 
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cGMP pathway components (MacPherson et al. 2004b; Day et al. 2005). Therefore, this 
may result in cells deficient in the proteins needed for cGMP signalling, or alternatively, 
S2 cells expressing inactive versions of the needed components. Consequently, based on 
the data obtained, it can be concluded that S2 cells are not a valid system to investigate 
the effects of cGMP signalling on Imd pathway regulation in Drosophila.    
 
Finally, a role for cAMP in regulation of immune response in the Drosophila tubule is 
demonstrated here, where data shows that expression of cecropin (A1, A2 and C) is 
significantly reduced in response to cAMP. As mentioned earlier, previous studies have 
implicated a role for cecropin as a potent anti-fungal agent (Ekengren and Hultmark 
1999). This would suggest that cAMP might play a role in regulation of anti-fungal 
response, possibly through interaction with the main anti-fungal signalling pathway in 
Drosophila, the Toll pathway. Further investigation into this effect is required. However, 
given the similarities between cGMP and cAMP signalling, and the fact that cGMP and 
cAMP are both regulated by a number of common PDEs, a complementary role for 
cAMP signalling in immune response to that of cGMP signalling would not be surprising. 
Therefore, the effect of cAMP signalling on Drosophila immune response pathways is a 
subject for future work. 
   
 
 
 
 
4 Chapter 4 
 
Modulation of immune response by cGMP is mediated 
by the Drosophila cGKs DG1 and DG2 
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4.1 Summary 
In the previous chapter, cGMP was shown to modulate expression of Imd pathway-
associated AMPs in the Malpighian tubules. In Drosophila, cGMP is known to mediate 
its effects via the cognate cGMP-dependent kinases DG1 and DG2, both of which are 
expressed in the tubule (Dow et al. 1994a). Therefore, in this chapter, the possible 
effector role of Drosophila cGKs in cGMP-mediated immune regulation was investigated. 
This was carried out using a transgenic approach, whereby expression of dg1 and the two 
main transcripts of dg2, P1 and P2, was modulated in the principal cells of the tubule 
using the GAL4/UAS binary system (Brand and Perrimon 1993). Transgenic flies were 
then assessed for changes in diptericin expression in the tubule by Q-PCR. Additionally, 
in order to determine the impact of cGMP pathway-mediated modulation of AMP 
expression in the tubules on the whole organism, survival in response to septic infection 
with both Gram-negative and Gram-positive bacteria was monitored in each transgenic 
fly line. Furthermore, the potential role of cGKs in the tubule in response to natural 
infection was investigated by both Q-PCR and bacterial clearance assays. Results 
demonstrate that targeted over-expression or knock-down via RNAi of cGKs in tubule 
principal cells of the adult fly results in differential effects of DG1 and DG2 on Imd 
pathway regulation. It is shown here that diptericin expression is stimulated by DG1 in 
the tubule of the adult fly. Similarly, the effects of DG1 in the tubule are sufficient to 
impact positively on whole fly survival in response to septic infection with Gram-
negative bacteria, and are also shown to mediate enhanced bacterial clearance in the gut 
following natural infection with E.coli. Alternatively, DG2P1 and DG2P2 are 
demonstrated to have an inhibitory effect on diptericin expression in the tubule. These 
effects are shown to have a negative impact on survival of whole flies in response to 
septic infection with Gram-negative bacteria. Additionally, it is demonstrated that 
modulation of DG2P1 in the tubule is sufficient to significantly inhibit bacterial clearance 
in the gut following natural infection with E.coli. Interestingly, it is shown that the effects 
mediated by cGKs on AMP regulation are tissue-specific, as modulation of cGK 
expression in the fat body does not confer similar survival phenotypes in the adult fly.  
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4.2 Drosophila cGKs, DG1 and DG2, mediate differential effects on 
diptericin expression in the tubule 
4.2.1 Introduction 
To date, investigation of functional effects of Drosophila cGKs has mainly focussed on 
neuronal function. For example, expression analysis studies have demonstrated that DG1 
and the various isoforms of DG2 are enriched in the head of the adult fly (Kalderon and 
Rubin 1989; Foster et al. 1996). Additionally, a number of studies involving genetic 
analysis of the dg2 (for) gene have implicated cGKs to play a role in neuronal processes 
such as feeding behaviour, sensory responsiveness, and learning and memory (Osborne et 
al. 1997; Scheiner et al. 2004; Mery et al. 2007). However, in recent years, a role for 
cGKs in tubule function has also emerged (MacPherson et al. 2004a; 2004b). Studies 
involving the analysis of the gene products of both dg1 and dg2 have demonstrated that 
the tubule contains almost as much endogenous cGK activity as the head (tubules: 10.8 + 
1.3 pmol of ATP/min/mg; heads: 14.9 + 0.9 pmol of ATP/min/mg – data from 
MacPherson et al. 2004b). Interestingly, a mutation in dg2 which results in a behavioural 
phenotype does not result in a dg2-associated phenotype in tubules; suggesting tissue-
specific effects of such mutations; and/or effects of other components of the GMP 
signalling pathway (Osborne et al. 1997; MacPherson et al. 2004a). Additionally, 
targeted overexpression of DG1, DG2P1 and DG2P2 to the principal cells of the tubule is 
demonstrated to result in significantly enhanced fluid secretion in the tubule in response 
to exogenous cGMP (MacPherson et al. 2004b).  
 
Given the significance of cGK activation in mediating the effects of cGMP in the tubule, 
it is possible that cGKs mediate the effects of cGMP on the Imd pathway. Interestingly, 
previous studies have already indicated a role for a mammalian cGK, protein kinase G 
type 1 (PKG1), as an important immune regulator. For example, studies in mice have 
shown that PKG1 is highly expressed in a number of murine lymphoid tissues such as the 
thymus, lymph nodes and the spleen (Kurowska et al. 2002). Additionally, PKG1 has 
been implicated to play a role in inhibition of T-cell proliferation, and has been identified 
in a number of studies as an important regulator of neutrophil chemotaxis and granule 
secretion (Wyatt et al. 1991; Pryzwansky et al. 1995; VanUffelen et al. 1997; Fischer et 
al. 2001).      
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In order to determine the involvement of Drosophila cGKs in regulation of the Imd 
pathway, a transgenic approach was used. In this approach, targeted expression or knock-
down of cGKs was achieved using transgenic lines for dg1, dg1RNAi, dg2P1, dg2P2 and 
dg2RNAi under control of the UAS promoter (flies generated by Dr M. R. MacPherson, 
University of Glasgow; (MacPherson et al. 2004b)). In order to target overexpression or 
knockdown of these genes, the UAS-transgene fly lines described above were crossed to 
the tubule principal cell-specific GAL4 driver line, c42. Specificity of this driver line has 
been established previously in a number of studies using both UAS-aequorin and UAS-
YFP transgenic flies, and counter-staining of cell nuclei (Rosay et al. 1997; Sozen et al. 
1997; Broderick et al. 2004; McGettigan et al. 2005). It should also be noted that the 
UAS-dg1, UAS-dg2P1 and UAS-dg2P2 transgenic lines used in this study have also 
been previously validated to show increased expression and cGK activity in the tubule 
when crossed to c42 driver flies (MacPherson et al. 2004b). Validation of knockdown of 
cGK activity in the tubules of c42/UAS-dg1RNAi and c42/UAS-dg2RNAi flies is 
demonstrated in later in this chapter. Diptericin expression was monitored in acutely-
dissected tubules from the resultant progeny of the crosses described above using Q-PCR. 
       
4.2.2 DG1 is a positive regulator of diptericin expression in the principal cells of 
the tubule 
To date, functional roles of Drosophila DG1 in vivo have not been extensively 
documented. Previous studies have demonstrated that dg1 encodes an enzyme with bona 
fide cGK activity that is highly expressed in optic lobes and proximal cortex of the head, 
suggesting a role in neuronal function (Foster et al. 1996). Additionally, studies have 
shown that DG1 is highly expressed in the Malpighian tubules, where it has been 
demonstrated to be important in cGMP-mediated fluid secretion (MacPherson et al. 
2004b). Interestingly, microarray studies have demonstrated that DG1 expression is 
actually approximately 16-fold enriched in the tubule compared to the rest of the fly 
(http://www.mblab.gla.ac.uk/%7Ejulian/arraysearch.cgi; Wang et al. 2004). Thus, there 
may be other, yet unexplored, roles of DG1 in tubule function.  
 
In order to determine whether any of the effects of cGMP seen in the previous chapter are 
mediated by DG1, diptericin expression was monitored in response to various stimuli in  
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Figure 4.1 – Targeted overexpression of dg1 to the principal cells of the tubule results in increased 
diptericin expression. Expression of diptericin in response to specific stimuli was assessed by Q-PCR in 
excised tubules of adult flies in which dg1 expression was modulated in tubule principal cells using the 
GAL4/UAS binary system. Resulting data were normalised against expression of the standard, rp49, and 
expressed as a fold change of parental control expression where control =1 (N = 4, + SEM). Significance of 
data was determined by Two-way ANOVA and post hoc analysis was carried out using Bonferroni tests, 
whereby significant data are indicated by * (P<0.05). [A] Diptericin expression in the tubule in response to 
cGMP when dg1 is overexpressed. Analysis by two-way ANOVA reveals a significant interaction between 
genotype and stimulus (See table). Interestingly, post hoc analysis shows a significant difference in 
diptericin expression in the tubules of c42/UAS-dg1 flies compared to parental flies in response to cGMP. 
[B] Diptericin expression in the tubule in response to E.coli when dg1 is overexpressed. Analysis by two-
way ANOVA reveals no significant interaction between genotype and stimulus. However, the effect of 
stimulus alone and genotype alone is considered significant. Although diptericin expression levels are 
higher in the tubules of c42/UAS-dg1 flies compared to parental flies in response to E.coli, post hoc 
analysis did not reveal a significant difference. 
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the excised tubules of adult flies either over-expressing dg1 or flies where dg1 expression 
was significantly reduced in the tubules via RNAi. To do this, parental lines containing 
either UAS-dg1 or UAS-dg1RNAi transgenes were crossed to c42 driver flies. Tubules 
were excised from 7-day old adult flies of both the UAS-transgene parental lines (as a 
control) and the c42/UAS-transgene progeny. Excised tubules were then incubated for 3 
h in either sterile Schneider’s medium (control) or sterile Schneider’s medium containing 
100 µM cGMP. cDNA was then generated from these samples and diptericin expression 
quantified by Q-PCR. Similarly, in order to test the effect of DG1 on diptericin 
expression in the tubule after infection, the same fly lines were inoculated via bacterial 
injection of E.coli, a Gram-negative bacteria known to induce the Imd pathway (Lemaitre 
et al. 1995a). In order to control for possible changes in diptericin expression as a result 
of injury from injection, a number of flies from each fly line were also mock-injected 
using a sterile needle. Tubules were then excised 3 h post infection and diptericin 
expression quantified by Q-PCR as described above.  
 
Interestingly, it can be seen from the results that DG1 acts as a positive regulator of 
diptericin expression in the tubule. As Figure 4.1A shows, targeted overexpression of dg1 
results in an approximately 2-fold increase in diptericin expression in the tubules of 
c42/UAS-dg1 flies compared to parental controls, even in the absence of stimulation. 
Unsurprisingly, when tubules of UAS-dg1 parental flies are stimulated with 100 µM 
cGMP, diptericin expression is significantly reduced in the tubule, which is similar to the 
response of wild-type flies demonstrated in the previous chapter. However in contrast, 
diptericin expression is significantly increased in the tubules of c42/UAS-dg1 flies in 
response to cGMP stimulation. These data therefore indicate that the changes in 
diptericin expression seen in the tubules of c42/UAS-dg1 flies are a result of activation of 
DG1 by cGMP. When flies are infected with E.coli (Figure 4.1B), diptericin expression 
levels are significantly higher in the tubules of both the UAS-dg1 parental and the 
c42/UAS-dg1 flies. However, it can be seen that diptericin expression is induced to a 
higher degree in the tubules of flies where dg1 is overexpressed than those where dg1 
expression has not been modulated, although, according to statistical analysis, expression 
levels between genotypes are not significantly different. Therefore, although it is 
indicated from Figure 4.1B that DG1 acts as a positive regulator  
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Figure 4.2 – Targeted reduction of dg1 expression in the principal cells of the tubule results in 
reduced diptericin expression. Expression of diptericin in response to specific stimuli was assessed by Q-
PCR in excised tubules of adult flies as described previously (N = 4, + SEM). Significance of data was 
determined by Two-way ANOVA and post hoc analysis carried out using Bonferroni tests, whereby 
significant data are indicated by * (P<0.05) or, where relevant, ns (not significant). [A] cGK activity in the 
tubules when dg1 expression is knocked-down (N  = 6, + SEM). cGK activity is significantly reduced in the 
tubules of c42/UAS-dg1RNAi flies compared to parental controls. [B] Diptericin expression in the tubule 
in response to cGMP after dg1-knockdown in the tubule. Analysis by two-way ANOVA reveals a 
significant interaction between genotype and stimulus (See table). Additionally, post hoc analysis shows a 
significant difference in diptericin expression in the tubules of c42/UAS-dg1RNAi flies compared to 
parental flies in response to cGMP. [C] Diptericin expression in the tubule in response to E.coli when dg1 
expression is reduced in the tubule. Analysis by two-way ANOVA reveals no significant interaction 
between genotype and stimulus. Interestingly, post hoc analysis shows that tubules with reduced dg1 
expression are unable to significantly induce diptericin expression in response to E.coli, unlike controls.  
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of diptericin expression in the tubule in response to E.coli, further investigation is 
required to determine the significance of this effect. 
 
Therefore, in order to confirm the positive effect of DG1, studies were carried out to 
monitor diptericin expression in tubules where dg1 expression was knocked-down by 
RNAi. Experiments were carried as above, using progeny with the c42/UAS-dg1RNAi 
genotype. This was compared with tubules from 7-day old parental line UAS-dg1RNAi 
and c42/UAS-dg1RNAi transgenic flies. 
 
 Figure 4.2A shows that assay of cGK activity in the tubules of UAS-dg1RNAi and 
c42/UAS-dg1RNAi flies results in a significant reduction in cGK activity in the tubules 
of flies where dg1 expression is knocked down. These data therefore confirm that dg1 
expression has been knocked down sufficiently enough to significantly effect cGK 
activity in the tubules of c42/UAS-dg1RNAi flies.  
 
It can be seen from Figure 4.2B that, as with wild type flies, diptericin expression is 
reduced in the tubules of UAS-dg1RNAi parental controls in response to cGMP. 
However, in contrast to results seen in Figure 4.1A, diptericin expression is also 
significantly reduced in the tubules of c42/UAS-dg1RNAi flies in response to cGMP. 
Interestingly, results show that the reduction of diptericin expression seen in response to 
cGMP in the tubules of the flies where dg1 expression is knocked-down is significantly 
greater than in those of parental controls. Given that the negative effect of 100 µM cGMP 
on diptericin expression normally seen in the tubules of both wild-type flies and parental 
controls is significantly enhanced in the absence of DG1, these data therefore further 
suggest that DG1 plays a role in positively regulating diptericin expression in the tubule. 
In support of this data, it can be seen from Figure 4.2C that tubules from c42/UAS-
dg1RNAi flies are unable to significantly induce diptericin expression in response to 
infection with E.coli, unlike parental controls. These data would therefore suggest that 
DG1 is required by the tubule in order to sufficiently induce diptericin expression in 
response to infection with Gram-negative bacteria. Overall, the data presented in Figures 
4.1 and 4.2 demonstrate a stimulatory role for DG1 in the regulation of diptericin 
expression in the tubule.   
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4.2.3 DG2P1 and DG2P2 are negative regulators of diptericin expression in the 
principal cells of the tubule 
To date, a definitive role for the dg2 gene has been established in a number of neuronal 
processes such as feeding behaviour, sensory responsiveness, and learning and memory 
(Osborne et al. 1997; Scheiner et al. 2004; Mery et al. 2007). However, as with dg1, dg2 
has also been established to play an important role in cGMP-mediated epithelial fluid 
transport in the Malpighian tubules (MacPherson et al. 2004a; 2004b). As mentioned 
previously, dg2 is a complex gene that encodes ten major transcripts 
(http://flybase.bio.indiana.edu/cgi-bin/uniq.html?FBgn0000721%3Efbtr). However, to 
date, functional studies have only identified the two major transcripts of dg2, DG2P1 and 
DG2P2 to exhibit bona fide cGK activity (MacPherson et al. 2004b). Interestingly, these 
studies also revealed that these transcripts are differentially localised within the tubule, 
whereby DG2P1 is located on the apical membrane and DG2P2 is located on both the 
basolateral and apical membrane (MacPherson et al. 2004b). As mentioned above, 
DG2P1 and DG2P2 have both been implicated in the regulation of fluid secretion in the 
tubule. However, due to the presence of multiple isoforms of DG2 in the tubule, and the 
demonstration that the two major transcripts of DG2 are differentially localised within 
this tissue, it can be suggested that there may be multiple roles for DG2 in tubule function 
that have yet to be explored.     
 
Therefore, studies were initiated in order to determine the possible effect of the two 
major isoforms of DG2, P1 and P2, on cGMP-mediated immune regulation. As with 
previous experiments, expression of diptericin was monitored in response to either 100 
µM cGMP or infection with E.coli in the tubules of flies either over-expressing dg2P1 or 
dg2P2, or flies where expression of the dg2 gene has been knocked-down in the tubules 
via RNAi. Targeted expression of dg2P1 and dg2P2 in the tubule was achieved by 
crossing parental lines containing UAS-dg2P1 or UAS-dg2P2 transgenes to c42 GAL4 
driver flies. Tubules were then excised from both UAS-transgene parental lines and the 
resultant c42/UAS-transgene progeny and stimulated as described in section 4.2.2. 
Similarly, each fly line was inoculated with E.coli by bacterial injection as described 
previously. Diptericin expression was then quantified for each sample obtained by Q-
PCR. 
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Figure 4.3 - Targeted overexpression of dg2P1 to the principal cells of the tubule results in decreased 
diptericin expression. Expression of diptericin in response to specific stimuli was assessed by Q-PCR in 
excised tubules of adult flies whereby dg2P1 expression was modulated in tubule principal cells using the 
GAL4/UAS binary system. Resulting data were normalised against expression of the standard, rp49, and 
expressed as a fold change of parental control expression where control =1 (N = 4, + SEM). Significance of 
data was determined by Two-way ANOVA and post hoc analysis was carried out using Bonferroni tests 
whereby significant data are indicated by * (P<0.05). [A] Diptericin expression in the tubules in response to 
cGMP when dg2P1 is overexpressed. Analysis by two-way ANOVA reveals no significant interaction 
between genotype and stimulus (See table). However, the effects of stimulus alone and genotype alone are 
considered  significant. Post hoc analysis shows a significant difference in diptericin expression in the 
tubules of c42/UAS-dg2P1 flies compared to parental flies both in the absence and in the presence of 
cGMP. [B] Diptericin expression in the tubules in response to E.coli when dg2P1 is overexpressed. 
Analysis by two-way ANOVA reveals a significant interaction between genotype and stimulus. 
Additionally, post hoc analysis shows that diptericin expression is significantly lower in the tubules of 
c42/UAS-dg2P1 flies than in UAS-dg2P1 parents in response to E.coli.  
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Figure 4.4 - Targeted overexpression of dg2P2 to the principal cells of the tubule results in decreased 
diptericin expression. Expression of diptericin in response to specific stimuli was assessed by Q-PCR in 
excised tubules of adult flies whereby DG2P2 expression was modulated in tubule principal cells using the 
GAL4/UAS binary system. Resulting data were normalised against expression of the standard, rp49, and 
expressed as a fold change of parental control expression where control =1 (N = 4, + SEM). Significance of 
data was determined by Two-way ANOVA and post hoc analysis was carried out using Bonferroni tests 
whereby significant data are indicated by * (P<0.05) or , where relevant, ns (not significant). [A] Diptericin 
expression in the tubule in response to cGMP when dg2P2 is overexpressed. Analysis by two-way 
ANOVA reveals no significant interaction between genotype and stimulus (See table). However, the effect 
of stimulus alone and genotype alone are considered significant. Additionally, post hoc analysis shows a 
significant difference in diptericin expression in the tubules of c42/UAS-dg2P2 flies compared to parental 
flies both in the absence and in the presence of cGMP. [B] Diptericin expression in the tubule in response 
to E.coli when dg2P2 is overexpressed. Analysis by two-way ANOVA reveals a significant interaction 
between genotype and stimulus. However, post hoc analysis shows that tubules of c42/UAS-dg2P2 flies are 
unable to significantly induce diptericin expression in response to E.coli. Additionally, diptericin 
expression is significantly lower in the tubules of c42/UAS-dg2P1 flies than in UAS-dg2P1 parents in 
response to E.coli.  
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As Figure 4.3A shows, diptericin expression is significantly reduced in the tubules of 
flies overexpressing dg2P1 even in the absence of exogenous cGMP. When stimulated 
with 100 µM cGMP, it can be seen that expression of diptericin is even further reduced in 
the tubules of c42/UAS-dg2P1 flies. This reduction in expression follows the same trend 
as parental lines, however it can be seen that diptericin expression is significantly lower 
in the tubules of c42/UAS-dg2P1 flies than in the tubules of parental flies in response to 
cGMP. These data therefore indicate that, in contrast to DG1, DG2P1 may play an 
inhibitory role in regulation of diptericin expression. In support of this data, it is 
demonstrated in Figure 4.3B that when flies are infected with E.coli, the tubules of 
c42/UAS-dg2P1 flies are unable to induce diptericin expression to the same degree as the 
tubules of parental flies, further suggesting a role for DG2P1 as a negative regulator of 
diptericin expression in the tubule.     
  
Similarly, it can be seen from Figure 4.4 that DG2P2 also plays an inhibitory role in 
regulation of diptericin expression. As with the tubules of flies over-expressing dg2P1, 
when dg2P2 is over-expressed in the tubule, expression of diptericin is significantly 
lower than in the tubules of parental controls, even in the absence of stimulation with 
cGMP (Figure 4.4A). Equally, when tubules are stimulated with 100 µM cGMP, it can be 
seen that expression of diptericin is even further reduced in the tubules of c42/UAS-
dg2P2 flies. Again it can be seen that changes in diptericin expression in the tubules of 
both the parental control flies and the c42/UAS-dg2P2 progeny are following the same 
trend in response to 100µM cGMP, however diptericin expression is significantly lower 
in c42/UAS-dg2P2 flies, thus suggesting that activation of DG2P2 by cGMP acts to 
negatively regulate diptericin expression in the tubule. In support of these data, it can be 
seen from Figure 4.4B that the tubules of c42/UAS-dg2P2 flies are unable to significantly 
induce diptericin expression in response to infection with E.coli. This is in contrast to the 
tubules of parental controls whereby an approximately 7-fold increase in diptericin 
expression is demonstrated in response to infection.   
 
In order to confirm the inhibitory role of DG2P1 and DG2P2 on regulation of diptericin 
expression in the tubule, the effect of knock-down of dg2 expression was investigated. 
This was achieved using a UAS-dg2RNAi transgenic line (generated by Dr JP Day, 
University of Glasgow). Unfortunately, when this line was crossed to c42, therefore 
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knocking down dg2 expression in the principal cells of the tubule, survival of the progeny 
beyond pupal stage was minimal, suggesting a critical role for DG2 in the tubules during 
pupal development. In order to overcome this problem the GAL80 system was used (Lee 
and Luo 1999). GAL80 is a temperature-sensitive yeast repressor enzyme able to potently 
inhibit GAL4 activity by binding to its transcriptional activation domain. Fortunately, 
GAL80 is only active at temperatures under 30 °C, therefore GAL4 activity can be 
resumed by means of a simple heat-shock step. As such, by combining flies expressing 
GAL80 with an appropriate GAL4 driver line, it is possible to reversibly repress GAL4-
induced expression of target UAS-transgenes in both developing and adult Drosophila. 
For this study, a homozygous stable fly line was generated by crossing flies expressing 
the GAL80 transgene under the control of a tubulin promoter ([w*]; P{tubP-GAL80ts}; 
TM2/TM6b - Bloomington Stock Centre) with the c42 GAL4 driver line (P-element 
insertion on the 3rd chromosome). Following the generation of this stable line ([w*]; 
P{tubP-GAL80ts}; c42), inducible knock-down of dg2 expression was achieved by 
crossing with UAS-dg2RNAi transgenic flies. In the progeny of this cross, GAL4 
expression was inhibited until 24 h before dissection, at which time flies were incubated 
at 30°C in order to inactivate GAL80. It should be noted that UAS-dg2RNAi parental 
flies were also incubated at 30°C for 24 h in order to control for changes in expression as 
a result of temperature.  
 
In order to firstly confirm the expression of the UAS-dg2RNAi transgene in the tubules 
of the GAL80;c42/UAS-dg2RNAi flies, cGK activity was assessed in both the UAS-
dg2RNAi parental line and the GAL80;c42/UAS-dg2RNAi progeny. As Figure 4.5A 
shows, cGK activity is significantly reduced in the tubules of the GAL80;c42/UAS-
dg2RNAi flies, thus confirming that dg2 expression has been sufficiently reduced. 
Following this, experiments were carried out as described previously, whereby diptericin 
expression was quantified in the tubules of both UAS-dg2RNAi and GAL80;c42/UAS-
dg2RNAi flies in response to either stimulation with cGMP or infection with E.coli. As 
expected, it can be seen from Figure 4.5B that in parental controls diptericin expression is 
significantly reduced in the tubules in response to 100 µM cGMP. However, in contrast 
to data shown in Figure 4.3A and 4.4A, it is demonstrated that knock-down of dg2 
expression in the tubules of adult flies results in a significant increase in diptericin 
expression in response to cGMP. These data therefore further support the indication from  
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Figure 4.5 - Targeted knock-down of dg2 expression by RNAi results in increased diptericin 
expression in the tubule. Expression of diptericin in response to specific stimuli was assessed by Q-PCR 
in excised tubules of adult flies as described previously (N = 4, + SEM). Significance of data was 
determined by Two-way ANOVA and post hoc analysis carried out using Bonferroni tests whereby 
significant data are indicated by * (P<0.05). [A] cGK activity in the tubules when dg2 expression is 
knocked-down (N  = 6, + SEM). Shows that cGK activity is significantly reduced in the tubules of 
GAL80;c42/UAS-dg2RNAi flies compared to parental controls. [B] Diptericin expression in the tubule in 
response to cGMP after dg2-knockdown in the tubule. Analysis by two-way ANOVA reveals a significant 
interaction between genotype and stimulus (See table). Post hoc analysis shows a significant difference in 
diptericin expression in the tubules of GAL80;c42/UAS-dg2RNAi flies compared to parental flies in 
response to cGMP. [C] Diptericin expression in the tubule in response to E.coli when dg2 expression is 
knocked-down in the tubule. Analysis by two-way ANOVA reveals a significant interaction between 
genotype and stimulus. Additionally, post hoc analysis shows that when dg2 expression is knocked-down, 
diptericin expression is significantly higher in the tubules of GAL80;c42/UAS-dg2RNAi flies in response 
to E.coli than in parental flies.  
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previous results that DG2P1 and DG2P2 act as negative regulators of diptericin 
expression. Similarly, it can be seen from Figure 4.5C that in tubules where dg2 
expression has been knocked-down, diptericin expression is significantly higher than 
UAS-dg2RNAi parental controls in response to infection with E.coli. These data 
therefore confirm that the cGKs encoded by dg2 act as suppressors of diptericin 
expression in the tubule. 
 
4.3 Modulation of immune response by cGKs in the tubule is critical to 
fly survival in response to septic infection 
4.3.1 Introduction 
The data described in previous sections of this chapter clearly demonstrate that the 
Drosophila cGKs DG1, DG2P1 and DG2P2 exhibit differential effects on diptericin 
expression in the tubules of the adult fly. However, the relevance of these findings with 
regards to overall immunity of the whole animal has not been determined. Traditionally, 
the fat body has been considered the critical tissue with regards to systemic production of 
AMPs in response to infection (Silverman and Maniatis 2001). Therefore, it could be 
suggested that the tubule may only play an auxiliary role as an immune-sensing tissue in 
the adult fly, and might not impact on survival of the whole organism when under 
immune challenge. However, as mentioned previously, it has been indicated in a recent 
study that this is not the case (McGettigan et al. 2005).  In this study, it was shown that 
targeted expression of dNOS to tubule principal cells results in increased diptericin 
expression in the tubules, which in turn was demonstrated to enhance overall survival of 
adult flies in response to infection with E.coli. These data therefore indicate that the 
tubule comprises an important immune system, with a significant role to play in 
maintaining fly survival in response to infection.  
 
Studies were therefore initiated in order to determine the overall impact of cGK-mediated 
modulation of diptericin expression in the tubule. In these studies, each of the transgenic 
cGK fly lines described previously were monitored for survival in response to septic 
infection with various bacteria. For each transgenic line, bacteria were introduced directly 
into the hemolymph of adult flies using a sterile needle dipped into a concentrated 
suspension of bacterial culture. Similarly, as with previous experiments, a number of flies 
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from each transgenic line were also mock injected in order to control for any negative 
impact on survival caused solely by injury. Following infection, each fly line was then 
monitored for survival and results plotted using a Kaplin-Meier survival curve (Graphpad 
Prism Version 4.0).   
 
4.3.2 Modulation of immune response by cGKs in the tubule is critical to survival 
in response to septic infection with Gram-negative bacteria. 
As mentioned previously, expression of diptericin is induced following the activation of 
the Imd signalling pathway. A number of studies have identified a fundamental role of 
the Imd pathway in response to invasion by Gram-negative bacteria (reviewed in 
(Lemaitre and Hoffmann 2007). Therefore, in order to test whether cGK-mediated 
immune regulation in the tubule is sufficient to effect survival of the whole animal, 
assays were performed to assess survival of cGK transgenic flies in response to septic 
infection with Gram-negative bacteria. Given that the previous data in this chapter has 
already revealed that diptericin expression is induced in the tubule in response to E.coli, 
and that this expression can be differentially modulated by DG1, DG2P1 and DG2P2, 
studies were first of all carried out in order to assess survival of cGK transgenic flies in 
response to infection with E.coli. Targeted expression of UAS-dg1, UAS-dg1RNAi, 
UAS-dg2P1, UAS-dg2P2 and UAS-dg2RNAi to the principal cells of the tubule was 
achieved as described previously. In addition, in order to confirm that the modulatory 
effects of cGKs on immune regulation are tubule-specific, UAS-parental flies were also 
crossed to the fat body-specific GAL4 driver line c564 (kind gift from Professor S Kurata, 
University of Sendai, Japan). Finally, it should be noted that, under normal conditions 
E.coli is not a natural pathogen of Drosophila. Therefore, it was expected that infection 
with this bacteria would not confer any significant survival phenotypes in samples of 
wild-type or parental control flies. 
 
Figure 4.6 shows survival in response to infection with E.coli in flies where dg1 is either 
overexpressed or knocked-down in the tubule. Previous data has demonstrated that dg1 
acts as a positive regulator of diptericin expression in the tubule, therefore it was 
expected that overexpression of dg1 in the tubule would enhance survival of flies in 
response to E.coli. As Figure 4.6A shows, there is no significant difference in survival of 
c42/UAS-dg1 flies compared to either wild-type flies (OrR) or parental controls.  
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Figure 4.6 – Survival in response to E.coli when dg1 is over-expressed or knocked-down in the 
tubules.  Survival was monitored in 5-day old adult flies that were either infected with a concentrated 
suspension of E.coli via a thin needle, or were mock infected using a sterile needle. Survival of flies was 
then monitored at appropriate intervals for a 50 h period (N = 30). This protocol was repeated three times 
on each fly line. Results for each line were then pooled and expressed as a percentage of survival using a 
Kaplin-Meier survival curve (+ SEM). [A] Survival in response to E.coli when dg1 is overexpressed in 
either the tubule (c42) or the fat body (c564) [B] Survival in response to E.coli when dg1 is knocked-down 
in either the tubule (c42) or the fat body (c564). Data shows a significant decrease in survival in response to 
E.coli when dg1 is knocked-down in the tubule.  
 
However, as E.coli is not naturally pathogenic to Drosophila, no definite conclusions can 
be drawn from this data. However, it can be seen from Figure 4.6B that when dg1 
expression is knocked-down in the tubule, a significant decrease in survival is observed, 
with approximately 30% of flies dying in the first 5 h after infection. These data therefore 
indicate, in support of previous data, that DG1 is required by the tubule to mount an 
appropriate immune response when challenged with E.coli. Importantly, it is also 
demonstrated from this data that sufficient activation of immune responses in the tubule 
appears to be critical to survival of the whole organism. Interestingly, it can be seen that  
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Figure 4.7 - Survival in response to E.coli when dg2 is over-expressed or knocked-down in the 
tubules.  Survival was monitored in 5-day old adult flies that were either infected with a concentrated 
suspension of E.coli via a thin needle, or were mock infected using a sterile needle. Survival of flies was 
then monitored at appropriate intervals for a 50 h period (N = 30). This protocol was repeated three times 
on each fly line. Results for each line were then pooled and expressed as a percentage of survival using a 
Kaplin-Meier survival curve (+ SEM). [A] Survival in response to E.coli when dg2P1 is overexpressed in 
either the tubule (c42) or the fat body (c564). Data shows a significant decrease in survival in response to 
E.coli when dg2P1 is overexpressed in the tubule. [B] Survival in response to E.coli when dg2P2 is 
overexpressed in either the tubule (c42) or the fat body (c564) Data shows a significant decrease in survival 
in response to E.coli when dg2P2 is overexpressed in the tubule. [C] Survival in response to E.coli when 
DG2 is knocked-down in either the tubule (GAL80;c42)  
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DG1 appears to have no effect on survival when expression is modulated in the fat body, 
further suggesting that cGK-mediated immune regulation is tubule-specific. When 
survival is monitored in response to E.coli in flies overexpressing the two DG2 isoforms, 
it can be seen that targeted expression of dg2P1 or dg2P2 to the tubules results in 
significant survival phenotypes in each line. As Figures 4.7A and 4.7B show, in each case, 
infection with E.coli results in an approximately 40% decrease in survival when dg2P1 or 
dg2P2 are overexpressed in the tubule. Again, these data support previous results where 
it was demonstrated that DG2P1 and DG2P2 act as negative regulators of diptericin 
expression in the tubule. In contrast, it can be seen that when dg2 expression is knocked-
down in the tubule, there is no significant difference in fly survival in response to E.coli 
infection compared to controls (Figure 4.7C). Overall, this data further demonstrates the 
inhibitory role DG2P1 and DG2P2 play in maintaining appropriate levels of immune 
function in the tubules in response to infection with E.coli. As before, the important role 
of the tubules in overall fly immunity is also highlighted from the data. Interestingly, 
again it can be seen from Figures 4.7A and 4.7B that the modulatory effects of either 
DG2P1 or DG2P2 on immune function do not extend to the fat body. Therefore, again it 
can be seen that this effect appears to be specific to the tubule.    
 
Overall, it can be seen from this data that cGK-mediated modulation of immune response 
in the tubule is necessary for the survival of the whole fly in response to E.coli. 
 
As mentioned above, E.coli is not a natural pathogen to Drosophila under normal 
circumstances. Thus, it is difficult to confirm any enhancement to survival in response to 
infection in the c42/UAS-dg1 or GAL80;c42/UAS-dg2RNAi fly lines. Therefore, studies 
were initiated in order to determine survival of transgenic cGK fly lines in response to 
Pseudomonas aeruginosa, an opportunistic and versatile Gram-negative bacterium that is 
highly pathogenic to wild-type Drosophila, whereby 100% fly mortality has been 
observed within 30 h of infection (D'Argenio et al. 2001; Apidianakis et al. 2005). 
Previous studies have shown that resistance to infection with these bacteria is both Imd 
and Toll-dependent, and that a wide variety of AMPs, especially those associated with 
the Imd pathway, are induced in response to infection. However, despite induction of 
systemic immune mechanisms in response to these bacteria, it has been shown that 
P.aeruginosa is able to overcome and suppress this induction (Lau et al. 2003; 
Apidianakis et al. 2005). Therefore, it was hypothesised that, in flies where cGK activity 
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has been modulated in the tubules in order to either stimulate or inhibit AMP expression 
prior to infection, different rates of survival may be observed in response to infection 
with P.aeruginosa. Targeted expression or knock-down of cGKs was achieved as 
described previously and adult flies were inoculated as before using a sterile needle 
dipped into an appropriate suspension of P.aeruginosa.  
 
 
 
Figure 4.8 - Survival in response to P.aeruginosa when dg1 is over-expressed or knocked-down in the 
tubules. Survival was monitored in 5-day old adult flies that were either infected with a concentrated 
suspension of P.aeruginosa via a thin needle, or were mock infected using a sterile needle. Survival of flies 
was then monitored at appropriate intervals for a 30 h period (N = 30). This protocol was repeated three 
times on each fly line. Results for each line were then pooled and expressed as a percentage of survival 
using a Kaplin-Meier survival curve (+ SEM). [A] Survival in response to P.aeruginosa when dg1 is 
overexpressed in either the tubule (c42) or the fat body (c564). Data shows a slight, but non-significant 
enhancement of survival in response to P.aeruginosa in c42/UAS-dg1 flies [B] Survival in response to 
P.aeruginosa when dg1 is knocked-down in either the tubule (c42) or the fat body (c564). Data shows a 
slight, but non-significant, decrease in survival in response to P.aeruginosa in c42/UAS-dg1RNAi flies.     
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It can be seen from the results shown in Figures 4.8 and 4.9 that, in agreement to previous 
studies, infection with P.aeruginosa results in 100% mortality within 30 h in all fly lines 
tested. However, it can also be seen that in flies where cGK activity has been modulated 
in the tubule, rates of survival are either enhanced or decreased in response to infection, 
although this effect is not significant. To explain further, it can be seen from Figure 4.8A 
that when dg1 is overexpressed in the tubule, complete fly mortality does not occur until 
~28 h post infection, unlike in all other fly lines whereby 100% mortality is observed at 
24-25 h post infection. Similarly, in Figure 4.8B, it can be seen that when dg1 is 
knocked-down in the tubule, rate of survival is decreased compared to all other fly lines 
whereby complete fly mortality is observed at ~21 h and 24-25 h post infection 
respectively. Although these data do not exhibit a significant change in survival rates in 
response to P.aeruginosa infection when dg1 expression is modulated in the tubule, they 
do imply that DG1 may act in the tubule to enhance immune response and therefore 
survival of flies in response to infection with these bacteria. Additionally, as with 
infection by E.coli, modulation of DG1 in the fat body does not appear to mediate any 
effect on survival in response to P.aeruginosa. Similarly, it can be seen that when dg2 is 
modulated in the tubules, a negative effect on fly survival is observed in response to 
infection with P.aeruginosa (Figure 4.9). As Figure 4.9A and 4.9B shows, when 
expression of dg2P1 or dg2P2 is increased in the tubule, complete fly mortality is seen at 
~20 h post infection. Again it can be seen that 100 % mortality of all other lines tested is 
observed at 24-25 h after infection, suggesting that DG2P1 and DG2P2 confer an 
inhibitory effect on immune responses in the tubule in response to P.aeruginosa. When 
dg2 is knocked-down in the tubule, a very slight enhancement of survival is observed 
compared to all other fly lines tested, although again this enhancement is not significant 
(Figure 4.9C). It can therefore be implied from the data shown in Figure 4.9 that again, 
although modulation of DG2 in the tubule does not confer a significant effect on survival 
of flies in response to P.aeruginosa, DG2P1 and DG2P2 may act to inhibit induction of 
immune responses in the tubule in response to infection with these bacteria.   
 
Overall, the role of cGK-mediated immune regulation in the tubule in response to 
infection with P.aeruginosa can only be implied from the data shown in Figures 4.8 and 
4.9. Although modulation of cGKs in the tubule has a clear effect on survival in the 
majority of cases, the effects observed are not deemed significantly different. Therefore 
further investigation is required in order to confirm these findings.  
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Figure 4.9 - Survival in response to P.aeruginosa when dg2 is over-expressed or knocked-down in the 
tubules. Survival was monitored in 5-day old adult flies that were either infected with a concentrated 
suspension of P.aeruginosa via a thin needle, or were mock infected using a sterile needle. Survival of flies 
was then monitored at appropriate intervals for a 30 h period (N = 30). This protocol was repeated three 
times on each fly line. Results for each line were then pooled and expressed as a percentage of survival 
using a Kaplin-Meier survival curve (+ SEM). [A] Survival in response to P.aeruginosa when dg2P1 is 
overexpressed in either the tubule (c42) or the fat body (c564). Data shows a slight, but non-significant, 
decrease in survival in response to P.aeruginosa when dg2P1 is overexpressed in the tubule. [B] Survival 
in response to P.aeruginosa when dg2P2 is overexpressed in either the tubule (c42) or the fat body (c564) 
Data shows a slight, but non-significant decrease in survival when dg2P2 is overexpressed in the tubule. 
[C] Survival in response to P.aeruginosa when dg2 expression is knocked-down in the tubule. Data shows 
a very slight, but non-significant, increase in survival in GAL80;c42/UAS-dg2RNAi flies. 
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4.3.3 Modulation of immune response by cGKs in the tubule does not effect 
survival in response to septic infection with the Gram-positive bacteria 
Bacillus subtilis. 
As mentioned previously, activation of the Imd pathway is deemed critical to the 
production of specific AMPs in response to infection with Gram-negative bacteria 
(Lemaitre et al. 1995a). In contrast, the other systemic immune pathway, the Toll 
pathway, has been demonstrated as fundamental to responses against infection with either 
Gram-positive bacteria or fungi. Therefore, studies were initiated in order to determine 
the effect of cGK-mediated AMP modulation in the tubule in response to Gram-positive 
bacteria. Since previous data has only demonstrated an effect of cGMP on Imd pathway-
associated AMPs, it was hypothesised that cGKs would also only play a role in regulation 
of Imd pathway-associated AMP expression.  
 
In order to carry out this experiment, flies were inoculated as before with the Gram-
positive bacteria Bacillus subtilis. Previous studies have shown that, although harmless to 
humans, B. subtilis is naturally pathogenic to Drosophila (Tzou et al. 2002b). However, 
as with P. aeruginosa, observations that flies carrying mutations in both imd and spz 
(Spaetzle) are more susceptible to infection with B. subtilis than wild-type flies suggest 
that Drosophila is able to induce a limited defence against this pathogen. This defence 
appears to be dependent on the induction of the Toll pathway-dependent AMP defensin, 
as studies show that ubiquitous overexpression of this AMP prior to infection is enough 
to confer complete resistance against B.subtilis (Tzou et al. 2002). Therefore, as data 
presented in this thesis so far has not indicated a role for cGMP or cGKs in regulation of 
defensin expression, it is hypothesised that cGK-mediated immune regulation in the 
tubule will have no effect on survival in response to infection with B.subtilis.  
 
As Figure 4.10A shows, when dg1 is over-expressed in the tubules, no significant effect 
on survival in response to infection with B. subtilis is observed compared to controls. 
Equally, when dg1 is knocked-down in the tubule (Figure 4.10B), there is no significant 
difference in survival between all fly lines tested in response to B. subtilis.  Additionally, 
it can be seen that, as with all previous survival data, modulation of dg1 expression in the 
fat body does not effect survival in response to infection. These data therefore 
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demonstrate that DG1 is not required for regulation of immune responses in either the 
tubule or the fat body in response to infection by B. subtilis.  
 
Similarly, it can be seen from Figure 4.11 that modulation of dg2 expression in the tubule 
also has no effect on fly survival in response to B. subtilis. As both Figures 4.11A and 
4.11B show, there is no significant difference in rate of survival in any of the fly lines 
tested. Similarly, it can be seen from Figure 4.11C that knock-down of dg2 in the tubule 
does not confer a significantly different survival phenotype in response to infection either. 
Again, there is also no significant effect when dg2P1 or dg2P2 are overexpressed 
 
 
Figure 4.10 - Survival in response to B. subtilis when dg11 is over-expressed or knocked-down in the 
tubules. Survival was monitored in 5-day old adult flies that were either infected with a concentrated 
suspension of B. subtilis via a thin needle, or were mock infected using a sterile needle. Survival of flies 
was then monitored at appropriate intervals for a 3 day period (N = 30). This protocol was repeated three 
times on each fly line. Results for each line were then pooled and expressed as a percentage of survival 
using a Kaplin-Meier survival curve (+ SEM). [A] Survival in response to B. subtilis when dg1 is 
overexpressed in either the tubule (c42) or the fat body (c564). [B] Survival in response to B. subtilis when 
dg1 is knocked-down in either the tubule (c42) or the fat body (c564).  
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Figure 4.11 - Survival in response to B. subtilis when dg2 is over-expressed or knocked-down in the 
tubules. Survival was monitored in 5-day old adult flies that were either infected with a concentrated 
suspension of B. subtilis via a thin needle, or were mock infected using a sterile needle. Survival of flies 
was then monitored at for a 3 day period (N = 30). This was repeated three times on each fly line. Results 
for each line were then pooled and expressed as a percentage of survival using a Kaplin-Meier survival 
curve (+ SEM). [A] Survival in response to B. subtilis when dg2P1 is overexpressed in either the tubule 
(c42) or the fat body (c564). [B] Survival in response to B. subtilis when dg2P2 is overexpressed in either 
the tubule (c42) or the fat body (c564) [C] Survival in response to B. subtilis when dg2 is knocked-down in 
the tubule. 
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in the fat body. As with data shown in Figure 4.10, it can therefore be concluded that 
DG2 does not play a role in regulation of immune response in the tubule or the fat body 
in response to infection with B. subtilis.   
 
Overall, the data shown in this section indicates that cGK-mediated regulation of immune 
response in the tubule is not relevant to infection with B. subtilis and therefore, as 
expected, does not extend to regulation of defensin expression in the tubule. 
 
4.4 Modulation of immune response by cGKs in the tubule is 
important in response to natural infection with E.coli. 
4.4.1 Introduction 
The data described previously in this chapter has demonstrated an important regulatory 
role for Drosophila cGKs in the tubules in response to septic infection with Gram-
negative bacteria. However, in nature it is far more common for an insect to become 
infected via the ingestion of microbe-contaminated food, as opposed to infection as a 
result of wounding. Despite the central role of the systemic immune response following 
septic infection, systemic AMP production is not deemed critical to host survival in 
response to natural infection (Ferrandon et al. 1998; Liehl et al. 2006; Ryu et al. 2006). 
Instead, Drosophila are known to combat natural infection via the local induction of 
AMP synthesis in several epithelial tissues, including the tubules (Ferrandon et al. 1998; 
Tzou et al. 2000). Studies have shown that, following oral infection with the Gram-
negative bacteria E. carotovora, the tubules are able to induce strong expression of 
diptericin, as well as moderate expression of both cecropin and the anti-fungal 
metchnikowin (Tzou et al. 2000). Additionally, it has been demonstrated that local 
induction of all AMPs in epithelial tissues, including the anti-fungal drosomycin and 
metchnikowin, is dependent on the activation of the Imd pathway (Ferrandon et al. 1998; 
Tzou et al. 2000; Onfelt Tingvall et al. 2001) 
 
Given that data shown previously in this study has demonstrated a critical role for 
Drosophila cGKs in the regulation of diptericin expression in the tubules following septic 
infection with Gram-negative bacteria, studies were initiated in order to investigate the 
potential regulatory role for cGKs in the tubules following natural infection. In this 
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approach, UAS-cGK transgenic flies were crossed to the principle cell-specific GAL4 
driver c42, as described previously, and the progeny assessed following natural infection 
with Gram-negative bacteria. As with previous experiments, these studies were carried 
out using E.coli, where adult flies of the appropriate genotype were fed for 24 h on filter 
paper soaked in 5 % sucrose solution contaminated with concentrated E.coli. Control flies 
were fed for 24 h on filter paper soaked in a sucrose-only solution. The impact of cGK 
modulation in the tubules following natural infection was then assessed in each 
transgenic fly line by analysis of bacterial proliferation in the gut. In addition, diptericin 
expression was monitored in the tubules of each transgenic fly line by Q-PCR.  
 
4.4.2 Natural Infection with E.coli induces diptericin expression in the Malpighian 
tubules of the adult fly. 
Previous studies have shown that following oral infection with E.carotovora, diptericin 
expression is strongly induced in the tubules and the midgut of the adult fly (Tzou et al. 
2000). However, as all previous experiments in this chapter have used E.coli as an 
effective immune inducer, and, to date, the effects of natural infection with E.coli on 
epithelial AMP expression have not yet been reported, studies were initiated in order to 
determine whether E.coli elicits a similar response to that of E. carotovora after natural 
infection. To achieve this, adult flies expressing a fluorescent diptericin-GFP reporter 
gene were orally infected with E.coli as described above. Following infection, the entire 
gut, with tubules attached, was dissected from each fly and mounted in Phosphate 
Buffered Saline (PBS) for immediate viewing under fluorescence using the Zeiss 510 
Meta confocal system.  
 
As Figure 4.12 shows, diptericin expression is strongly induced in the tubules following 
oral infection with E.coli. Interestingly, unlike the diptericin response observed following 
infection with E. carotovora shown in previous studies, it can be seen that there is no 
visible expression of diptericin in any areas of the gut following infection with E.coli, 
despite the obvious exposure of this tissue to the invading micro-organism. This would 
suggest that the gut induces a different set of AMPs in response to E.coli than it does in 
response to E. carotovora. Therefore, it can be suggested that the tubules are the critical 
epithelial tissue with regards to local diptericin expression following natural infection 
with E. coli.  
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Overall, it is shown here for the first time, that natural infection with E.coli results in an 
epithelial immune response in the adult fly, and that the tubules play an important role in 
the induction of diptericin expression during this response. 
 
 
Figure 4.12 – Expression of diptericin-GFP in the Malpighian tubules after oral infection with E.coli. 
7-day old adult flies expressing diptericin-GFP were monitored for diptericin expression 24 h after oral 
infection with E.coli using the Zeiss 510 Meta confocal system. [A] Control flies were fed on a 5 % sucrose 
solution for 24 h prior to dissection. Data shows no visible expression of diptericin in the tubules or the gut. 
[B] Infected flies were fed on a concentrated E.coli pellet re-suspended in 5 % sucrose solution for 24 h 
prior to dissection. Results show strong expression of diptericin in the tubule but no visible expression of 
diptericin in the gut.   
 
4.4.3 Modulation of cGK expression in the tubule results in differential effects on 
bacterial clearance in the gut following natural infection with E.coli. 
In order to assess the potential importance of cGKs in the tubule with regards to immune 
response following natural infection, studies were initiated in order to assess bacterial 
persistence in the midguts of flies whereby cGK expression was modulated in the tubule. 
In these experiments, UAS-dg1, UAS-dg1RNAi and UAS-dg2P1 flies were crossed to 
the principle cell-specific GAL4 driver c42, and progeny naturally infected with 
ampicillin-resisitant E.coli as described above. Following infection, fly midguts were 
dissected and surface-sterilised in 70 % (v/v) ethanol before homogenisation in PBS. 
Homogenates were then diluted 1:100 and spread on LB-Agar plates containing 
100µg/ml ampicillin. Each plate was then assessed for its number of colony forming units 
(CFUs).   
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As Figure 4.13 shows, modulation of cGK expression in the tubule has a significant 
effect on the ability of flies to clear bacteria from the gut following natural infection with 
E.coli. To explain further, it can be seen from Figure 4.13A that, compared to that of 
parental control flies, intestinal bacterial load is significantly lower in flies where dg1 is 
overexpressed in the tubule. This would suggest that, as with septic infection, DG1 acts 
to stimulate an immune response in tubules in response to natural infection. In support of 
this data, it can be seen from Figure 4.13B that when dg1 expression is knocked-down in 
the tubules, the ability of the flies to clear bacteria from the gut is significantly impaired. 
These data therefore demonstrate an important role for DG1 in the activation of immune 
response in the tubule following natural infection. Furthermore, these results also reveal 
an important role for the tubule itself with regards to bacterial elimination in the gut in 
response to oral infection with E.coli.  
 
Similarly, it can be seen from Figure 4.13C that DG2P1 appears to play an inhibitory role 
in the tubule in response to natural infection. Data shows that in flies where dg2P1 has 
been over-expressed in the tubule, intestinal bacterial load is significantly higher than that 
of parental controls. These data therefore further demonstrate an important role for the 
tubules in bacterial clearance following natural infection with E.coli and show that this 
effect is negatively regulated by DG2P1. Unfortunately, due to time limitations, these 
experiments were not carried out in order to assess the effect of either overexpression of 
dg2P2 or knock-down of dg2 expression by RNAi, therefore the inhibitory effect shown 
here can only currently be applied to the DG2P1 isoform of DG2. However, as previous 
data has demonstrated a similar role for both DG2P1 and DG2P2 with regards to 
regulation of immune function in the tubule, it can be hypothesised that DG2P2 may also 
play an important inhibitory role in the tubule in response to natural infection. 
Investigation into the role of DG2P2 in the tubule in response to natural infection 
therefore remains a subject for future work.   
 
Overall, these results demonstrate, for the first time, that the tubules play an important 
role in eliminating invading bacteria in the gut following natural infection with E.coli. 
Additionally, it is shown here that, as with septic infection, cGKs play an important role 
in regulation of this effect. 
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Figure 4.13 - Targeted overexpression or knock-down of cGKs to the principal cells of the tubule results in 
differential effects on bacterial clearance in the gut following natural infection with E.coli. Bacterial 
clearance was assessed in the midguts of 7-day old flies whereby cGK expression was modulated in the 
tubules after natural infection with ampicillin-resistant E.coli. Following infection, ten midguts were 
dissected per sample and surface-sterilized before homogenation in PBS. Homogenate was then diluted and 
spread on LB-ampicillin plates and resultant CFUs counted. Results are displayed as a mean of N = 4 (+ 
SEM). Significance of data was determined by Students t-tests and data significant from control indicated 
by * (P < 0.05). [A] Bacterial load in the midguts of flies where dg1 is overexpressed in the tubule. [B] 
Bacterial load in the midguts of flies where dg1 expression is knocked-down in the tubule. [C] Bacterial 
load in the midguts of flies where dg2P1 is overexpressed in the tubule.    
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4.4.4 Modulation of cGKs in the tubule results in differential effects on diptericin 
expression following natural infection with E.coli. 
In order to confirm that the results shown in Figure 4.13 are a result of cGK-mediated 
modulation of AMP production, experiments were carried out to assess diptericin 
expression in the tubules of c42/UAS-dg1, c42/UAS-dg1RNAi and c42/UAS-dg2P1 flies 
following natural infection with E.coli. In these experiments, each of the fly lines above 
were infected with E.coli as described before. Following infection, the tubules of each fly 
line were excised and diptericin expression monitored by Q-PCR.  
 
Figure 4.14 shows that, as expected, diptericin expression is significantly increased in the 
tubules of control flies in response to natural infection with E.coli. Interestingly, in 
support of the data shown in Figure 4.13, it can be seen that when dg1 is overexpressed in 
the tubules, diptericin expression is further increased in response to E.coli in comparison 
to controls (Figure 4.14A). Unfortunately, due to variable results in the tubules of the 
infected flies, analysis has shown that this effect is not statistically significant. Therefore 
a stimulatory role for DG1 on diptericin expression in the tubule following natural 
infection can only be implied from this data, and further work is required in order to 
confirm this hypothesis. Equally, when dg1 expression is knocked-down in the tubules, 
diptericin expression is reduced in response to E.coli in comparison to parental tubules 
(Figure 4.14B). These data therefore further suggest a role for DG1 as a positive regulator 
of diptericin expression in response to natural infection. However, as with the tubules of 
dg1-overexpressing flies, due to large variability in data, these results are not deemed 
statistically significant. Therefore, despite the indication from the data shown in both 
Figure 4.14A and Figure 4.14B that DG1 acts to positively regulate diptericin expression 
in the tubule in response to natural infection with E.coli, further work is required in order 
definitively confirm this role. 
 
In contrast, it is demonstrated by the data shown in Figure 4.15 that overexpression of 
dg2P1 in the tubules has a very significant effect on diptericin expression following 
natural infection with E.coli. Data shows that, unlike parental controls, c42/UAS-dg2P1 
flies are unable to significantly induce diptericin expression in the tubules following oral 
infection. These data therefore indicate an important inhibitory role for DG2P1 in the 
tubule in response to natural infection with E.coli. As before, due to time limitations, it 
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Figure 4.14 – Targeted overexpression or knock-down of dg1 to the principal cells of the tubule 
results in differential effects on diptericin expression following natural infection with E.coli. 
Expression of diptericin was assessed by Q-PCR in response to natural infection with E.coli in excised 
tubules of adult flies in which cGK expression was modulated in tubule principal cells. Resulting data were 
normalised against expression of the standard, rp49, and expressed as a fold change of parental control 
expression where control =1 (N = 4, + SEM). Significance of data was determined by Two-way ANOVA 
and post hoc analysis was carried out using Bonferroni tests, whereby significant data are indicated by * 
(P<0.05) or ns (not significant) as appropriate. [A] Diptericin expression in the tubules in response to 
natural infection when dg1 is overexpressed. Analysis by two-way ANOVA reveals no significant 
interaction between genotype and stimulus. The effect of stimulus alone is considered significant, but the 
effect of genotype alone is not considered significant. Post hoc analysis shows a significant difference in 
diptericin expression in the tubules of both parental flies and progeny in response to E.coli. Diptericin 
expression is higher in the tubules of c42/UAS-dg1 flies compared to parents, though not significantly so 
[B] Diptericin expression in the tubules in response to natural infection when dg1 is knocked-down in the 
tubule. Analysis by two-way ANOVA reveals no significant interaction between genotype and stimulus. 
The effect of stimulus alone is considered significant, however genotype alone is not considered 
significant. Post hoc analysis shows a significant difference in diptericin expression in the tubules of both 
parental flies and progeny in response to E.coli. However, diptericin expression is lower in the tubules of 
c42/UAS-dg1RNAi flies compared to parents, though not significantly so.  
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Figure 4.15 - Targeted overexpression of dg2P1 to the principal cells of the tubule results in a 
negative effect on diptericin expression following natural infection with E.coli. Expression of diptericin 
was assessed by Q-PCR in response to natural infection with E.coli in excised tubules of adult flies in 
which dg2P1 expression was modulated in tubule principal cells. Resulting data were normalised against 
expression of the standard, rp49, and expressed as a fold change of parental control expression where 
control =1 (N = 4, + SEM). Significance of data was determined by Two-way ANOVA and post hoc 
analysis was carried out using Bonferroni tests, whereby significant data are indicated by * (P<0.05), or ns 
(not significant) as appropriate. TWO-way ANOVA reveals an extremely significant interaction between 
stimulus and genotype. Additionally, the effect of stimulus and genotype alone are considered significant. 
Post hoc analysis shows that, unlike parents, the tubules of c42/UAS-dg2P1 flies are unable to significantly 
induce diptericin expression in response to natural infection with E.coli. 
 
was not possible to carry out these experiments in order to investigate the effect of dg2P2 
overexpression in the tubule or knock-down of dg2 by RNAi. However, as before, it can 
be hypothesised that DG2P2 may play a similar inhibitory role to that of DG2P1 on 
diptericin expression in the tubule in response to natural infection with E.coli.  
 
Overall, the data shown here demonstrates differential effects of DG1 and DG2P1 on 
diptericin expression in the tubule in response to natural infection with E.coli. Given that 
previous data has demonstrated that cGK modulation in the tubule has a significant effect 
on bacterial clearance in the gut following infection, it can be suggested from the data 
shown here that this effect is due to cGK modulation of diptericin expression. 
Unfortunately, in the case of DG1, the data obtained is not deemed statistically 
significant. Therefore, further work is required in order to definitively determine the 
importance of DG1 with regards to diptericin regulation in response to natural infection. 
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4.5 Discussion 
In this chapter, a novel role has been described for the cognate Drosophila cGKs, DG1 
and DG2 in the tubules of Drosophila. cGKs are known to function as part of the cGMP 
signalling pathway and, in the previous chapter, it was demonstrated that cGMP is able to 
either stimulate or inhibit expression of Imd pathway-associated AMPs in a dose-
dependent manner. Data shown here demonstrates that the differential effects of cGMP 
on AMP expression in the tubules are mediated via activation of cGKs, whereby DG1 is 
shown to stimulate diptericin expression and the two main isoforms of DG2, P1 and P2, 
are shown to inhibit diptericin expression. Importantly, it has been demonstrated that the 
distinct effects exhibited by DG1 and DG2 are sufficient to confer differential survival 
phenotypes in the whole organism in response to septic infection with Gram-negative 
bacteria but not infection with Gram-positive bacteria. Additionally, it is shown here that 
the differential effects mediated by DG1 and DG2 on diptericin expression in the tubule 
play an important role in maintaining the ability of the fly to clear bacteria from the gut 
following natural infection with E.coli.   
 
To date, due to a high sequence homology in the both the cGMP-binding and kinase 
domains of DG1 and DG2, Drosophila cGKs have been implicated to share related 
function (Kalderton and Rubin, 1989). Indeed, studies have shown that each of these 
cGKs share similar expression patterns and both have been implicated to play a role in 
neuronal function, as well as act as positive regulators of fluid secretion in the tubule 
(Kalderon and Rubin 1989; Foster et al. 1996; MacPherson et al. 2004a; MacPherson et 
al. 2004b). However, for the first time, it is shown here that DG1 and DG2 exhibit 
distinct function in the tubule, whereby DG1 is shown to stimulate diptericin expression 
and DG2 is shown to inhibit it. It can be suggested that the contrasting roles of DG1 and 
DG2 on Imd pathway regulation are a result of activation by different sources of cGMP. 
As described in the previous chapter, cGMP signalling is known to be compartmentalised 
within each cell in order to facilitate the regulation of a number of simultaneous 
physiological processes. Therefore, given that DG1, DG2P1 and DG2P2 are localised 
differently within the tubule, it is perhaps not surprising that DG1 and DG2 may play 
different roles in tubule function. 
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Interestingly, the data shown in this chapter supports the hypothesis presented in the 
previous chapter. In chapter 3, it was suggested that the stimulatory effect on Imd 
pathway regulation by cGMP seen in the tubule may be a result of activation of the 
cGMP pathway by NO. As mentioned previously, NO has been established in a number 
of studies as a positive regulator of the Imd pathway. It is a diffusible molecule known to 
activate cGMP signalling via the cytosolic enzyme sGC. Interestingly, DG1 has also been 
demonstrated to be localised to the cytosol in the tubule, implying that it may reside in 
close proximity to the cGMP generated by activation of sGC (MacPherson et al. 2004b). 
Indeed, dg1 overexpression in tubules has previously been linked to the sensing of 
cytosolic cGMP (MacPherson et al. 2004b). It can therefore be suggested that NO-
dependent regulation of the Imd pathway may be mediated by DG1.  
 
Similarly, if the negative effect of cGMP on Imd pathway regulation is mediated by NO-
independent means, i.e. through activation of a receptor guanylate cyclase, it is likely that 
the cGMP generated would mediate its effects through effector molecules in close 
proximity to the plasma membrane such as DG2P1 or DG2P2. Unfortunately to date, it is 
not known whether DG2P1 or DG2P2 reside in close proximity to any of the rGCs 
known to be expressed in the tubule, as expression studies have not yet been carried out. 
However, it can be implied that DG2-mediated regulation of immune response in the 
tubule may occur via activation of an rGC.  
 
Importantly, cGK regulation of immune response in the tubules has been shown here to 
have a significant impact on whole fly survival in response to infection. It is 
demonstrated here for the first time that modulation of cGKs in the tubule significantly 
effects survival in response to septic infection with E.coli. Unfortunately, when the same 
fly lines were infected with another Gram-negative bacteria P.aeruginosa, despite the 
fact that cGK modulation in the tubule exhibited a clear but small effect on survival, the 
levels of survival observed were not significantly different. The reason for this is not 
known, however previous studies have demonstrated that P.aeruginosa is a very potent 
pathogen, known to overcome Drosophila’s immune responses by suppressing induction 
of AMP expression (Lau et al. 2003; Apidianakis et al. 2005). It is suggested therefore 
that although cGK modulation of AMP expression in the tubules may have had some 
stimulatory or inhibitory effects on immune response immediately upon infection, 
resulting in the small differences in fly survival seen, these effects may have been 
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superseded after infection by the pathogenic action of the bacteria. Therefore, although 
the effect of cGK modulation in the tubule is confirmed to impact survival of flies in 
response to E.coli, it can only be implied from data that tubule cGKs may have a role to 
play in the regulation of immune mechanisms in response to P.aeruginosa. Interestingly, 
in support of data from the previous chapter, it is demonstrated here that cGK modulation 
in the fat body has no effect on survival in response to septic infection with Gram-
negative bacteria. Additionally, as expected, when assessing the effect of cGK 
modulation in the tubule in response to infection with Gram-positive bacteria, no 
significant survival phenotypes were observed in flies infected with B.subtilis. These data 
therefore confirm previous data, which has shown that the cGMP signalling pathway is 
important in Imd pathway regulation, and not Toll pathway regulation. 
 
Perhaps unsurprisingly, these studies have also demonstrated an important role for the 
tubule in response to natural infection. Previous studies have already reported the local 
induction of AMPs in the epithelia following natural infection with Gram-negative 
bacteria (Ferrandon et al. 1998; Tzou et al. 2000; Onfelt-Tingvall. 2001; Liehl et al. 
2006). However, it is shown here for the first time, that activation of immune responses 
in the tubule have a significant effect on the ability of the fly to clear bacteria from the 
gut following natural infection with E.coli. Importantly, data has indicated that as with 
septic infection, this effect is regulated by the differential action of DG1 and DG2 on 
diptericin expression in the tubule. Unfortunately, statistical analysis has deemed the 
effect of DG1 on diptericin expression following natural infection as not significant due 
to the large variability of expression in the tubules of infected flies. The reason for this 
effect is unknown, however it can be suggested that the variability of these results may 
simply be due to some inconsistency in the feeding of the flies. Certainly, the same 
degree of variability of diptericin expression is not seen in the tubules of flies fed on the 
sucrose-only solution. Furthermore, a clear effect of DG1 modulation in the tubule is 
observed in experiments assessing bacterial clearance in the gut, thus indicating a 
significant role for DG1 in regulation of immune response in the tubule. Therefore, 
although it is implied from the data obtained in this study that DG1-mediated stimulation 
of diptericin expression in the tubules is important following natural infection, further 
confirmation of the significance of this effect is required.    
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Overall, the data presented in this chapter not only demonstrate a completely novel role 
for Drosophila cGKs in the regulation of Imd pathway-associated immune response in 
the tubule, but they also highlight the fact that the tubule appears to be a critical tissue in 
the induction of immune mechanisms in response to both septic and natural infection 
with Gram-negative bacteria. At this time, it is not known whether the tubule acts as a 
completely independent immune tissue, or whether it acts as a signalling tissue in order to 
alert other tissues, such as the fat body, to activate or suppress immune mechanisms. 
Certainly, a role for NO has already been suggested in mediating signalling between 
tissues (Bassett et al. 2000; Foley and O’Farrell. 2003; Silverman. 2003). However, the 
answer to this question is beyond the scope of this study and therefore remains a subject 
for future work.  
 
 
  
 
 
 
5 Chapter 5 
 
Epistatic analysis of cGK-mediated Imd pathway       
regulation 
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5.1 Summary 
In the previous chapter, the Drosophila cGKs, DG1 and DG2, were demonstrated to play 
a novel role in the regulation of Imd pathway-associated immune response within the 
tubule of the adult fly. Given that kinases are known to mediate their effects via direct 
phosphorylation of target proteins, it is hypothesised that DG1 and DG2 may therefore 
interact with components of the Imd pathway. Therefore in this chapter, studies were 
initiated in order to identify potential targets for DG1 and DG2 within the Imd pathway. 
This was carried out using a transgenic approach, whereby fly lines were generated in 
order to epistatically assess the effects of cGK modulation in the tubules of flies where 
components of the Imd pathway were either mutated or overexpressed. The tubules of 
transgenic flies were then either assessed for changes in diptericin expression by Q-PCR, 
or were monitored directly using an immuno-cytochemistry (ICC) approach. Data 
obtained demonstrates that DG1 acts downstream of Imd in the immune pathway. 
Furthermore, studies reveal that the dose-dependent modulation of diptericin expression 
by cGMP demonstrated in chapter 3 (Figure 3.4) is a result of regulation of Relish 
activation; whereby translocation of Relish into the nucleus is enhanced in response to 
low nanomolar concentrations of cGMP, and inhibited in response to higher micromolar 
concentrations. Additionally, data further demonstrates that these effects are mediated by 
DG1 and DG2. Results show that when both Relish and DG1 are overexpressed in the 
tubule, translocation of Relish into the nucleus is enhanced. Conversely, overexpression 
of Relish with either DG2P1 or DG2P2 in the tubule is demonstrated to inhibit 
translocation. 
  
5.2 Introduction 
Drosophila cGKs have been implicated in a number of neuronal processes such as 
foraging, learning and memory, and sensory responsiveness (Osborne et al. 1997; 
Scheiner et al. 2004; Mery et al. 2007). Additionally, cGKs have been demonstrated to 
play a stimulatory role in fluid secretion in the tubules . However, despite the established 
role of cGKs in Drosophila, to date there are no identified phosphorylation targets of 
these kinases. Conversely, a number of substrates for vertebrate cGKs have been 
identified, including Vasodilator-Stimulated Phosphoprotein (VASP) (Butt et al. 1994), 
the small GTPase RhoA (Gudi et al. 2002; Zhuang et al. 2004) and the transcription 
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factors TFII-I (Casteel et al. 2002) and cAMP response element-binding (CREB) (Gudi et 
al. 1996). Additionally, the NFκB transcription factors p49/52, p50 and p65 have been 
identified as phosphorylation targets for the vertebrate cGK, PKG, where studies have 
demonstrated that the transcriptional activity of p49/52, p50 and p65 is significantly 
enhanced as a result of direct phosphorylation by PKG (He and Weber 2003). 
Interestingly, p50 and p65 are known to dimerize to form the NFκB transcription factor 
involved in the mammalian Tumour Necrosis Factor α (TNFα) signalling pathway, 
which is known to share several homologous components with the Drosophila Imd 
pathway (reviewed in Li and Lin 2008). Consistent with the Imd pathway, the TNFα 
pathway is known to trigger activation of NFκB through a number of signalling 
molecules such as Receptor Interacting protein (RIP - Imd homologue), FADD, TRAF6 
(which acts as an E3 ligase through its RING domain, much like Drosophila dIAP2) 
TAB2, TAK1, IKKα, IKKβ (ird5 homologue) and NEMO (Kenny homologue). 
Activation of NFκB in this pathway results in the regulation of a number of biological 
processes such as cell proliferation, differentiation, apoptosis and immune responses. To 
date, a number of studies have identified NO/cGMP/PKG as playing an important role in 
regulation of the TNFα pathway (Gertzberg et al. 2000; Kalra et al. 2000; Aizawa et al. 
2003). For example, studies have demonstrated that NO acts to provoke TNFα/NFκB 
activation through a cGMP/PKG-dependent pathway in both mammalian heart tissues 
and T-lymphocytes (Kalra et al. 2000; He and Weber. 2003).  Conversely, cGMP has 
been shown to significantly inhibit TNFα/NFκB activation in vascular smooth muscle 
cells (VSMCs) via both sGC and rGC (Aizawa et al. 2003). Significantly, in addition to 
the NFκB substrates for PKG, p50 and p65, it has also been demonstrated that PKG is 
able to activate the TNFα pathway via direct phosphorylation of IκB, the NFκB 
inhibitory protein (Kalra et al. 2000).  
 
Given the established role of cGMP/PKG in the regulation of the TNFα pathway, and the 
identification that this regulation occurs via direct phosphorylation of two TNFα pathway 
components by PKG, perhaps Drosophila cGKs play a similar role in the direct 
regulation of the Imd pathway. Indeed, it can be suggested from the results obtained in 
mammalian studies that a putative target for DG1 and/or DG2 may be the NFκB 
transcription factor Relish, which consists not only of an N-terminal Rel-homology 
domain (RHD) but also a C-terminal IκB inhibitory domain (Dushay et al. 1996). 
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However, due to the opposing effects of DG1 and DG2 on Imd pathway regulation, it is 
likely that these cognate kinases mediate their effects via the phosphorylation of distinct 
substrates. Therefore, studies were initiated in order to determine the potential target(s) of 
DG1 and DG2 in the Imd pathway. This was carried out using a transgenic approach, 
where the effects of cGK-mediated modulation of the Imd pathway were assessed 
epistatically.    
 
5.3 Generation of transgenic lines for epistatic analysis 
In order to carry out epistatic analysis of cGK-regulation of the Imd pathway within the 
tubule, several fly lines were generated which express the tubule principal cell-specific 
driver, c42, in a transgenic Imd pathway background (Figure 5.1 - original imd1, UAS-
imd and Key1 (Kenny) transgenic fly strains, kind gift of Professor S Kurata, University of 
Tohoku, Japan; original UAS-relish transgenic fly strain, kind gift of Professor D 
Hultmark, University of Umea, Sweden). This was achieved using the crossing scheme 
shown in Figure 5.1, whereby balanced Imd pathway transgenic strains were crossed to a 
balanced c42 transgenic line. The resultant progeny were then selected to contain one 
copy of the Imd pathway transgene, over the 2nd chromosome curly (CyO) balancer, and 
one copy of c42, over either the stubble (Sb) or tubby (Tb) 3rd chromosome balancers. 
Selected flies were then crossed to homozygous UAS-cGK transgenic flies as appropriate 
and progeny selected to contain one copy of each transgene. Following selection, the 
tubules of transgenic flies were then either assessed for changes in diptericin expression 
by Q-PCR, or were monitored directly using an ICC approach. 
 
Unfortunately, due to time limitations, and low yield of progeny of the correct genotype 
from some of the crosses, data was not obtained from crosses involving the                    
w
(-);cn-bw(Key1)/CyO;c42/TM2Tb and w(-);UAS-imd/CyO;c42/TM3Sb transgenic fly lines. 
Therefore, the results shown here represent preliminary data from epistatic analysis.  
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Figure 5.1 – Crossing scheme depicting generation of transgenic c42 driver flies in an Imd pathway 
mutant background. Balanced Imd pathway transgenic flies were crossed to a balanced c42 driver line. In 
order to maintain a balanced parental stock, for each cross progeny were selected to contain one copy of 
each transgene over an appropriate balancer gene [curly (CyO) on the 2nd chromosome and stubble (Sb) or 
tubby (Tb) on the 3rd chromosome]. Parental Imd-transgene/c42 flies were then crossed to homozygous 
UAS-cGK flies as appropriate and tubules of the progeny of the desired phenotype assessed for diptericin 
expression by Q-PCR or monitored directly by immunocytochemistry (ICC).    
 
 
5.4 Peptidoglycan (PGN) activation of the Imd pathway in the 
Drosophila Malpighian tubule  
Traditionally, in experiments requiring activation of the Imd pathway, crude preparations 
of lipopolysaccharide (LPS), a major component of the outer membrane of Gram-
negative bacteria, were used as an immune stimulant. However in recent years, a number 
of studies have been published regarding the efficiency of LPS for activating an immune 
response in Drosophila tissues (Leulier et al. 2003; Werner et al. 2003; Kaneko et al. 
2004). In these studies, it has been demonstrated that LPS is a very weak activator of the 
Imd pathway and that DAP-type PGN(-), derived from Gram-negative bacteria, is a 
significantly stronger activator of the Imd pathway.  
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Therefore, for a number of the epistatic experiments carried out in this chapter, PGN(-) 
(derived from E.coli strain 0.111:B4 - Invivogen) was used as an Imd pathway activator. 
The use of PGN(-) as an immune stimulant in the Drosophila Malpighian tubule has not 
been published previously. Therefore, the effect of PGN(-) on activation of AMP 
expression in the tubules was first of all validated using Oregon R wild-type flies. In this 
experiment, tubules were excised and incubated in sterile Schneider’s medium for 3 h 
both in the absence (as a control) or presence of 5 µg/ml PGN(-). Diptericin expression 
was then quantified by Q-PCR. As Figure 5.2 shows, diptericin expression is 
significantly increased in PGN(-)-stimulated tubules, thus confirming the potency of 
PGN(-) as an Imd pathway activator in the tubule.        
 
 
 
 
Figure 5.2 – PGN(-) stimulation of diptericin expression in the Drosophila Malpighian tubule. 
Expression of diptericin was assessed by Q-PCR in the excised tubules of Oregon R flies following 
stimulation with 5 µg/ml PGN(-). Resulting data were normalised against expression of the standard, rp49, 
and expressed as a fold change of control expression where control =1 (N = 3, + SEM). Data significant 
from control are indicated by *** (P = <0.0001) (as analysed by Students t-test) 
 
 
5.5 DG1 modulation of the Imd pathway in the tubule occurs 
downstream of Imd 
As shown in the previous chapter, DG1 has been demonstrated to act as a positive 
regulator of Imd pathway activation. Therefore, for epistatic analysis of DG1-mediated 
regulation of Imd pathway, initial experiments were carried out to assess the effect of 
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overexpression of DG1 in the tubules of flies deficient in Imd. For this experiment, DG1 
expression was targeted to the principal cells of the tubules by crossing homozygous 
UAS-dg1 transgenic flies to the w(-);pr(imd1)/CyO;c42/TM3Sb imd-deficient tubule driver 
line. Progeny were then selected to contain one copy of each transgene. As with previous 
experiments, tubules were then excised from 7-day old adult flies of both the 
imd1/CyO;c42/Sb parental lines (as a control) and the imd1/+;c42/UAS-dg1 progeny. 
Excised tubules were then incubated for 3 h in sterile Schneider’s medium alone (control) 
or sterile Schneider’s medium containing 100 µM cGMP. Following incubation, RNA 
was extracted from each sample and diptericin expression quantified by Q-PCR (Figure 
5.3).  
 
 
 
Figure 5.3 - Targeted overexpression of DG1 to the principal cells of the tubule in imd-deficient flies. 
Expression of diptericin was assessed by Q-PCR in excised tubules of imd-deficient adult flies following 
targeted overexpression of DG1 in tubule principal cells using the GAL4/UAS binary system. Resulting 
data were normalised against expression of the standard, rp49, and expressed as a Log 10 of fold change of 
parental control expression where control =1 (N = 3, + SEM). Significance of data was determined by Two-
way ANOVA and post hoc analysis was carried out using Bonferroni tests, whereby significant data are 
indicated by * (P<0.05) or ns (not significant) where appropriate. Analysis by two-way ANOVA reveals a 
significant interaction between genotype and stimulus. The effect of stimulus and genotype alone are also 
considered significant (See table). Additionally, post hoc analysis shows a significant difference in 
diptericin expression in the tubules of imd1/+;c42/UAS-dg1 flies compared to imd1/CyO;c42/sb parental 
flies in both controls and in cGMP-stimulated tubules. Furthermore, it can be seen that there is no 
significant effect on diptericin levels in the tubules of parental flies in response to cGMP, whereas 
diptericin expression is significantly increased in response to cGMP in the tubules of imd1/+;c42/UAS-
dg1flies.   
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It can be seen from the results in Figure 5.3 that, due to the presence of the imd1-
transgene, diptericin expression is extremely low in the tubules of the imd1/CyO;c42/Sb 
parental controls. However, when dg1 expression is targeted to the tubule in the imd-
deficient flies, expression of diptericin is drastically increased (approximately 350-fold) 
compared to parental controls. Furthermore, when tubules from imd1/+;c42/UAS-dg1 
flies are stimulated with exogenous cGMP, diptericin expression levels are further 
increased, confirming that the data observed are a result of activation of DG1 by cGMP. 
These findings are in support of data shown in chapter 4 (Figure 4.1), where it is 
demonstrated that overexpression of dg1 in the tubule not only results in an up-regulation 
of diptericin expression in the tubule, but that this effect is enhanced in response to 100 
µM cGMP. Interestingly, when the tubules of imd1/CyO;c42/Sb parental flies are 
incubated with cGMP, there is an increase in diptericin expression, though this effect is 
not deemed significant (as determined by Bonferroni post-tests). Previous data has 
demonstrated an inhibitory effect of 100 µM cGMP on AMP expression in the tubule in 
both wild-type and parental flies (Figures 3.3, 4.1 – 4.5). However, it is probable that 
initial expression levels of diptericin are so low in the imd1 mutant flies that incubation 
with cGMP would have no significant effect on expression. Alternatively, it could be 
suggested that the inhibitory effect on AMP expression normally seen in response to high 
concentrations of cGMP is mediated upstream of Imd. Since these inhibitory effects are 
mediated via DG2, it can therefore be implied from this parental data that DG2-mediated 
regulation of the Imd pathway may occur upstream of Imd. However, further 
investigation is required in order to confirm this hypothesis.    
 
Overall, it can be seen from results that overexpression of DG1 in the tubule is sufficient 
to significantly rescue activation of diptericin expression in the tubules of imd-deficient 
flies. These data therefore confirm that DG1-mediated regulation of the Imd pathway 
occurs downstream of Imd.  
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5.6 cGMP pathway regulation of the Imd pathway is a result of 
modulation of Relish activation 
5.6.1 Introduction 
As mentioned previously, stimulation of the Imd pathway in Drosophila ultimately 
results in the activation of the NFκB transcription factor, Relish. Relish is a 110 kDa 
protein, homologous to mammalian p105, comprising an N-terminal Rel-homology 
domain (RHD) and a C-terminal IκB-like inhibitory domain (Dushay et al. 1996). Studies 
have shown that upon activation full-length Relish is rapidly cleaved by the caspase-8 
homologue DREDD to form two stable fragments; REL-68, containing the RHD, which 
translocates into the nucleus immediately upon cleavage, and REL-49, which contains the 
IκB inhibitory domain and is retained in the cytoplasm (Stoven et al. 2000; Stoven et al. 
2003). Given that previous studies have identified mammalian NFκB as a 
phosphorylation target for PKG (He and Weber 2003), and that initial epistatic analysis 
has confirmed a role for DG1 downstream of Imd, studies were initiated in order to 
investigate Relish as a potential target for the action of cGMP/cGKs. 
 
In recent years, a number of studies have used either fluorescent reporters or ICC 
methods to visualise translocation of REL-68 into the nucleus in both Drosophila cell 
lines and ex vivo in the fly (Stoven et al. 2000; Stoven et al. 2003; Bettencourt et al. 2004; 
Foley and O'Farrell 2004). The ability to visualise Relish activation in a cellular context 
has provided a valuable tool for defining upstream regulators of the Imd pathway. 
Therefore for this study, activation of Relish was fluorescently monitored in the tubules 
in order to assess the effects of cGMP/cGK-mediated regulation of the Imd pathway. In 
this approach, w(-);UAS-relish/CyO;c42/Sb flies (described in Section 5.3) were either 
monitored directly for Relish activation in response to stimulation with either cGMP or 
PGN(-), or were crossed to homozygous UAS-cGK transgenic flies and the activation of 
Relish assessed in the resultant progeny. To do this, the tubules of each transgenic line 
were excised and the localisation of Relish in each set of tubules was then determined by 
ICC. It should be noted that the original UAS-relish transgenic fly line used to generate 
the w(-);UAS-relish/CyO;c42/Sb parental flies has been described previously  and can be 
characterised by its expression of a Relish fusion protein comprising the full-length 
Relish protein downstream of a N-terminal hexahistidine tag. Therefore, in these 
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experiments Relish activation was fluorescently detected using an anti-tetra-HIS primary 
antibody (QIAGEN) followed by a FITC-labelled secondary antibody (Jackson).  
Additionally, tubules were stained with 4, 6-diamidino-2-phenylindole (DAPI), a 
fluorescent dye known to bind double-stranded DNA, thus allowing visualisation of cell 
nuclei. Samples were then viewed using the Zeiss 510 Meta confocal system.   
  
5.6.2 Nuclear translocation of Relish in the tubule is modulated by cGMP in 
response to immune challenge 
 Prior to carrying out experiments to determine the effect of cGK modulation on Relish 
activation, initial studies were carried out in order to assess the effect of stimulation with 
cGMP and/or PGN(-) on Relish activation in the tubules of the w(-);UAS-
relish/CyO;c42/TM3Sb parental flies. To do this, tubules were excised and incubated for 
3 h in either sterile Schneider’s medium (as a control), or sterile Schneider’s medium 
containing either 100 µM cGMP and/or 5 µg/ml PGN(-). Levels of Relish activation were 
then detected by ICC as described above. It should be noted that ICC experiments were 
also carried out on the tubules of w(-);UAS-relish;TM3Sb/TM6e- parental flies to act as a 
negative control for antibody staining. 
 
As Figure 5.4A shows, in the absence of stimuli Relish localisation in the tubule is 
mainly basolateral (yellow arrows). Interestingly, low levels of Relish can also be 
detected in the nucleus (white arrows), despite the absence of an immune stimulant. This 
is in agreement with previous studies however, where it has been demonstrated that 
Relish is constitutively active at a basal level (Stoven et al. 2000; Bettencourt et al. 2004). 
Conversely, it can be seen that when an immune response is stimulated in the tubules via 
incubation with PGN(-), complete translocation of Relish into the nucleus is observed 
(Figure 5.4B). This data therefore further confirms the effectiveness of PGN(-) as an Imd 
pathway-activator in the tubule. When tubules are stimulated with 100 µM cGMP, a 
concentration shown previously to inhibit diptericin expression in the tubules, it can be 
seen that localisation of Relish remains predominately basolateral (Figure 5.4C). As with 
controls, only minimal levels of nuclear Relish can be detected in cGMP-stimulated 
tubules, though it appears that levels of nuclear localisation of Relish are lower in cGMP-
stimulated tubules compared to control tubules. Interestingly, it can be seen from Figure  
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Figure 5.4 – Nuclear translocation of Relish in the tubules. Relish localisation was monitored in the 
tubules of c42/UAS-relish(6xHis) flies using ICC. [A] In the absence of stimuli Relish is mainly localised 
to the basolateral membrane with basal levels of localisation to the nucleus, indicating a basal level of 
relish activation. [B] When an immune response is activated in the tubule using PGN(-), there is complete 
translocation of Relish to the nucleus, with no basolateral localisation. [C] Relish localisation in response to 
100 µM cGMP. As with controls, Relish is mainly localised to the basolateral membrane, with minimal 
localisation to the nucleus [D] Immune activation with PGN(-) in the presence of 100 µM cGMP results in 
the inhibition of nuclear translocation. [E] UAS-relish parental control. Left hand panel – FITC (Green); 
right hand panel – FITC and DAPI (Red) merged (staining in the nuclei may appear red/yellow or 
yellow/green depending on levels of Relish translocation). White arrows – nuclear staining, yellow arrows 
– basolateral staining    
 
5.4D that incubation of the tubules with both 5 µg/ml PGN(-) and 100 µM cGMP results 
in mainly basolateral localisation of Relish, with only slightly higher levels of Relish 
translocation into the nucleus than in control tubules, despite the presence of an immune 
stimulant. This data therefore confirms that the negative effect of 100 µM cGMP on 
AMP expression shown in previous results is a result of regulation of Relish activation, 
and subsequent regulation of AMP transcription.  
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5.6.3 Nuclear translocation of Relish is modulated by cGMP in a dose-dependent 
manner.   
In chapter 3, it was demonstrated that the effect of cGMP on AMP expression in the 
tubule is dependent on concentration; whereby low, nanomolar concentrations of cGMP 
were shown to enhance diptericin expression, and high, micromolar concentrations were 
shown to inhibit diptericin expression. Therefore, in order to investigate this effect with 
regards to Relish activation, studies were initiated using the w(-);UAS-
relish/CyO;c42/TM3Sb transgenic flies described previously. In these experiments, 
tubules were excised and incubated for 3 h in sterile Schneider’s medium in the presence 
of varying concentrations of cGMP. Levels of Relish activation were then detected by 
ICC as described above.  
 
As Figure 5.5 shows, the dose-dependent effect of cGMP on diptericin expression 
described previously is a result of cGMP-mediated modulation of Relish activation 
within the tubule. To explain further, it can be seen from control tubules (Figure 5.5A) 
that, as before, Relish is localised mainly basolaterally with only basal levels of nuclear 
Relish observed. Conversely, it is demonstrated that when tubules are stimulated with 1 
nM cGMP (Figure 5.5Bi), complete translocation of Relish to the nucleus occurs, thus 
indicating complete activation of the protein. Similarly, as Figures 5.5Bii and 5.5Biii 
show, when tubules are stimulated with either 10 nM or 100 nM cGMP respectively, 
almost complete nuclear translocation occurs, with only minimal levels of inactivated 
Relish observed basolaterally.  
 
Equally, it can be seen from Figure 5.5C that incubation of the tubules with micromolar 
concentrations of cGMP appears to have an inhibitory effect on Relish activation. When 
tubules are incubated with 1 µM cGMP (Figure 5.5Ci), Relish localisation appears to be 
very similar to that of control tubules, whereby Relish appears to be mainly basolateral 
with only low levels of nuclear translocation. Similarly, when tubules are incubated with 
either 10 µM or 100 µM cGMP (Figures 5.5Cii and 5.5Ciii respectively), Relish 
localisation is again mainly basolateral. However, it can be seen from the results that as 
cGMP concentration is increased, levels of nuclear Relish are decreased. Indeed, it is 
demonstrated in Figure 5.5Ciii that, as before, only minimal levels of nuclear Relish can  
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Figure 5.5 - Nuclear translocation of Relish is modulated by cGMP in the tubules. Relish localisation 
was monitored in the tubules of c42/UAS-relish(6xHis) flies in response to various concentrations of 
cGMP. [A] Control - In the absence of challenge Relish is mainly localised to the basolateral membrane 
with slight localisation to the nucleus, indicating a basal level of activation. [B] Relish localisation in 
response to low nanomolar concentrations of cGMP. Stimulation with 1 nM cGMP [i] results in complete 
translocation of Relish into the nucleus. Stimulation with 10 nM cGMP [ii] or 100 nM cGMP [iii] results in 
almost complete nuclear translocation of Relish, however some basolateral staining is still observed. [C] 
Relish localisation in response to high micromolar concentrations of cGMP. As with controls, stimulation 
with either 1 µM cGMP [i] or 10 µM cGMP [ii] results in high levels of basolateral staining, with low 
levels of localisation to the nucleus, however basal levels of nuclear translocation in response to 10 µM 
appears to be slightly decreased compared to controls. Stimulation with 100 µM cGMP [iii] results in 
almost completely basolateral staining, with minimal nuclear localisation.   Left hand panel – FITC 
(Green); right hand panel – FITC and DAPI (Red) merged (staining in the nuclei may appear red/yellow or 
yellow/green depending on levels of Relish translocation). White arrows – nuclear staining, yellow arrows 
– basolateral staining    
Control 
1nM cGMP 
10nM cGMP 
100nM cGMP 
1µM cGMP 
10µM cGMP 
100µM cGMP 
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be observed in the tubules compared to controls in response to 100 µM cGMP, 
suggesting an inhibitory effect of cGMP at this concentration.  
 
Overall, these data show for the first time, that dose-dependent regulation of the Imd 
pathway by cGMP is a result of modulation of Relish activation. 
 
5.6.4 DG1 modulation of the Imd pathway activates Relish translocation in the 
tubule  
As demonstrated previously, stimulation of the Imd pathway by cGMP is mediated by 
DG1. Therefore, given that the results shown in Figure 5.4B demonstrate that cGMP-
mediated stimulation of the Imd pathway occurs via modulation of Relish activation, it is 
probable that this effect occurs via activation of DG1. Studies were therefore initiated in 
order to assess Relish activation in the tubules of flies whereby dg1 was either 
overexpressed or knocked-down via RNAi. To do this, homozygous transgenic flies 
containing either UAS-dg1 or UAS-dg1RNAi transgenes were crossed to w(-);UAS-
relish/CyO;c42/TM3Sb flies and resultant progeny were selected to contain one copy of 
each transgene. Tubules were then excised and incubated for 3 h in either sterile 
Schneider’s medium (as a control), or sterile Schneider’s medium containing either 100 
µM cGMP and/or 5 µg/ml PGN(-). Relish activation was then monitored in the tubules of 
selected flies by ICC as described previously. 
 
As Figure 5.6A shows, it can be seen that targeted expression of dg1 to the tubule 
principle cells results in enhanced levels of Relish activation, even in the absence of an 
immune stimulus. It is demonstrated that, in contrast to UAS-relish/CyO;c42/Sb parental 
controls (Figure 5.3A), targeted overexpression of dg1 to the tubules results in almost 
total activation of Relish, with only minimal basolateral staining detected (Figure 5.6Ai). 
Interestingly, it can be seen that enhanced Relish activation also occurs in the tubules of 
flies over-expressing dg1 in response to 100 µM cGMP (Figure 5.6Aiii). These results 
support previous data (Figure 4.1) which shows that diptericin expression is increased in 
the tubules in response to 100 µM cGMP when dg1 is overexpressed. As expected, when 
the tubules are stimulated with exogenous PGN(-), complete translocation of Relish is 
observed (Figure 5.6Aii). However, in contrast to results obtained from the tubules of the 
UAS-relish/CyO;c42/Sb parental flies (Figure 5.3D), it can be seen that complete  
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Figure 5.6 - Nuclear translocation of Relish is stimulated by DG1 in the tubules. Relish localisation 
was monitored in the tubules of flies whereby dg1 expression was modulated using the GAL4/UAS binary 
system. Targeted overexpression or knock-down of dg1 was achieved by crossing c42/UAS-relish(6xHis) 
flies to UAS-dg1 or UAS-dg1RNAi flies respectively. [A] Relish localisation in the tubule when dg1 is 
overexpressed [i] Control – Shows high levels of nuclear translocation of Relish with minimal basolateral 
staining [ii] +5 µg/ml PGN(-) – results in complete nuclear translocation of Relish [iii] +100 µM cGMP – 
shows almost complete translocation of Relish, with a low level of basolateral staining [iv] +100 µM 
cGMP/5 µg/ml PGN(-) – results in complete nuclear translocation of Relish. [B] Relish localisation in the 
tubule when dg1 expression is knocked-down [i] Control – As with parental controls (See Figure 5.4A), 
shows mainly basolateral staining with low levels of nuclear localisation [ii] +5 µg/ml PGN(-) – results in 
partial nuclear translocation of Relish with low levels of basolateral staining [iii] +100 µM cGMP - results 
in complete basolateral localisation [iv] +100 µM cGMP/5 µg/ml PGN(-) – results in low levels of nuclear 
translocation of Relish with high levels of basolateral localisation. Left hand panel – FITC (Green); right 
hand panel – FITC and DAPI (Red) merged (staining in the nuclei may appear red/yellow or yellow/green 
depending on levels of Relish translocation). White arrows – nuclear staining, yellow arrows – basolateral 
staining    
Control 
Control 
+PGN (-) 
+PGN (-) 
+100 µM cGMP 
+100 µM cGMP 
+PGN (-)/100 µM cGMP 
+PGN (-)/100 µM cGMP 
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translocation of Relish is also observed in response to PGN(-) in the presence of 100 µM 
cGMP (Figure 5.6Aiv).  
 
In support of this data, it is demonstrated that when dg1 expression is knocked-down in 
the tubule principal cells, Relish activation is inhibited. As Figure 5.6B shows, it can be 
seen that the tubules of dg1-deficient flies are unable to induce Relish activation to the 
same degree as the tubules of UAS-relish/+;c42/Sb parental flies (Figure 5.3B) in 
response to stimulation with PGN(-) (Figure 5.6Bii). Results show that, unlike in parental 
tubules where Relish is localised completely in the nucleus after PGN(-) stimulation, only 
partial nuclear translocation of Relish can be observed in the tubules of dg1-deficient 
flies, with low levels of basolateral staining also detected. These results therefore indicate 
an inhibitory effect on the Imd pathway in the tubules when dg1 expression is depleted. 
Indeed, this effect is further enhanced when tubules are stimulated with 100 µM cGMP. 
It can be seen from Figure 5.6Biii that in the presence of cGMP alone, Relish localisation 
is completely basolateral, with no nuclear staining detected. This suggests that the 
negative effect on Relish activation normally seen in the tubules of parental flies in 
response to 100 µM cGMP is enhanced in the absence of DG1, resulting in significant 
inhibition of basal levels of Relish activation. In support of this, it can be seen that when 
the tubules of dg1-deficient flies are stimulated by PGN(-) in the presence of 100 µM 
cGMP, Relish localisation remains mainly basolateral with only a low level of nuclear 
translocation detected.  
 
Overall, the data shown in Figure 5.6 demonstrates a completely novel role for DG1 in 
the tubule as a positive regulator of Relish activation. 
 
 
5.6.5 DG2 modulation of the Imd pathway inhibits Relish translocation in the 
tubule 
As shown in the previous chapter, the two main isoforms of DG2, DG2P1 and DG2P2, 
have been demonstrated to act as negative regulators of diptericin expression. Therefore, 
given that the results shown in Figure 5.4C indicate that cGMP-mediated inhibition of the 
Imd pathway is a result of modulation of Relish activation, it is probable that this effect 
occurs via activation of DG2P1 and DG2P2. Therefore, studies were initiated to assess 
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Relish activation in the tubules of flies where expression of either dg2P1 or dg2P2 was 
modulated. To do this, homozygous transgenic flies containing either UAS-dg2P1 or 
UAS-dg2P2 transgenes were crossed to w(-);UAS-relish/CyO;c42/TM3Sb flies and, as 
with previous experiments, resultant progeny were selected to contain one copy of each 
transgene. Tubules were then excised and incubated with either PGN(-) and/or cGMP and 
Relish activation monitored by ICC. 
 
It can be seen from Figure 5.7 that targeted expression of either dg2P1 or dg2P2 to the 
tubule results in inhibition of Relish activation. As with UAS-relish/+;c42/Sb parental 
controls, it can be seen that in the control tubules of flies overexpressing either dg2P1 or 
dg2P2 (Figures 5.7Ai and 5.7Bi respectively), localisation of Relish is mainly basolateral 
with only minimal levels of nuclear localisation detected. It cannot be concluded from 
these figures, however, whether or not overexpression of dg2P1 or dg2P2 alone is 
enough to inhibit Relish activation in the tubule. Conversely, a clear inhibition of Relish 
activation can be seen in the tubules of both dg2P1 and dg2P2 overexpressing flies in 
response to PGN(-) (Figures 5.7Aii and 5.7Bii respectively). Unlike the tubules of 
parental flies, whereby complete translocation of Relish to the nucleus is observed in 
response to stimulation with PGN(-) (Figure 5.3B), it can be seen that in the tubules of 
the dg2P1 and dg2P2 overexpressing flies, a great deal of Relish is retained in the 
cytoplasm, with only partial translocation of Relish into the nucleus observed. Similarly, 
it is shown that this inhibitory effect is enhanced in the presence of cGMP. As Figure 
5.7Aiii shows, when the tubules of dg2P1-overexpressing flies are stimulated with 100 
µM cGMP, localisation of Relish is almost completely basolateral, with only minimal 
levels of nuclear Relish observed. This effect is further enhanced in the tubules of dg2P2-
overexpressing flies, where it can be seen that stimulation with 100 µM cGMP results in 
completely basolateral localisation of Relish (Figure 5.7Biii). Importantly, when the 
tubules of either dg2P1 or dg2P2 overexpressing flies are stimulated with PGN(-) in the 
presence of 100 µM cGMP (Figures 5.7Aiv and 5.7Biv respectively), Relish activation 
does not appear to be enhanced above a basal level, despite PGN(-) stimulation.  
 
Unfortunately, experiments assessing the impact of knock-down of dg2 expression on 
Relish activation in the tubule could not be carried out. As mentioned in the previous 
chapter, when UAS-dg2RNAi flies are crossed to c42, only minimal survival of the  
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Figure 5.7 - Nuclear translocation of Relish is inhibited by DG2 in the tubules. Relish localisation was 
monitored in the tubules of flies in which DG2 expression was modulated using the GAL4/UAS binary 
system. Targeted overexpression of dg2P1 and dg2P2 was achieved by crossing c42/UAS-relish(6xHis) 
flies to UAS-dg2P1 or UAS-dg2P2 flies respectively. [A] Relish localisation in the tubule when dg2P1 is 
overexpressed [i] Control – shows minimal levels of nuclear translocation of Relish with high levels of 
basolateral localisation [ii] +5 µg/ml PGN(-) – results in partial nuclear translocation of Relish with low 
levels of basolateral localisation [iii] +100 µM cGMP – shows minimal levels of nuclear translocation of 
Relish with high levels of basolateral localisation [iv]  +100 µM cGMP/5 µg/ml PGN(-) – results in 
minimal nuclear translocation of Relish with high levels of basolateral localisation. [B] Relish localisation 
in the tubule when dg2P2 is over-expressed [i] Control – shows mainly basolateral staining with minimal 
levels of nuclear localisation [ii] +5 µg/ml PGN(-) – results in partial nuclear translocation of Relish with 
low levels of basolateral localisation [iii] +100 µM cGMP - results in almost complete basolateral 
localisation with minimal nuclear localisation [iv] +100 µM cGMP/5 µg/ml PGN(-) – results in very low 
levels of nuclear translocation of Relish with high levels of basolateral localisation. Left hand panel – FITC 
(Green); right hand panel – FITC and DAPI (Red) merged (staining in the nuclei may appear red/yellow or 
yellow/green depending on levels of Relish translocation). White arrows – nuclear staining, yellow arrows 
– basolateral staining    
+PGN (-)/100 µM cGMP 
+PGN (-)/100 µM cGMP +100 µM cGMP 
+100 µM cGMP 
+PGN (-) 
+PGN (-) 
Control 
Control 
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progeny is observed beyond pupal stage. Therefore it was not possible to investigate the 
effect of dg2 knock-down using the w(-);UAS-relish/CyO;c42/Sb transgenic line 
generated for this study. Unfortunately, the use of the inducible GAL80;c42 transgenic 
line generated to facilitate UAS-dg2RNAi expression in the previous chapter was also not 
possible, as the generation of a transgenic line that expressed both UAS-dg2RNAi and 
UAS-relish alongside both GAL80 and c42 could not be achieved due to the 
chromosomal location of each of the transgenes. However, it is hypothesised that had it 
been possible to investigate the effect of dg2 knock-down on Relish activation in the 
tubule, results would show stimulation of Relish in the absence of DG2.   
 
Overall, a clear inhibition on Relish activation can be seen in the tubule of flies 
overexpressing either dg2P1 or dg2P2 in the tubule (Figure 5.7). Therefore the data 
shown here demonstrates a novel role for both DG2P1 and DG2P2 in the tubule as 
negative regulators of Relish activation. 
 
5.7 Discussion 
In the previous chapter, the Drosophila cGKs, DG1 and DG2, were demonstrated for the 
first time to play an important role in regulation of immune response in the tubules of the 
adult fly. In chapter 4, it was reported that these cognate kinases mediate differential 
effects on the production of the anti-microbial peptide diptericin, and that these effects 
are sufficient to impact on whole fly survival in response to bacterial challenge. As 
mentioned previously, induction of diptericin production is known to occur as a direct 
result of activation of the Imd pathway. Therefore, it can be hypothesised that cGK 
modulation of diptericin expression occurs either through interaction with one or more 
components of the Imd pathway, or by transcriptional regulation of diptericin expression 
itself. In this chapter, it is demonstrated for the first time that activation of the NFκB 
transcription factor, Relish, is dose-dependently modulated by cGMP and that these 
effects are mediated differentially by DG1 and DG2. 
 
Initial epistatic analysis has shown that overexpression of DG1 is sufficient to 
significantly rescue activation of diptericin expression in the tubules of imd-deficient flies. 
This data has therefore confirmed the regulatory role of DG1 downstream of Imd. 
Interestingly, analysis of diptericin expression in the tubules of parental imd-deficient 
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flies has shown that, unlike in wild type tubules, where incubation with 100 µM cGMP 
has an inhibitory effect on diptericin expression, tubules from imd-deficient flies show no 
significant change in diptericin expression in response to 100 µM cGMP. This effect is 
most likely explained by the fact that initial expression levels of diptericin are already 
extremely low in the tubules of the imd1 mutant flies, and therefore incubation with 
cGMP would have no significant effect on expression. Alternatively, this data may have 
revealed a potential serendipitous upstream role for DG2 in Imd pathway modulation. 
The typical inhibitory effect of 100µM cGMP on diptericin expression in the tubules is 
known to be mediated by DG2. As this effect is not observed in the tubules of imd-
deficient flies, it can therefore be suggested that DG2 may act upstream of Imd. However, 
this can only be implied from the data obtained. Further epistatic analysis is required in 
order to conclusively determine a potential target for DG2 within the Imd pathway. 
  
Importantly, it is demonstrated here that dose-dependent modulation of AMP expression 
by cGMP/cGKs is a result of activation/inhibition of Relish. Unfortunately, extensive 
epistatic analysis could not be carried out, thus it is not known whether the effects of 
these kinases are a consequence of upstream regulation of the Imd pathway, or are 
occurring through direct interaction with Relish itself. Therefore, further analysis is 
required in order to determine the exact target of action of each of these kinases. 
Furthermore, it cannot be concluded from this data whether DG1 or DG2 are mediating 
their effects on the Imd pathway directly or indirectly; i.e. – whether the action of these 
kinases is a result of direct phosphorylation of components of the Imd pathway, or via 
phosphorylation of an as of yet unidentified substrate. However, given that previous 
studies have identified NFκB as a phosphorylation target for mammalian PKG, it can be 
hypothesised that one, or both, of these kinases may be acting to modulate Relish 
activation through direct phosphorylation of Relish itself.  
 
Overall, this study has identified that the novel, differential regulatory roles of DG1 and 
DG2 on AMP expression are a result of either stimulation or inhibition of Relish 
activation respectively, however further investigation is required in order to identify 
definitive candidates as substrate(s) for either DG1 or DG2 in this regulation. 
 
 
  
 
 
 
6 Chapter 6 
 
The role of other cGMP pathway components in Imd 
pathway regulation 
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6.1 Summary 
As mentioned previously, cGMP is known to exist in localised pools, generated in close 
proximity to particular upstream activators, i.e. soluble or receptor guanylate cyclases 
(Davies and Day 2006). As such, the effect of each distinct cGMP signal within the cell is 
then determined by its proximity and affinity to particular downstream effectors such as 
cGKs, PDEs and CNG channels (Beavo and Brunton 2002; Piggott et al. 2006). This 
study has demonstrated that, in the tubule, cGMP mediates differential regulation of the 
Imd pathway, via the activation of the cGKs, DG1 and DG2. Due to their differing 
localisation within the tubule, it has been hypothesised that DG1 and DG2 are activated 
via different ‘sources’ of cGMP within the cell, thus facilitating the distinct action of 
these otherwise cognate kinases. Similarly, the activation of the kinases themselves is 
known to be finely regulated via the hydrolysis of cGMP to 5΄GMP by specific PDEs. 
Therefore, using a combination of transgenic, pharmacological and Q-PCR approaches, 
preliminary studies were carried out in order to investigate the role of other cGMP 
pathway components in Imd pathway regulation in the tubule. Data obtained has 
demonstrated that the differential effects of cGMP on diptericin expression are mediated 
by activation of distinct guanylate cyclases, whereby diptericin expression is stimulated 
by sGC and inhibited by rGC. Similarly, a role for the dual-specificity phosphodiesterase, 
DmPDE11, is described here, where it is demonstrated that knockdown of this enzyme in 
the tubule principal cells by RNAi results in inhibition of diptericin expression and 
reduced survival in response to septic infection with E.coli.  
 
6.2 The differential effects of cGMP signalling on Imd pathway 
regulation are mediated via distinct guanylate cyclases 
6.2.1 Introduction 
To date, as with studies investigating cGK-related effects in Drosophila, investigation 
into the functional effects of Drosophila guanylate cyclases have mainly focussed on 
neuronal function. For example, isoforms of both sGC and rGC have been mapped to the 
head and nervous system (Yoshikawa et al. 1993; Liu et al. 1995; McNeil et al. 1995; 
Shah and Hyde 1995; Langlais et al. 2004; Morton et al. 2005). Similarly, a number of 
studies have identified GCs to play a role in such processes as foraging, axonal guidance, 
synaptic transmission and neuromuscular junction vesicle release (Wildemann and Bicker 
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1999; Ayoob et al. 2004; Riedl et al. 2005; Morton et al. 2008). In addition, a role for 
sGC has been described with regards to visual system development, where studies have 
shown that sGC is highly expressed in the retina and optic lobes and acts to regulate 
growth cone behaviour (Yoshikawa et al. 1993; Shah and Hyde 1995; Gibbs et al. 2001).   
 
Rather unsurprisingly, given the important role of cGMP signalling in tubule function, 
studies have also demonstrated that sGC and a number of rGC isoforms, particularly 
Gyc76C, are enriched in the Malpighian tubule (Wang et al. 2004; Davies 2006; 
www.flyatlas.org). In addition, an important role for both sGC and rGC in the regulation 
of epithelial fluid secretion in the tubule has also been demonstrated (Davies et al. 1997; 
Kerr et al. 2004). However to date, aside from a role in fluid secretion, the specific 
function of each of these GCs with regards to the downstream physiological effects of 
cGMP signalling in the tubule has not yet been defined. Given that a number of GCs are 
expressed in the tubule, it can be suggested that the numerous physiological effects 
regulated by cGMP signalling in this tissue may be mediated via the activation of specific 
guanylate cyclases, which act to generate distinct localised cGMP signals within each cell. 
Indeed in this study, it has been hypothesised that the contrasting effects of cGMP 
signalling on Imd pathway regulation in the tubule are a result of the differential 
activation of cGKs by different ‘sources’ of cGMP. Therefore, in order to determine 
whether the contrasting roles of cGKs with regards to immune function are mediated by 
differential activation of GCs, preliminary studies were carried out, using a combination 
of transgenic, pharmacological and Q-PCR approaches, to investigate the role of 
guanylate cyclases in Imd pathway regulation.  
 
6.2.2 Activation of soluble guanylate cyclase by NO mediates positive regulation of 
diptericin expression in the tubule 
As described previously, soluble guanylate cyclases are activated through interaction 
with NO, a diffusible molecule that is produced by a family of enzymes known as nitric 
oxide synthases (NOS) (Stuehr 1999; Marletta and Spiering 2003). Recently, a number of 
studies have identified the Drosophila NOS, DNOS, as an important positive regulator of 
immune function (Foley and O’Farrell. 2003; McGettigan et al. 2005). In the first of 
these studies, it was shown that DNOS inhibition results in decreased survival of larvae 
in response to E.caratovora. Similarly, larvae that had been fed the NO donor S-Nitroso-
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N-acetylpenicillamine (SNAP) were shown to exhibit elevated levels of diptericin 
expression (Foley and O’Farrell 2003). Interestingly, in the second of these studies, an 
important role for DNOS in tubule immune function has been described. In this study, the 
tubules were identified to exhibit increased NOS activity in response to immune 
challenge. Additionally, overexpression of dNOS in the tubule was demonstrated to 
increase tubule diptericin expression, which was sufficient to confer increased survival of 
the whole organism in response to septic infection with E.coli (McGettigan et al. 2005).   
 
Considering that the main intracellular receptor for NO is sGC, it is probable that the 
effects of dNOS on immune regulation in the tubule are linked, via activation of sGC, to 
cGMP/cGK-mediated regulation of the Imd pathway, demonstrated earlier in this study. 
Furthermore, given that the role of dNOS has been demonstrated as stimulatory, it can be 
suggested that it may be mediating its effects, via sGC, through downstream activation of 
DG1. Indeed, if the differential effects of DG1 and DG2 on Imd pathway regulation in 
the tubule are mediated via the generation of distinct pools of cGMP within the cell, then 
the mainly cytosolic localisation of DG1 would suggest that activation of this kinase is 
mediated via a cytosolic source of cGMP, i.e. cGMP that has been generated via the 
activation of sGC by NO. Therefore in this study, preliminary experiments were initiated 
in order to determine whether NO-mediated immune regulation in the tubule is facilitated 
by activation of sGC and therefore subsequent activation of downstream cGMP 
signalling.  
 
Prior to investigating the role of sGC in immune activation in the tubule, studies were 
first of all initiated in order to investigate the mechanism by which NO is mediating its 
effects on immune response. Previously in this study, it has been demonstrated that cGK-
mediated regulation of diptericin expression is a result of modulation of Relish activation, 
whereby DG1 has been shown to enhance Relish activation and DG2 has been shown to 
inhibit it. Recent studies have demonstrated that, similar to DG1, NO acts to increase 
diptericin expression in the tubule (McGettigan et al. 2005). However, the mechanism by 
which NO achieves its effects has not yet been demonstrated. It can be suggested 
however, that if NO-mediated stimulation of diptericin in the tubule is a result of 
modulation of Relish activation, then perhaps NO may be mediating its effects via the 
cGMP signalling pathway. Therefore, in order to investigate this hypothesis, Relish 
activation was monitored in the tubules in response to the nitric oxide donor SNAP. To 
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do this, an ICC approach was used. Briefly, the tubules of w(-);UAS-
relish/CyO;c42/TM3sb transgenic flies, described in chapter 5, were excised and 
incubated for 3 hr in either sterile Schneider’s medium (as a control), or sterile 
Schneider’s medium containing 1 mM of SNAP. Levels of Relish activation were then 
detected by ICC as described previously.  
 
 
 
Figure 6.1 – Nuclear translocation of Relish in the tubules is stimulated by NO. Relish localisation was 
monitored in the tubules of c42/UAS-relish(6xHis) flies in response to the NO donor SNAP. [A] Control - 
In the absence of challenge Relish is mainly localised to the basolateral membrane with slight localisation 
to the nucleus, indicating a basal level of activation. [B] Incubation of the tubules with 1 mM SNAP results 
in almost complete nuclear translocation of Relish, with only minimal levels of basolateral staining 
observed.  Left hand panel – FITC (Green); right hand panel – FITC and DAPI (Red) merged (staining in 
the nuclei may appear red/yellow or yellow/green depending on levels of Relish translocation). White 
arrows – nuclear staining, yellow arrows – basolateral staining    
 
 160
Figure 6.1 shows that, as with previous results, in the absence of stimuli Relish 
localisation is mainly basolateral, with only basal levels of activated Relish localised to 
the nucleus (Figure 6.1A). However, when the tubules are stimulated with SNAP, thus 
increasing intracellular NO concentration, almost complete translocation of Relish into 
the nucleus is observed (Figure 6.1B). These results therefore demonstrate that, similar to 
modulation of AMP production by cGMP signalling, NO-mediated stimulation of 
diptericin expression in the tubule is a result of increased Relish activation. It is therefore 
indicated by this data that NO is likely to mediate its effects on Imd pathway regulation 
through the cGMP signalling pathway, via activation of sGC. 
 
In order to extend these studies, diptericin expression was monitored in the tubules of 
flies overexpressing dNOS in the presence of the sGC inhibitor 1H-(1,2,4) oxadiazolo-
(4,3-a) quinaxalin-1-one (ODQ) (data generated by Dr Susan Wan, University of 
Glasgow). To do this, expression of dNOS was targeted to the tubules by crossing UAS-
dN1-8 (McGettigan et al. 2005), a transgenic line containing the dNOS gene under the 
control of a UAS promoter, to the principle cell-specific tubule GAL4 driver, UO 
(Terhzaz et al, in prep.). Tubules were then excised from 7-day old adult flies of both the 
UAS-dN1-8 parental line (as a control) and the UO/UAS-dN1-8 progeny. Excised tubules 
were then incubated for 1 h in either sterile Schneider’s medium (control) or sterile 
Schneider’s medium containing 1 µM ODQ. Diptericin expression was then monitored in 
each sample by Q-PCR. 
 
As Figure 6.2 shows, in support of data shown in McGettigan et al (2005), when dNOS 
expression is targeted to the tubule, diptericin expression is significantly enhanced 
compared to parental controls. However, in contrast, when dNOS overexpressing tubules 
are incubated with the sGC inhibitor ODQ, this effect is reversed. Indeed, it can be seen 
that diptericin expression is not only significantly lower in ODQ-treated UO/UAS-dN1-8 
tubules compared to non-stimulated UO/UAS-dN1-8 tubules, but is also lower compared 
to diptericin expression in the control tubules of parental lines. These data would 
therefore suggest that not only does sGC play a critical role in facilitating NO-mediated 
stimulation of diptericin expression, but also that NO/sGC/cGMP signalling may play an 
important role in maintaining basal levels of diptericin expression in the absence of 
immune challenge.   
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 Overall, the data described here have demonstrated that the stimulatory effects of NO on 
diptericin expression in the tubule are mediated via regulation of Relish activation. 
Importantly, it has been shown here that this effect occurs as a result of downstream 
activation of the cGMP signalling pathway, via soluble guanylate cyclase. 
 
 
Figure 6.2 - NO-mediated stimulation of diptericin expression in the tubules is a result of sGC 
activation. Expression of diptericin in response to the soluble guanylate cyclase inhibitor ODQ was 
assessed by Q-PCR in the excised tubules of dNOS overexpressing flies. Resulting data were normalised 
against expression of the standard, rp49, and expressed as a fold change of parental control expression 
where control =1 (N = 4, + SEM). Significance of data was determined using One-way ANOVA (See table). 
Additionally, in order to compare significance between individual genotypes, post hoc analysis was carried 
out using Dunnett’s multiple comparison tests (See table). Data shows that diptericin expression is 
significantly increase in the tubules of flies overexpressing dNOS compared to parental controls. However, 
when the tubules of these flies are incubated with 1 µM ODQ, diptericin expression is significantly lower, 
thus suggesting that NO-mediated effects on diptericin expression in the tubule are facilitated by sGC. 
 
6.2.3 Ectopic expression of the rat rGC, GC-A, results in negative regulation of 
diptericin expression in the tubule 
In addition to sGC, there are a number of rGCs expressed in the tubule. These include 
Gyc76C (Liu et al. 1995; McNeil et al. 1995; Ayoob et al. 2004), and the as of yet 
uncharacterised rGCs CG4224, CG9873 and CG5719. Of these, Gyc76C is particularly 
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enriched in the tubule compared to other tissues, thus suggesting an important role in 
tubule function (Wang et al. 2004; www.flyatlas.org). In this study, it has been suggested 
that the differential effects of cGMP/cGKs on Imd pathway regulation in the tubule are a 
result of activation by different sources of cGMP, generated via distinct guanylate 
cyclases. As data shown earlier in this chapter has demonstated, cGMP/DG1-mediated 
positive regulation of the Imd pathway is facilitated by activation of sGC. Therefore, it 
can be hypothesised that cGMP/DG2-mediated inhibition of the Imd pathway may be 
facilitated via activation of an rGC. Indeed, given the localisation of DG2P1 and DG2P2 
(MacPherson et al. 2004b), it can be suggested that they may be activated via a source of 
cGMP generated near the plasma membrane, i.e. in close proximity to a receptor 
guanylate cyclase.  
 
Unfortunately, due to the lack of information regarding natural ligands for Drosophila 
rGCs, experimental manipulation of these enzymes is difficult to carry out. However, a 
recent study has demonstrated the successful activation of the cGMP pathway in the 
tubule via ectopic expression of a characterised mammalian rGC, GC-A (Kerr et al. 
2004). GC-A is a well characterised rGC involved in natriuresis/diuresis in the kidneys of 
mammals and is activated by atrial natriuretic peptide (ANP) (Drewett and Garbers 1994). 
GC-A is also a homologue of Gyc76c, the Drosophila rGC found most abundantly in 
tubules (Wang et al. 2004). Therefore, in this study, in the absence of a suitable activating 
ligand for indigenous tubule rGCs, changes in diptericin expression were monitored in 
flies where GC-A is expressed ectopically in the tubule principal cells via the 
UAS/GAL4 system. To do this, flies containing a UAS-GCA transgene were crossed to 
the principle cell-specific GAL4 driver c42. Tubules were then excised from 7-day old 
adult flies of both the UAS-GCA parental line (as a control) and the c42/UAS-GCA 
progeny. Excised tubules were then incubated for 3 hr in either sterile Schneider’s 
medium (control) or sterile Schneider’s medium containing 10-7 M ANP. Diptericin 
expression was then monitored in each sample by Q-PCR. It should be noted that there is 
no natural receptor for ANP in Drosophila, therefore ensuring that any effect seen is due 
to specific activation of GC-A (Kerr et al. 2004).  
 
It can be seen from the data shown in Figure 6.3 that, as expected, incubation of UAS-
GCA parental flies with ANP has no effect on diptericin expression in the tubule. 
Similarly, when GC-A is expressed in the tubule in the absence of ligand, there is no 
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significant effect on diptericin expression. However, when the tubules of c42/UAS-GCA 
flies are incubated with exogenous ANP, diptericin expression is significantly inhibited. 
These data therefore indicate that, as with DG2P1 and DG2P2, activation of GC-A has a 
negative effect on Imd pathway regulation in the tubule. As such, given that GC-A is the 
mammalian homologue of Drosophila Gyc76C, it can be suggested that Gyc76C may 
function in a similar way in response to its natural ligand.  
 
Overall, it is demonstrated by the data shown here that negative regulation of the Imd 
pathway in the tubule by cGMP/DG2 is likely to be mediated via activation of an rGC. 
Unfortunately, the identity of the specific Drosophila rGC involved in this effect remains 
elusive and is a subject for future work.  
 
 
Figure 6.3 - Targeted overexpression of the rat rGC, GC-A, to the principal cells of the tubule results 
in reduced diptericin expression in response to ANP. Expression of diptericin was assessed by Q-PCR in 
the excised tubules of flies overexpressing GC-A in response to its natural ligand, ANP.  Resulting data 
were normalised against expression of the standard, rp49, and expressed as a fold change of parental 
control expression where control =1 (N = 4, + SEM). Significance of data was determined by Two-way 
ANOVA and post hoc analysis was carried out using Bonferroni tests, whereby significant data is indicated 
by * (P<0.05) or ns (not significant) where appropriate. Analysis by two-way ANOVA reveals a significant 
interaction between genotype and stimulus. Addittionally, the effect of stimulus and genotype alone are 
also considered significant (see table). Post hoc analysis shows no significant difference in diptericin 
expression in the tubules of UAS-GCA parental flies in response to ANP. However, diptericin expression is 
extremely reduced in the tubules of GC-A overexpressing flies when incubated with ANP. Data therefore 
suggests that cGMP-mediated inhibition of diptericin expression is facilitated by an rGC.   
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6.3 A regulatory role for the dual-specificity PDE, DmPDE11, in Imd 
pathway immune function in the tubule 
As mentioned previously, PDEs comprise a superfamily of metallophosphohydrolases 
that act as negative regulators of cGMP and cAMP signalling and are therefore pivotal in 
maintaining the role of cyclic nucleotides in cellular function (Omori and Kotera 2007). 
To date, studies investigating Drosophila PDEs have mainly focused on the cAMP-
specific mammalian PDE4 homologue, dunce, which has been demonstrated to play a 
critical role in learning and memory (Davis and Dauwalder 1991). However, a recent 
study using the Malpighian tubule as a model system has identified a further five novel 
Drosophila PDEs (Day et al. 2005). Of these, the cGMP-specific DmPDE6, the dual-
specificity DmPDE11 and the as yet to be characterised DmPDE8 are highly enriched in 
the tubules compared to other tissues, suggesting an important role for each of these 
enzymes in tubule function (www.flyatlas.org). Surprisingly, despite its dual-specificity, 
DmPDE11 has been demonstrated to exhibit the highest specificity for cGMP of all other 
Drosophila PDEs (Km: 6 + 2µM) (Day et al. 2005).   
 
In this study, it has been suggested that the contrasting effects of cGMP/cGKs on Imd 
pathway regulation are a result of generation of specific pools of cGMP. Over the years, 
it has become clear that PDEs are pivotal to the regulation of cyclic nucleotide 
compartmentalisation within each cell, i.e. by controlling the duration, amplitude and 
localisation of each cyclic nucleotide signal (Bender and Beavo 2006; Omori and Kotera 
2007). Therefore, it can be hypothesised that one or more Drosophila PDEs may have an 
important role to play in the regulation of cGMP/cGK-mediated Imd pathway modulation 
in the tubule. In order to investigate this, studies were initiated to assess both diptericin 
expression in the tubule and survival in response to E.coli in PDE transgenic flies. Due to 
its high specificity for cGMP, and its enrichment in the tubule, focus was placed on the 
dual-specificity PDE, DmPDE11. Briefly, expression of PDE11 was knocked-down in 
the tubule by crossing UAS-pde11RNAi transgenic flies (generated by Dr Jon Day, 
University of Glasgow) to the principle cell-specific GAL4 driver c42 (validation of 
pde11 knockdown is shown in Figure 6.4A). Tubules of 7-day old adult flies were then 
dissected and incubated for 3 hr in sterile Schneider’s medium alone (control) or 
Schneider’s medium containing 100 µM cGMP. Diptericin expression was then 
monitored in each sample by Q-PCR. Additionally, in order to determine the survival of 
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the flies in response to immune challenge, adult flies were infected using a thin needle 
coated in a concentrated suspension of E.coli, as described previously. As before, in order 
to control for possible death as a result of injury, a number of flies from each line tested 
were mock-infected using a sterile needle. Survival of each fly line was then monitored 
over a number of hours and results plotted using a Kaplein-Meier survival curve 
(GraphPad Prism 4.0). 
 
As figure 6.4B shows, when pde11 expression is knocked down in the tubule, diptericin 
expression is significantly reduced compared to parental controls. Indeed, it can be seen 
that expression of diptericin in these flies is of a similar level to that of the tubules of 
UAS-pde11RNAi parental flies following stimulation with 100 µM cGMP. This would 
therefore suggest that knock-down of pde11 expression in the tubules results in an in vivo 
increase of intracellular cGMP levels similar to that of the levels achieved in the tubules 
of wild-type or parental flies after ex vivo incubation with 100 µM cGMP. Interestingly, 
when the tubules of c42/UAS-pde11RNAi flies are incubated with 100 µM cGMP, a 
further decrease in diptericin expression is not observed. However, it can be suggested 
that the levels of intracellular cGMP reached within the tubule due to the knock-down of 
pde11 expression are at the maximum level required to affect Imd pathway regulation. In 
support of this data, it can be seen from Figure 6.4C that knockdown of pde11 expression 
in the tubule confers decreased survival of flies in response to E.coli. These data therefore 
demonstrate that regulation of cGMP signalling in the tubule by PDE11 is critical to 
survival of the whole fly when under immune attack.    
 
Overall, the data described in Figure 6.4 demonstrates that cGMP-mediated modulation 
of the Imd pathway is finely regulated. Furthermore, it is shown here that the cGMP 
signal responsible for inhibition of diptericin expression in the tubule is regulated by 
PDE11. 
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Figure 6.4 - Targeted knock-down of pde11 in the principal cells of the tubule results in reduced 
diptericin expression and decreased survival in response to E.coli. For Q-PCR experiments, expression 
was assessed in the excised tubules of 7-day old adult flies and analysed as described previously (N = 4,     
+ SEM). Where appropriate, significance of data was determined by Two-way ANOVA (see table) and post 
hoc analysis was carried out using Bonferroni tests, whereby significant data are indicated by * (P<0.05) or 
ns (not significant) where appropriate. [A] Q-PCR validation of the knock-down of pde11 expression in the 
tubules of c42/UAS-pde11RNAi flies. [B] Diptericin expression in the tubule in response to cGMP after 
pde11-knockdown. Analysis by two-way ANOVA reveals that interaction between stimulus and genotype 
is not significant. Similarly, the effect of stimulus or genotype alone is not considered significant. However, 
post hoc analysis shows that diptericin expression is significantly lower in the tubules of c42/UAS-
pde11RNAi flies compared to parents. Diptericin expression is not further reduced in response to cGMP, 
however, the maximum effective concentration of cGMP may have been reached by the knock-down alone. 
[C] Survival in response to E.coli. Data shows that survival of c42/UAS-pde11RNAi flies is significantly 
reduced compared to wild-type and parental lines when infected with E.coli.   
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6.4 Discussion 
In previous chapters, an important role for the cGMP signalling pathway in the regulation 
of Imd pathway-related immune response has been described. However, thus far in this 
study, investigation into cGMP pathway-mediated regulation of the Imd pathway has 
focused on the role of the downstream cGMP effector proteins, DG1 and DG2. Therefore, 
in this chapter, the potential role of other cGMP pathway components in  
Imd pathway regulation was investigated. For the first time, it is shown here that NO-
mediated stimulation of the Imd pathway occurs through activation of the cGMP 
signalling pathway, via sGC. Similarly it has been demonstrated in this chapter that 
cGMP-mediated inhibition of the Imd pathway in the tubule is facilitated by the 
activation of an rGC. Finally, an important regulatory role for the dual-specificity PDE, 
PDE11, has been described; where it was shown that knock-down of pde11 expression in 
the tubule results in significantly decreased levels of diptericin expression.  
 
It has been hypothesised throughout this study that the differential regulatory effects of 
cGMP/cGKs on the Imd pathway in the tubule are mediated through the generation of 
different sources of cGMP. As such, it has also been hypothesised that these different 
sources of cGMP are generated as a consequence of differential activation of guanylate 
cyclases; where, following activation by NO, sGC is thought to generate a cytosolic 
cGMP signal and rGCs are thought to mediate the generation of cGMP in close proximity 
to the plasma-membrane. In this study, these hypothesises have been confirmed. Data has 
shown that positive regulation of the Imd pathway in the tubule is mediated by 
NO/cGMP/DG1 via the activation of sGC. Similarly, through the ectopic expression of a 
mammalian rGC homologous to Drosophila Gyc76C, it has been demonstrated that 
cGMP/DG2 inhibition of the Imd pathway is mediated via activation of an rGC. 
Unfortunately, due to the lack of information regarding their activating ligands, the 
Drosophila rGC(s) that mediate this effect remain elusive. It can be hypothesised 
however that, as Gyc76C is the Drosophila homologue of mammalian GC-A and is so 
highly expressed in the tubule, it may be a good candidate for future investigation into the 
identity of the activating rGC in cGMP/DG2-mediated Imd pathway regulation.    
 
Importantly, it has been shown here that the action of the cGMP signalling pathway on 
Imd pathway regulation in the tubule is finely regulated by PDEs. Data has shown that 
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when pde11 expression is knocked-down in the tubule, inhibition of diptericin expression 
is observed. These data therefore indicate that PDE11 acts to negatively regulate 
cGMP/DG2 inhibition of the Imd pathway and therefore describes a role for this PDE for 
the first time. Unfortunately, the regulation of PDE11 itself is currently unknown. 
Previous studies have shown that PDEs can be regulated by diverse biochemical reactions 
including phosphorylation/dephosphorylation, allosteric binding of cGMP or cAMP, 
binding of Ca2+/calmoldulin and various protein-protein interactions (Bender and Beavo 
2006; Omori 2007). It can be hypothesised that, with regards to tubule immune response, 
PDE11 activation may be stimulated following immune challenge in order to repress the 
cGMP signal responsible for activating DG2, and thus repress inhibition of the Imd 
pathway. Unfortunately, the mechanism by which PDE11 activity is regulated in the 
tubule is beyond the scope of this study and therefore remains a subject for future work. 
 
Overall, the data described in this chapter has demonstrated that the action of the cGMP 
signalling pathway on Imd pathway modulation in the tubule is elegantly regulated via 
the activation and inhibition of distinct sources of cGMP within each cell. As such, given 
the wealth of genetic tools available for manipulation of the cGMP pathway in this tissue, 
the tubule can be considered a powerful model for future investigation into Imd pathway 
regulation.        
 
 
 
  
 
 
 
7 Chapter 7  
 
Summary and future work 
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7.1 Summary 
In recent years, due to the wealth of powerful and cost-effective genetic and genomic 
tools available, Drosophila has emerged as a potent model organism for integrative 
organismal studies. As such, our understanding of the fundamental mechanisms 
controlling the Drosophila innate immune response has progressed considerably over the 
years and, as a result, Drosophila melanogaster exhibits one of the best characterised 
host defence systems of all metazoans. Importantly, the Drosophila innate immune 
response has been demonstrated to share a number of similarities with the defence 
systems of other Diptera species, such as Anopheles, and also essential aspects of 
vertebrate innate immunity (Dimopoulos 2003; Rutschmann and Hoebe 2008). Therefore, 
Drosophila has emerged as a critical model organism for deciphering general innate 
immune mechanisms in both invertebrates and vertebrates. 
 
Over the years, NO has been identified as an important regulator of the Imd pathway in 
Drosophila, however the mechanism by which this diffusible messenger acts has not yet 
been determined. Given that the main intracellular receptor for NO is sGC, it was 
hypothesised that NO may be mediating its effects via the cGMP signalling pathway. 
Therefore in this study, the role of cGMP signalling in regulation of the Imd pathway was 
investigated. This was carried out using the Drosophila Malpighian tubule as a model 
system. The suitability of the tubule as a model tissue for this study was two-fold: Firstly, 
previous studies have identified the tubule as an important immune-sensing tissue (Tzou 
et al. 2000; Kaneko et al. 2006), in which NO plays an important regulatory role 
(McGettigan et al. 2005). Secondly, the NO/cGMP signalling pathway has been 
demonstrated as critical to tubule function (Davies 2006; Davies 2007). In this chapter, 
the main findings and implications of this study are summarised. Future work is also 
suggested.   
 
In this thesis, a novel role for the cGMP signalling pathway in the regulation of the Imd 
pathway in the Malpighian tubule of the adult fly has been described. Data has shown 
that cGMP is able to modulate the expression of Imd-pathway associated AMPs in the 
tubule in a dose-dependent manner; whereby low nanomolar concentrations of cGMP 
have been shown to stimulate diptericin expression and higher micromolar concentrations 
of cGMP have been shown to inhibit it.  
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These differential effects have been shown to be mediated via the activation of the 
cognate downstream effector molecules of cGMP, DG1 and DG2. Data has shown that 
diptericin expression is positively regulated by DG1 and negatively regulated by DG2. 
Importantly, these effects have been demonstrated to occur as a result of modulation of 
Relish activation, thus revealing for the first time, a novel regulatory role for Drosophila 
cGKs in Imd pathway regulation in the tubule. The exact mechanism by which DG1 and 
DG2 are mediating their effects on the Imd pathway was not determined in this study. 
Therefore, it is not known whether these kinases are acting on the Imd pathway directly, 
or indirectly by phosphorylation of an, as of yet, unidentified substrate(s). However, it 
has been hypothesised that, as previous studies have identified NFκB as a 
phosphorylation target for mammalian PKG (He and Weber 2003), DG1 and/or DG2 
may be acting to modulate Relish activation via direct phosphorylation of Relish itself. 
 
Significantly, it has been demonstrated in this study that cGK-mediated modulation of the 
Imd pathway in the tubule is sufficient to impact on the survival of the whole organism. 
Data has shown that targeted overexpression or knockdown of cGK expression in the 
tubules significantly effects survival of the adult fly in response to septic infection with 
the Gram-negative bacteria, E.coli. These findings therefore not only confirm the 
importance of cGKs in Imd pathway regulation in the tubule, but also highlight the 
critical role of this tissue in systemic Imd pathway induction in the adult fly. 
Traditionally, the fat body has been described as the critical tissue involved in systemic 
immune response in Drosophila. However, these data indicate that the tubule may 
contribute just as significantly to systemic production of Imd-pathway associated AMPs 
in the adult fly in response to immune challenge. These findings are not entirely 
surprising given the morphology and function of this epithelial tissue. As with the fat 
body, the tubules are spread throughout the body cavity and are likely to be one of the 
first tissues in contact with any invading organisms present in the haemolymph. 
Furthermore, given the main role of the tubule as an osmoregulatory and detoxifying 
tissue, where waste metabolites and toxins are cleared from the haemolymph at very high 
rates compared to the haemolymph volume (Dow et al. 1994a), it is likely that the tubule 
would be the first tissue exposed to key components derived from the bacterial coat of 
microbial invaders, such as PGN or LPS. Certainly, previous studies have described the 
ability of acutely-dissected tubules to autonomously bind and internalise exogenous LPS 
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(McGettigan et al. 2005). In addition, it has been demonstrated that constitutive secretion 
of AMPs by the tubule is sufficient to confer a significant killing effect on E.coli, with 
less than 50 % of bacteria remaining after the treatment of bacterial culture with the 
bathing media in which tubules have been incubated (McGettigan et al. 2005). Taken 
together, the data shown here and that described in previous studies therefore suggest that 
the role of the tubule may just as critical to the systemic production of AMPs in response 
to septic infection as that of the fat body. 
 
At present, it cannot be concluded from this study whether the tubule acts as a completely 
independent immune tissue in response to septic infection, or if the tubule acts as a ‘first-
response’ signalling tissue to alert other tissues, such as the fat body, to activate or 
suppress immune mechanisms appropriately. Certainly, a role for NO has already been 
suggested in mediating signalling between epithelial tissues and the fat body, possibly via 
hemocytes (Basset et al. 2000; Foley and O'Farrell 2003; Silverman 2003). Interestingly, 
it is shown here that regulation of the Imd pathway by cGMP does not appear to extend 
to the fat body, thus suggesting that the latter of these hypotheses may be correct. Overall, 
regardless of whether the tubule acts completely independently of other tissues, it has 
been demonstrated in this study that this tissue contributes significantly to the survival of 
the adult fly in response to septic infection with E.coli, and that cGK-mediated regulation 
of the Imd pathway in the tubule is critical to this mechanism.  
 
Importantly, a role for the tubule in response to natural infection has also been described 
in this study. Data has shown that not only does the tubule play a critical role in inducing 
diptericin expression following natural infection with E.coli, but that this expression is 
regulated, as with septic infection, by the differential action of DG1 and DG2. 
Importantly, it has been demonstrated in this study that the diptericin produced in the 
tubule following natural infection is secreted into the gut and subsequently contributes to 
bacterial clearance in this tissue. These findings therefore describe a completely novel 
role for the both the tubule and cGKs in the elimination of bacterial invaders after natural 
infection with Gram-negative bacteria.  
 
Finally, throughout this study, it has been suggested that the contrasting effects of the 
otherwise cognate cGKs, DG1 and DG2, are mediated via the generation of distinct 
sources of cGMP within the tubule. Certainly, the mainly cytosolic localisation of DG1 
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(MacPherson et al. 2004b) would suggest that it is activated via a cytosolic source of 
cGMP, such as that generated by the activation of sGC. Similarly, it was suggested that 
activation of DG2, localised near the plasma membrane of the tubule (MacPherson et al. 
2004b), is mediated via a source of cGMP generated by an rGC. In this study, these 
hypotheses were confirmed. Data has shown that positive regulation of the Imd pathway 
by cGMP in the tubule is mediated by the activation of sGC by NO. Similarly, through 
the ectopic expression of the mammalian rGC, GC-A, negative regulation of the Imd 
pathway in the tubule by cGMP has been demonstrated to be mediated via the activation 
of rGC. Unfortunately, due to the lack of information on the activating ligands of rGCs in 
Drosophila, the identity of the Drosophila rGC mediating this effect is not confirmed. 
However, given that the Drosophila rGC, Gyc76C, is abundantly expressed in the tubules 
and is also a homologue of GC-A, it has been hypothesised that Gyc76C may be a good 
candidate for further investigation.  
 
Interestingly, this study has also identified a regulatory element of the cGMP pathway 
itself with regards to Imd pathway modulation in the tubule. Data has shown that cGMP-
mediated inhibition of the Imd pathway is regulated by the hydrolysis of cGMP by 
PDE11. PDE11 is a dual-specificity PDE that is abundantly expressed in the tubules and 
has shown a high affinity for cGMP compared to other tubule PDEs (Day et al. 2005). 
PDE11 has not previously been characterised, therefore a functional role for this enzyme 
has been described here for the first time.  
 
Given the data obtained from this study, a model for the mechanism by which the cGMP 
signalling pathway is mediating its effects on the Imd pathway in the tubule is illustrated 
in Figure 7.1. In this model, it is proposed that the differential modulation of the Imd 
pathway by the cGMP signalling pathway in the tubule is finely regulated via the 
activation and inhibition of distinct sources of cGMP within each cell; whereby activation 
of sGC by NO results in a cytosolic source of cGMP and activation of rGC by an 
unknown ligand results in the generation of cGMP near the plasma membrane.  Each of 
these cGMP sources are then demonstrated to act to mediate the activation of either DG1 
or DG2 respectively, which then go on to mediate contrasting effects on the Imd pathway, 
and subsequently modulate AMP expression in the tubule. The exact mechanism of this 
action has not yet been determined, however it is known from data in this study that both 
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DG1 and DG2 act to modulate the activation of Relish, the NFκB transcription factor 
responsible for mediating the transcription of specific AMPs.  
 
  
 
Figure 7.1 – Model for the mechanism of cGMP pathway-mediated regulation of the Imd pathway in 
the Drosophila Malpighian tubule. It is suggested that the differential effects of cGMP/cGKs on the Imd 
pathway are mediated by different sources of cGMP. Stimulation of the Imd pathway is thought to be 
regulated by the generation of cGMP in the cytosol, via activation of sGC, which leads to activation of 
DG1 and subsequent activation of Relish. Inhibition of the Imd pathway is suggested to be regulated by the 
generation of cGMP near the plasma membrane, via activation of an rGC, which leads to activation of DG2 
and subsequent inhibition of Relish activation. Dashed lines indicate that the exact mechanism of action for 
this step has not yet been determined.  
 
 
It should be noted that, to date, the upstream activator of DNOS, the enzyme responsible 
for the generation of NO, has not yet been identified in the tubule with regards to immune 
activation, although it is very probable that calcium plays an important role in the 
regulation of this response. Recent work has shown that calcineurin, a calcium-dependent 
phosphatase, mediates NO-induced AMP production in the fat body, possibly via the 
regulation of DNOS activation (Dijkers and O'Farrell 2007). Similarly, a number of 
studies have demonstrated an important role for the neuropeptide capa in the activation of 
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NO/cGMP signalling in tubule (Davies et al. 1995; Davies et al. 1997; Rosay et al. 1997; 
Kean et al. 2002). There are three capa peptides expressed in Drosophila (capa 1-3) 
(Predel and Wegener 2006). Of these, capa-1 and capa-2 have been shown to function via 
the capa receptor (Iversen et al. 2002) to increase [Ca2+]i  in the principle cells of the 
tubule through activation of either L-type voltage-dependent Ca2+ channels in the plasma 
membrane (Rosay et al. 1997; MacPherson et al. 2001) or through the intracellular 
production of inositol triphosphate (IP3) (Pollock et al. 2003). This capa-induced raise in 
[Ca2+]i has been shown to trigger the activation of DNOS and subsequently NO/cGMP 
signalling (Davies et al. 1995; Davies et al. 1997). Studies have shown that capa is 
instrumental to NO/cGMP-mediated fluid secretion (Davies et al. 1995; Davies et al. 
1997; Kean et al. 2002) which is critical to tubule function. Therefore, it can be suggested 
that capa is a likely candidate as the upstream activator of DNOS in NO/cGMP-mediated 
Imd pathway regulation in the tubule, however this remains a subject for future work.       
 
The implications from the findings in this thesis are extremely significant. As mentioned 
earlier, the Drosophila innate immune response has been demonstrated to be very similar 
to that of other Dipteran insects, as well as vertebrates such as humans (Dimopoulos 2003; 
Rutschmann and Hoebe 2008). With regards to other Diptera, information on the 
regulation of immunity in many of these insects can potentially have a huge impact on 
research into the development of suitable insecticides for those insects which are known 
agricultural pests or, more importantly, for those insects which act as vectors for 
infectious diseases such as malaria, yellow fever or Dengue fever, e.g. Anopheles or 
Aedes aegypti. Certainly, a number of studies are now using Drosophila as a comparative 
model organism in order to understand the mechanisms by which these disease vectors 
combat infection (Christophides et al. 2002; Dimopoulos 2003; Brandt et al. 2008). 
 
With regards to the impact of these findings on what is currently known about human 
innate immunity, the data described here is also extremely significant. Despite the 
importance and sophistication of the acquired immune system in vertebrates, the innate 
immune system is still considered a critical component of host survival against many 
infectious agents. Indeed, studies have shown that many autoimmune and inflammatory 
diseases in humans, such as rheumatoid arthritis, multiple sclerosis, celiac disease, 
diabetes mellitus and lupus, are aggravated by alterations in the innate immune system 
(Lang et al. 2007). For example, studies have shown that diabetes mellitus is a major 
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cause of end-stage kidney disease in humans (Atkins 2005). Furthermore, it has been 
reported that activated innate immunity and inflammation, in particular activation of the 
TNFα signalling pathway, contributes significantly to the pathogenesis of this disease in 
the kidney (Navarro and Mora 2006). Given that the TNFα signalling pathway in 
mammals is highly homologous to the Drosophila Imd pathway, and that the Malpighian 
tubule represents the Drosophila equivalent of the mammalian kidney, the findings 
obtained in this thesis could therefore potentially prove valuable to research in this field, 
thus highlighting the suitability of Drosophila as a model organism for human disease. 
 
Overall, not only has this study confirmed the role of the tubule as an important immune-
sensing tissue in Drosophila melanogaster, but has also demonstrated, for the first time, 
completely novel roles for components of the cGMP signalling pathway, particularly 
DG1 and DG2, in the differential regulation of the Imd pathway in the tubule. The 
identification of cGMP signalling as an important regulator of immune response is 
therefore a significant advance in our understanding of the complexities of not only 
immune regulation in Drosophila, but also of the complexities of cGMP signalling, its 
compartmentalisation within each cell and subsequent regulation.         
 
7.2 Future Work 
Further epistatic analysis of cGK-mediated effects on the Imd pathway 
As mentioned previously in the text, several transgenic fly lines were generated in order 
to determine where in the Imd pathway DG1 and DG2 were mediating their effects. 
Unfortunately, due to time limitations, not all of these lines were used. Therefore, future 
work would entail using these lines for further epistatic analysis of cGK-mediated 
regulation of the Imd pathway. For this approach, these lines would be crossed to UAS-
cGK transgenic lines as appropriate and diptericin expression assessed by Q-PCR as 
before. 
 
Phosphorylation targets for DG1 and DG2 
Following the identification of potential targets for DG1 and DG2 through epistatic 
analysis, further work would be required to determine the mechanism by which these 
targets are modulated, i.e. whether they are directly phosphorylated by DG1 or DG2, or 
whether they are modulated by these kinases indirectly through phosphorylation of an 
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unknown substrate. For this approach, both immunoprecipitation (IP) and 
phosphorylation assays would be used. Initially, these experiments would be carried out 
using Drosophila S2 cells as a model system, whereby tagged components of the Imd 
pathway would be cloned and co-expressed with the appropriate cGK plasmid. 
Interaction between each cGK and its potential substrate could then be determined by IP 
of each cGK. Each IP fraction could then be analysed for potential cGK-interacting Imd 
pathway components by Western blot. Similarly, for phosphorylation assays, 
phosphorylation of potential targets of DG1 and DG2 would be investigated by 
incubating cell lysate, containing the co-expressed proteins, with the radioactive 
phosphate, γ-32P. Imd pathway components of interest could then be isolated by IP, and 
any levels of phosphorylation detected by autoradiography. These approaches could then 
be carried out in the adult fly following the generation of the appropriate antibodies.   
 
Identification of the rGC involved in Imd pathway inhibition in the tubule    
As mentioned in the text, at present there is no information regarding the natural ligands 
of rGCs in Drosophila. Therefore, examination of the rGC involved in Imd pathway 
inhibition in the tubule could not be carried out pharmacologically. Therefore, for future 
work, a transgenic approach would have to be used. For this approach, initial studies 
would focus on the tubule-enriched rGC, Gyc76C, whereby expression of this enzyme 
would be modulated in the tubule using the GAL4/UAS system. Transgenic flies would 
then be monitored for survival following infection with various bacteria. Similarly, 
tubules would be excised from these transgenic flies following infection and levels of 
diptericin expression assessed by Q-PCR as described previously.  
 
The role of other PDEs in Imd pathway regulation in the tubule 
In this study, a role for PDE11 in the regulation of cGMP-mediated Imd pathway 
inhibition has been described. Therefore, further work could be carried out in order to 
investigate the potential role of other tubule PDEs in the regulation of cGMP-mediated 
Imd pathway modulation, possibly as potential regulators of the cGMP signal responsible 
for stimulation of the Imd pathway. For this approach, initial studies would focus on 
another cGMP-dependent tubule enriched PDE, PDE6. As with PDE11, investigation 
into the role of PDE6 in Imd pathway regulation would involve assessment of both 
survival of the whole organism in response to infection, and diptericin expression by Q-
PCR in the tubules of PDE6 transgenic flies. 
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Initiation of tissue-tissue signalling by the tubule 
As mentioned previously in this text, it is not currently known from this study whether 
the impact of AMP modulation in the tubule on fly survival is solely a result of altered 
AMP expression only in the tubule, or if, following regulation of AMP expression, the 
tubule acts as a signalling tissue to alert other tissues, such as the fat body, to induce or 
suppress their immune response mechanisms in the same way, thus having a greater 
impact on fly survival. Further work would therefore focus on assessing the levels of 
AMP expression following infection in other Drosophila tissues, such as the fat body, in 
flies where AMP expression has been modulated in the tubules by cGKs. 
 
Visualisation of the cGMP signal in the tubule following infection 
With the development of fluorescence resonance energy transfer (FRET) techniques, it 
has become possible to visualise real-time activation of a number processes within each 
cell, including the activation of the second messengers cAMP and cGMP (Lissandron et 
al. 2007; Russwurm et al. 2007). Therefore, a suggestion for further work would be to 
investigate the spatio-temporal dynamics of cGMP in the tubule in response to immune 
challenge by visual imaging of a FRET-based cGMP reporter. The data obtained from 
these experiments could then be used to further validate the model proposed in this study, 
where it is suggested that the differential effects of cGMP signalling on the Imd pathway 
are due to compartmentalisation of cGMP.     
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Appendices 
Appendix 1: Media used in this study 
 
Drosophila Media 
Standard growth media per litre of water 
                                                            10 g agar 
     15 g sucrose 
     30 g glucose 
     35 g dried yeast 
     15 g maize meal 
     10 g wheat germ 
     30 g treacle 
     10 g soya flour 
 
 
 
 Escherichia coli growth media 
 
L-broth per litre of water 
     10 g Bacto-tryptone 
     5 g dried yeast  
     10 g NaCl 
 
L-agar per litre of water 
     10 g Bacto-tryptone 
     5 g dried yeast  
     10 g NaCl 
     15 g Bacto-agar 
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Appendix 2: Primers used in this study 
Table 7.1 – Primer sequences used in this study 
Primer Name Sequence (5’ – 3’) Application 
Dipt (Forward) 5’ – TTG CCG TCG CCT TAC TTT 
GCT G – 3’ 
RT-PCR, Q-PCR 
Dipt (Reverse) 5’ – TCC ATT CAG TCC AAT CTC 
GTG G – 3’ 
RT-PCR, Q-PCR 
AttC (Forward) 5’ – ATC GTC AGT CAA CAG TCA 
GCC – 3’ 
RT-PCR, Q-PCR 
AttC (Reverse) 5’ – GCC TTG CTT AGG TCC AAT CG 
– 3’ 
RT-PCR, Q-PCR 
AttD (Forward) 5’ – CAG GCT TCA GGA AAC CCA 
AAG – 3’ 
RT-PCR, Q-PCR 
AttD (Reverse) 5’ – GCA TTC AGA GCG GCG TTA 
TTG – 3’ 
RT-PCR, Q-PCR 
CecA1 (Forward) 5’ – AAC ATC TTC GTT TTC GTC 
GCT C – 3’  
RT-PCR, Q-PCR 
CecA1 (Reverse) 5’ – ATT GTG GCA TCC CGA GTG TG 
– 3’ 
RT-PCR, Q-PCR 
CecA2 (Forward) 5’ – CGT CGC TCT CAT TCT GGC – 3’ RT-PCR, Q-PCR 
CecA2 (Reverse) 5’ – AAC CTC GAG CAG TGG CTG – 
3’ 
RT-PCR, Q-PCR 
CecC (Forward) 5’ – CCA CAG CAG CTA AAC AGC – 
3’ 
RT-PCR, Q-PCR 
CecC (Reverse) 5’ – CTC ATC CTC TGG CGG TGG – 
3’ 
RT-PCR, Q-PCR 
rp49 (Forward) 5’ – TGA CCA TCC GCC CAG CAT AC 
– 3’ 
RT-PCR, Q-PCR 
rp49 (Reverse) 5’ – TTC TTG GAG GAG ACG CCG TG 
– 3’ 
RT-PCR, Q-PCR 
DiptprKpn1 
(Forward) 
5’ – GCA CGG TAC CCT GCA GTT 
GAA AAA CAT ACA AA – 3’ 
Cloning of  the diptericin 
promoter into pGL3 vector 
DiptprHindIII 
(Reverse) 
5’ – GCA CAA GCT TTG CTG ACT 
GAT ACC TTT GCT GC – 3’ 
Cloning of  the diptericin 
promoter into pGL3 vector 
AttDprKpnI 
(Forward) 
5’ – GCA CGG TAC CCA GGT GAC 
AAC AAT CAG TAC G – 3’ 
Cloning of  the attacinD 
promoter into pGL3 vector 
AttDprHindIII 
(Reverse) 
5’ – GCA CAA GCT TGA CTG CAT 
ATT TCC GAC GGT CG – 3’ 
Cloning of  the attacinD 
promoter into pGL3 vector 
CecA1prKpnI 
(Forward) 
5’ – GCA CGG TAC CGT ATT TTG 
GCC ATT TTC GGG G – 3’ 
Cloning of  the cecropinA1 
promoter into pGL3 vector 
CecA1prBglII 
(Reverse) 
5’ – GCA CAG ATC TGA CTG CGA 
TAC AAA AGG CGA G – 3’ 
Cloning of  the cecropinA1 
promoter into pGL3 vector 
PDE11 (Forward) 5’ – CAA CAT ACC AGA TGC TTA 
CCA GGA C – 3’ 
RT-PCR, Q-PCR 
PDE11 (Reverse) 5’ – TGT GGG TGA GAA TGC GGA 
AG – 3’ 
RT-PCR, Q-PCR 
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